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Abstract
The antitermination protein N from X and related E. coli bacteriophage interacts with
the nut RNA site and host factors to transform RNA polymerase (RNAP) into a
termination resistant transcription complex. The X, P22 and $21 phage N proteins share
a conserved amino-terminal, arginine-rich region, which confers phage-specific binding
to boxB hairpins within the phage nut site RNA. To facilitate nuclear magnetic
resonance (NMR) spectroscopy studies of the $21 N-nut RNA complex, we sought a
peptide model for the binding of N#21 protein to nut RNA. In order to test the specificity
of this model, and minimize the size of the complex, we developed a polyacrylamide
affinity co-electrophoresis (PACE) assay. This assay is well suited for measuring
affinities of small complexes, complexes in rapid equilibrium, and weak affinity
protein-RNA interactions. NMR methods were used to determine the solution structure
of a 22-amino acid peptide from the amino-terminal domain of N#21 in complex with the
24-nucleotide boxB. The boxB RNA hairpin adopts a stem-loop structure with a nine
base pair A-form helical stem, and a hexanucleotide loop (5'-CUAACC-3'), with the last
four bases continuously stacking on the 3'-half of the hairpin stem. The second
nucleotide in the loop (U11) is orientated into the center of the loop, packing against the
stacked bases. A core 13-amino acid region of N+21 peptide binds as an a-helix and
interact predominately with the major groove side of the 5'-half of the ascending upper
stem and the loop of boxB. There are a number electrostatic and hydrogen bond
interactions with the phosphodiester backbone. There appear to be no significant base-
specific interactions. The peptide-RNA interface is defined by surface complementarity
of polar and non-polar interactions. Comparison of the +21 complex to the X and P22
structures yields important information about RNA-protein interaction and
discrimination. All three peptides bind the RNA stems using polar and non-polar
contacts that are almost superimposable. Peptide-loop interactions diverge from this
structural similarity. The pentanucleotide loops of X and P22 adopt GNRA-type
tetraloop folds with exclusion of one of the five nucleotides. All three peptides show
loop-specific interactions. While not a tetraloop, the +21 boxB loop nevertheless adopts
a structure very similar to the X loop in shape and exposed surface groups. This
structural mimicry may be important for the interaction of the N-boxB complex with
host factors in the antitermination complex, particularly NusA.
Thesis Advisor: James R. Williamson
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Chapter 1. Introduction
1.1 RNA-Protein Complexes
1.1.1 Importance of RNA in biology
RNA-protein interactions play important roles in a variety of biological
processes- from small RNA-protein interactions that promote transcription termination,
antitermination and pausing; to large multi-protein and RNA complexes responsible for
protein synthesis. The Central Dogma of molecular biology holds that 'DNA goes to
messenger RNA (mRNA) goes to protein'. For the biologist interested in RNA,
increasingly we find that it has critical roles in all aspects of this schema. The "DNA"
part of the Central Dogma requires the active participation of RNA for its replication
and maintenance. In eukaryotic cells, telomeres of duplicating chromosomes are
maintained by telomerase, a ribonucleo-protein enzyme (Blackburn, 1991). While
mRNA may have initially been regarded as simply a passive carrier of information from
DNA to the ribosome for protein synthesis, it has become clear that mRNA itself
contains not only the coded message for the protein sequence, but often contains one or
more structural elements that can play a role in processes such as export from the
nucleus, regulation of translation, regulation of transcription, cellular localization and
stability. The bacterial ribosomal protein S15 regulates its own translation by binding to
a structured element in its own mRNA and blocking ribosome binding (Portier et al.,
1990). The mRNA of the human immunodeficiency virus (HIV) contains a Rev
Response Element (RRE) that interacts with the HIV Rev protein. Binding of Rev to the
RRE results in inhibition of splicing and accelerated nuclear export of the mRNA
(Malim et al., 1989). Protein synthesis also requires the active participation of RNA.
Early work on the ribosome demonstrated that it consisted of a number of proteins and
multiple RNAs. Investigators initially assumed the ribosomal RNA (rRNA) was a
passive component of the ribosome, providing a supporting framework for the proteins,
which were the important functional elements of the ribosome. Noller and colleagues
showed that rRNA has a principle role in the peptidyl transferase activity of the
11
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ribosome, in addition to being a scaffold for protein assembly (Noller et al., 1992).
1.1.2 RNA structural features
RNA can adopt a wide variety of secondary structures, in contrast to double-
helical DNA, as illustrated in figure 1.1.1. Sequence comparison and enzymatic analysis
of large rRNA molecules indicated that many of these motifs were not only common,
but tended to be conserved across a wide range of organisms (Fox and Woese, 1975).
Moreover, it was the non-Watson-Crick base paired nucleotides of the loops and bulges
that showed the highest degree of conservation, indicating their importance for
structure (Noller and Woese, 1981) and function (Endo and Wool, 1982). The first three
dimensional structure of a biological RNA was the yeast phenylalanine tRNA, solved
not long before these phylogenetic studies (Kim et al., 1973; Ladner et al., 1975), and
examples of helical Watson-Crick base pairing, loops, bulges and single-stranded
unpaired bases. The structure of the splicesomal protein U1A complexed to its cognate
RNA hairpin illustrates sequence specific recognition of a single-stranded loop by a
protein (Oubridge et al., 1994). Unlike B-DNA, in which the major groove is shallow
and wide, and therefore easily accessible for base sequence read-out by amino acid side
chains (Seeman et al., 1976; Jones et al., 1999; Leon and Roth, 2000; Luscombe et al.,
2000), the major groove in A-form RNA is deep and narrow and only available for
sequence specific recognition near the ends of helices (Weeks and Crothers, 1993).
1.1.3 The scope of RNA structures
The number of RNA structure has increased dramatically in the recent past.
Only 10 years ago it was a Herculean feat for the RNA NMR spectroscopist to
determine the structure of a small RNA-amino acid complex (Puglisi et al., 1992). Since
then, both advances in NMR techniques and the development of successful strategies
for crystallization of RNA and RNA-protein complexes have led to a growing bounty of
structural information to harvest (Draper, 1999). A range of recently solved RNA-
protein structures of different size and complexity are shown in figure 1.1.2. The Rev-
12
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Figure 1.1.1: Various RNA secondary structural elements. Lines represent Watson-
Crick base pairs.
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RRE complex (Battiste et al., 1996) contains an arginine rich peptide bound to its
cognate RNA. The peptide a-helix rests uncharacteristically deep in the RNA major
groove, facilitated by two non-canonical base pairs and two unpaired bases which
distort the backbone and widen the major groove for Rev binding. The U1A protein
binds its cognate RNA in a-manner wholly different from Rev. UlA binds a single-
stranded RNA loop on the edge of a complex p-sheet surface. The carboxy-terminal
domain of UlA is reorganized upon RNA binding to create a surface that recognizes
both the shape and sequence of the RNA. This p-sheet binding motif is termed the
ribonucleoprotein (RNP) domain. A related protein, the heterodimer U2B"-U2A'
bound to its cognate snRNA (Price et al., 1998) has an altered specificity compare to
UlA, yet the RNP domain binds in essentially the same way. The core particle of the
30S ribosomal central domain (Agalarov et al., 2000), also shown in figure 1.1.2, is
composed of a large RNA that contains two three-helical junctions and three proteins.
One direction that structural biologists have taken for studying protein-RNA
interactions is "bigger and bigger". Some principles of protein-RNA recognition are
beginning to emerge as the database of available complexes grows (De Guzman et al.,
1998; Jones et al., 2001), but definitive themes remain difficult to discern. Given RNA's
ability to adopt complex three dimensional structures, and proteins able to compliment
this structural diversity, a search for rules or a deeper understanding of protein-RNA
affinity and specificity must also include a detailed examination of related structures.
Careful examination of a family of related, yet different protein-RNA structures could
yield deeper insights. We take just such an approach in this thesis project. The
structures of two members of the N antitermination protein-nut RNA family have been
solved recently, X and P22 (Legault et al., 1998; Cai et al., 1998). These small arginine-
rich motif (ARM) peptides bind in a similar fashion to stem-loops of similar sequence
and structure. Our goal in solving the structure of the 421 N peptide-RNA complex,
another member of this family, is to learn how differences among peptides contribute to
specificity of RNA binding.
14
B)
Rev-RRE
C)
U1A-U1 RNA
hairpin I1
Ribosomal Proteins S6, S15 and
S18 bound to rRNA site
Figure 1.1.2: A brief survey of protein-RNA structures. For each structure, the peptide or protein (red) is shown bound
to its RNA target (blue). Only the heavy atoms are displayed. The three structures are A- Rev-RRE (Battiste et al., 1996),
B- U1A-U1 RNA (Oubridge et al., 1994), and C- T4 Ribosomal complex (Agalarov et al., 2000).
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1.2 The Antitermination System of Lambda Phage
1.2.1 Background
The Lambda family of bacteriophage uses a temporally programmed sequence of
gene expression during infection, controlled in part by termination of transcription
(reviewed in Szybalski et al., 1970; Greenblatt et al., 1980; Friedman, 1988). Shortly after
infection of Escherichia coli cells by bacteriophage K, or after induction of a K genome
already integrated into the host genome (lysogens, figure 1.2.1-A), transcription is
initiated by host RNA polymerase from the leftward promoter (pL) and rightward
promoter (pR) which both flank the cI repressor gene. Early transcription terminates at
specific sites downstream from each promoter (tL1 and tR1 respectively) generating
only two mRNA species (Konrad, 1968) (figure 1.2.1-B). Within a few minutes, longer
transcripts originating at pL and pR are produced (Rabovsky and Konrad, 1970),
eventually resulting in expression of the late genes required for the lysogenic or lytic
pathways of the phage life cycle (figure 1.2.1-C and D). In the early stages of K
infection, only the N and cro proteins are expressed. Loss of function mutants in the
early gene N result in production of only the two early transcripts (figure 1.2.1-B,
(Brooks, 1965; Radding and Echols, 1968; Kourilsky et al., 1968). Complementation tests
showed N is required for expression of the early cistrons responsible for X DNA
replication, as well as the late cistrons (Joyner et al., 1966; Eisen et al., 1966; Gottesman
and Weisberg, 1971). Lambda mutants that can grow without a functional N protein
were found to contain point mutations in or near the termination site (byp) or a deletion
of the region containing the putative termination signals (nin) (Court and Sato, 1969;
Hopkins, 1970). Therefore k has specific termination sites within its genome which
block expression of later functions until an early protein has accumulated to high
enough concentration to facilitate antitermination at these termination sites.
The site of action of N protein, the terminator site, is different from the site of
recognition of N protein, somewhere close to the promoter (Franklin, 1974). Based on
its ability to allow RNA polymerase to transcribe beyond specific termination sites in
16
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Figure 1.2.1: The Lambda phage genome. A- Specific organization of phage genes, including transcription
terminators and the sites of action for the antitermination proteins N and Q. B- mRNAs made early after
infection or induction of a lysogen. Dashed lines indicate incomplete termination at tL1 and tR1. C- mRNAs made
after formation of termination resistant transcription complexes. D- General temporal organization of the genome.
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the phage genome, N was dubbed an "antiterminator" protein (Roberts, 1969; Szybalski
et al., 1970). The presence of N protein in vivo enables E. coli RNA polymerase to read
past all rho-dependent and most rho-independent termination sites (reviewed in Adhya
and Gottesman, 1978). This antitermination activity can also work on host encoded
termination signals. In lysogens, transcription originating at the prophage promoter
can extend into adjacent host genes. After induction of an N+ prophage, transcription
from pL ignores termination signals caused by polar insertions and ochre mutations in
the gal operon (left side of figure 1.2.1-A). No antitermination was observed for N-
mutants (Adhya et al., 1974). This effect was found to work only in cis; transcription
initiated at the prophage promoter was antiterminated, but not transcription that was
initiated at the host gal promoter. Experiments fusing different length regions near pL
to trp genes supported the hypothesis that N recognizes some site other than a
terminator. Mutations abolishing antitermination in N+ phage were isolated and found
to be single nucleotide changes in a region just downstream of pL (Salstrom and
Szybalski, 1978). This region was required for the action of N, and was constrained in
size by deletion mapping and homology with another region downstream of pR. These
nut sites, for N-utilization, are the site of recognition for the N protein (reviewed in
Szybalski et al., 1986). Later work (Nodwell and Greenblatt, 1991) demonstrated that N
recognized the transcribed nut site RNA rather than the DNA.
The interaction between N and nut plays a central role in the initiation and
organization of the host factors required for formation of the termination resistant form
of the RNA polymerase transcription complex. These host factors are called nus for N-
under supply (Mason and Greenblatt, 1991). A working model for formation of the
antitermination complex is illustrated in figure 1.2.2. The various components and
interactions of this complex have been elucidated through identification of suppressers
of loss of function mutants in different components of the complex, as well as through
the use of individual proteins on solid support as an affinity column matrix (Epp and
Pearson, 1976; Greenblatt and Li, 1981). It has been demonstrated that the host factor
NusA protein, N protein, and a nut RNA site are necessary and sufficient for
18
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A) Initiation complex
©
/Y70nutRNAP
B) Early elongation complex
nut
D) N-modified elongation
complex nut
Figure 1.2.2: Assembly of the termination resistant transcription complex. A- RNA polymerase
(RNAP) in complex with the sigma-70 subunit initiate transcription. Ribosomal protein
S-10 (S) unstably binds this complex. B- Host protein nusA replaces the sigma-70 subunit
and transcription continues. C- After transcribing the nut site, N protein binds the boxB
hairpin, RNAP and nusA. Formation of N-boxB-nusA-RNAP facilitates binding of host
proteins nusG, nusB and S to the single-stranded boxA site in the nut RNA. D- The fully
assembled antitermination complex is formed. It is highly stable and able to read through
normal terminaion signals with high efficiency. This diagram was adapted from Mason and
Greenblatt, 1991.
19
I. Introduction
antitermination. This antitermination complex is metastable, however, and
antitermination activity diminishes as the distance from the nut site to the terminator
increases beyond 200 base pairs (Whalen et al., 1988). A complete, stable termination
resistant complex requires the presence of a nut site (in cis with the promoter and
terminator), an N protein, E. coli RNA polymerase, NusA, NusB, NusG and ribosomal
protein S10, as shown in figure 1.2.2. The full complex is able to remain in a termination
resistant state for kilobases. All of these factors are found to co-immunoprecipitate with
RNA polymerase in transcribing, termination resistant complexes in in vitro
experiments using reconstituted activity from purified components (Barik et al., 1987).
NusA has been shown to interact directly with N protein (Vogel and Jensen, 1997) and
this interaction activates NusA RNA binding (Mah et al., 2000). This interaction
appears to play a central role in the switching of NusA from a pause-promoting
component of the RNA polymerase complex to a transcription enhancer (Toulokhonov
et al., 2001).
1.2.2 nut sites
The nut site is composed of a 5'-boxA site and a 3'-boxB site, separated by a
variable length linker region of 8-14 nucleotides (reviewed in Szybalski et al., 1986). The
bacteriophages X, #21, and P22 all use similar methods of early regulation of
transcription with nut sites, N proteins and terminators. The genome organization is
conserved, but the sequences of the nut sites and N proteins are more diverse (Franklin,
1985). Figure 1.2.3-A shows an alignment of the phage nut sites. The striking homology
between the boxAs led to the hypothesis that this sequence was being recognized by one
or more host factors. The host factor NusB is not found in isolated in vitro transcription
complexes lacking a boxA (Das et al., 1985; Das and Wolska, 1984; Ghosh and Das, 1984).
NusB in complex with ribosomal protein S10 recognizes the boxA consensus sequence
5'-Pyr-GCTCTT(T)-3' (Olson et al., 1984; Horwitz et al., 1987; Nodwell and Greenblatt,
1993). boxA sequences have been found in E. coli operons known to utilize
antitermination. Examples include the rrnB and trp operon (Friedman and Olson, 1983).
20
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boxA linker boxB hairpin
CGCUCUUACACAUUCCA ------ -GCCCU GAAAA AGGGC
CGCUCUUAAAAAUUAA-------GCCCU GAAGA AGGGC
UGCUCUUUAACAGUUCUGGCCUUUCACCU
GGCUCUUUAACAUCGACGGAC-UCUCAAC
CGCUCUUUACCAAUCUGA----- -ACCGCC
CGCUCUUUAACUUCGAUGA --- -UGCGCU
CUAACC
CUAACC
GACAA
GACAA
GGGUGAG
GUUGAGA
CGCGGU
AGCGCG
N 421 MVTIVWKES Al
P22N MTVITYGKSTFA
R
D
96
--
Figure 1.2.3: RNA and protein alignments. A- Alignment of the three phage nut RNAs.
The three regions of the nut site are denoted. The boxA (red), the linker, and the boxBs
(blue), the boxB loop nucleotides are shown in italics. B- Alignment of the three phage N
proteins. Conserved residues are highlighted in green.
A)
nutR X
nutL
nutR$21
nutL $21
nutR P22
nutL P22
B)
MDAQTRRRERRAEKQAQ%
GTAKSRYKARRAELIAER
GNAKTRRHERRRKLAIEH
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There is a high degree of homology between the two boxB sequences (left and
right) within a given phage. There is, however, little sequence homology between
different phages. Single mutations at all five bases in the loop of nutLX-boxB showed
that the first guanine was the most critical for antitermination activity, and the
requirement for the loop sequence 5'-GPuPuPuA-3' emerged (Doelling and Franklin,
1989). Despite extensive mutagenesis screening in vivo, no NX mutant has been found
that suppresses point mutations in the boxB loop that fail to function with wild-type N
protein (Franklin, 1993).
1.2.3 N protein
The N protein was identified (Shaw et al., 1978) and purified (Greenblatt et al.,
1980) based on its ability to complement a X N- strain. The half-life of N protein in vivo
is approximately 3 minutes (Konrad, 1968). The sequence of the NX gene showed its
product is a highly basic protein of 107 amino acids, of which 12 are arginines and 11
are lysines (Franklin and Bennett, 1979). Mutagenesis studies have demonstrated that
all five arginines in the amino-terminal region of NX are important for N activity using
an in vivo antitermination assay scoring for lacZ expression from tester plasmids
(Franklin, 1993). No more than one arginine could be replaced without loss of function.
The three related phage N proteins are able to only function with their cognate
nut-boxB RNAs (Lazinski et al., 1989). Amino acid sequence alignment of the N proteins
from X, 421 and P22 show an amino-terminal 18 amino acid region of homology with
four invariant residues (Franklin, 1985) (figure 1.2.3-B). Chimeric N genes containing
the amino-terminal 23 amino acids of N 21 replacing the homologous region from NX
failed to antiterminate in a X genome that contained the nut sites. In experiments
where the bJoxBX was replaced by the boxB@21 sequences, the virus showed wild-type
antitermination activity (Lazinski et al., 1989).
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1.2.4 Significance
Our understanding of both specificity and affinity in RNA-protein complexes is
greatly enhanced by structural studies of a variety of complexes. It is our hope that
through combining thermodynamic and structural analysis of these complexes we can
begin to understand what contributions various types of interactions make to the
affinity and specificity of a given RNA-protein complex. An even more powerful
analysis is possible when we have a family of structures to compare and contrast. The
N21 peptide-boxBO21 RNA complex completes a family of three -related phage N-boxB
protein-RNA complexes that includes this complex, and those from X (Legault et al.,
1998), and P22 (Cai et al., 1998). As noted earlier, the RNA-binding domains from these
three phage N proteins are very similar to one another, all three boxB RNAs have a
similar hairpin secondary structure, and different loop sequences. The N-peptides have
some sequence similarity, yet discriminate between the various boxB RNAs (Cilley and
Williamson, 1997). An analysis of these three peptide-RNA structures yields insights
into the details of affinity and specificity demonstrated by these complexes.
1.3 Protein and RNA Structure Determination by NMR
1.3.1 Significance of isotopic labeling
Isotopic labeling was absolutely essential for this structure determination. NMR
experiments using isotope labels have matured dramatically over the past decade. With
the exception of some one dimensional (iD) and two dimensional (2D) homonuclear
NOESY (NOE SpectroscopY) experiments used to quickly survey the "quality" of the
spectra from these complexes, all experiments were performed with a singly- (15N)
labeled or doubly- (15 N and 13 C) labeled peptide, or a doubly labeled RNA.
A summary of some typical chemical shift values for various TIH, 13C and 15N
spins found in RNA is shown in figure 1.3.1. The numerous different proton resonances
in RNA are best separable in three dimensional experiments utilizing their attached
carbon or nitrogen. In homonuclear NMR (1H only) experiments, there is simply too
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much overlap in large molecules particularly in the ribose sugar 2', 3', 4', 5' and 5"
region. These resonances all fall within a relatively narrow (~ 1 ppm) chemical shift
range. This is one of the biggest problems with NMR on RNA - overlap. All of the
ribose sugars, save the Hi', crowd into the narrow region from 3.8 to 5 ppm, and the
base protons (H6, H8 and H2) show crowding in the region from 7 to 8 ppm. NMR
experiments on doubly-labeled samples add a third dimension by spreading the peaks
along the 13 C or 15 N "z" axis, allowing easy discrimination of an H2' from an H5', and a
cytosine H5 from a uracil H5.
All common 2D NMR experiments, including COSY (COrrelation SpectroscopY),
TOCSY (TOtal Correlation SpectroscopY) and NOESY, have three dimensional (3D)
equivalents, such as HCCH-TOCSY (Clore et al., 1990). These experiments take
advantage of the large 'JHC, 'Jcc, and 'JHN heteronuclear couplings for magnetization
transfer. Detection remains on the 1H signal to maintain sensitivity. For proteins,
whole spin systems can be identified and connected to neighboring residues using
experiments that correlate the H,, HN, or Ca through the carbonyl carbon in the peptide
backbone (Grzesiek and Bax, 1992), eliminating the need to rely on NOE data to make
sequential assignments. The experimental situation is not quite as good for RNA. 3D
versions of the TOCSY and COSY experiments can be used to assign ribose sugar spin
systems, and strong 1Jcc and 'JCN couplings can be used to correlate a base to a sugar in
an HCN experiment (Hu and Jiang, 1999). The 2JcP and 3JcP couplings across the
phosphate backbone are, however, often weak and broad making HCP-type
experiments difficult (Marino et al., 1995) and making sequential assignment of RNA
through the backbone more challenging than for proteins.
In addition to more complete and less ambiguous chemical shift and sequential
assignments of oligopeptides and oligonucleotides, isotope labeling and heteronuclear
NMR experiments allow the spectroscopist to study larger macromolecules. While
recent developments in TROSY experiments (Salzmann et al., 1998) have allowed NMR
spectroscopists to look at molecules well beyond the traditional 30 kDa size limit,
problems with spectra can arise well before reaching 30 kDa. As the size of a protein or
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RNA molecule gets larger, the number of proton signals in the NMR spectra increases.
Isotopic labeling of NMR samples spreads the signals into a third dimension to relieve
spectral crowding. Specific labeling of particular carbon or nitrogen atoms, or
deuteration of specific protons can remove their NMR signal altogether, further
reducing the complexity of the spectra. The NMR determination of the HIV Rev-RRE
peptide-RNA complex used samples where only the guanosines in the RNA were13C
labeled in order to resolve an important ambiguity in the assignments (Battiste et al.,
1996).
Finally, one class of NMR experiments that takes advantage of samples in which
only one molecule in a complex is isotopically labeled (15N and 13C) and all other
molecules are unlabeled (14N and 12C). These double-half-filtered NOESY (Otting and
Wuthrich, 1989) and filtered/edited NOESY (Otting and Wuthrich, 1990; Zwahlen et al.,
1997) experiments give spectra with cross peaks arising only from intermolecular NOEs,
thus reducing the complexity of the spectra and facilitating the detection and
identification of specific contacts in a complex.
1.3.2 RNA
Structural determination of an RNA molecule, or any biological macromolecule
of interest, using NMR relies on three experimental observables; the chemical shift of a
particular spin, the nuclear Overhauser effect (NOE) between a pair of spins, and the
scalar coupling (J-coupling) between a pair of spins. The chemical shift of a particular
spin is affected by its chemistry (bonds and angles), and its physical environment.
Chemical shift values can serve to narrow the identity of a particular spin, bearing in
mind that unusual physical environments can have a large impact on the chemical shift.
The nuclear Overhauser effect results in cross peaks whose intensity has a 1/r 6
dependence on the distance between the two protons contributing to the cross peak.
This 1/r 6 distance dependence means that only protons <6 A apart can be observed.
Finally, the value of the J-coupling constant is a function of the torsion angle between
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two protons separated by three bonds. Determination and analysis of J-coupling
constants can provide geometrical constraints in a structure calculation.
NMR observables particular to RNA are illustrated in figure 1.3.2. Imino protons
on guanine and uracil not only resonate far downfield from other protons (11.5-14.5
ppm), but they readily exchange with water. Imino protons not involved in hydrogen
bonding, usually are not seen in NMR spectra. The observation of an imino proton
strongly suggests the presence of secondary structure, such as canonical Watson-Crick
C:G and U:A base pairs (figure 1.3.2-A), and wobble G:U base pair. The sugar pucker
can be determined from the 3J-coupling constant for the ribose Hi' and H2'.
Nucleotides in an A-form helix have a C3'-endo sugar pucker conformation and a 3JH1'-
H2' value of <3Hz (figure 1.3.2-B). This coupling is usually not observed in COSY
experiments on medium to large RNA molecules. A 3 JH'-H2' value of >8Hz is typical for
nucleotides in a C2'-endo conformation. The glycosidic torsion (X) is crudely
determined by measuring the intranucleotide base (H8 or H6) to ribose (Hi') NOE
distances. The anti conformation is typical of Watson-Crick base pairs and is
energetically favorable compared to syn (figure 1.3.2-C).
With a good quality 2-dimensional (2D) water NOESY experiment and good
dispersion of the proton chemical shifts, it is possible to assign all of the imino protons,
the H1', and base H8/H6 for helical regions of the RNA (Wuthrich, 1986). Typically, a
2D NOESY in water is used to determine the chemical shifts of the various imino
protons. A-U base pairs are easy to distinguish from G-C base pairs in two ways. First,
the pattern of cross peaks in the 5-9 ppm region of the spectrum is examined. An A-U
base pair imino usually has few cross peaks, with a single strong cross peak to the AH2.
In contrast, a G-C imino proton often has cross peaks to the CH4 amino protons, the
CH5, and CH6. Second, U imino protons often lie further downfield (higher ppm
values) than G imino protons. G-U wobble pairs are distinguished from Watson-Crick
pairs by very strong imino-imino cross peaks. There are a number of NOE base-to-base
assignments that can be used to sequentially 'walk' the strand of helical RNA (figure
1.3.3-A). A side view of the A-form helical stem (figure 1.3.3-B) clearly shows the 5'-to-
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A) Imino protons: base pairing
G-C A-U
B) Sugar pucker: JH1'-H2'
C3'-endo, ~2Hz
R 
--" R
G-U
0 -B
C2'-endo, ~8Hz
C) Glycosidic conformation: H 1'-H8/H6
0 ~. 0
anti, -3.8A syn, -2.5A
Figure 1.3.2: RNA observables. A- The Watson-Crick G-C and A-U and a wobble G-U
basepairs. The observed imino protons are shown as balls. Sugars are denoted as R.
B- The two most commonly observed sugar puckers. The Hi' and H2 protons are
illustrated at grey balls. The 2' and 3' carbons are labelled and the bases are denoted by
the B. C- Rotation about the x bond determines the glycosidic conformation and is
determined by the NOE intensity (distance) between the H2' and its base proton.
A) Sequential connectivities
B) Sequential "walk"
* AH2 -> HI'
* H2' <-> Base Basei -> H1'i -> Basei, 1 -> H1'i.
Figure 1.3.3: NOE observables for sequential assignments. A- Protons are shown as balls and color-coded to illustrate the
various pathways. Not shown are common 'cross connections', such as imino->H2 (grey to purple). B- A side view of one
strand of the helix in A more clearly illustrates the polarity of the base to sugar sequential walk.
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3' polarity in the 'walk' from Hi'-to-base-to-Hi'. The imino protons in a helical region
are stacked and close enough to give NOE cross peaks (figure 1.3.3, gray balls and
lines). By making initial assignments of U and G imino protons, and then looking at the
pattern of imino-imino cross peaks, it is possible to 'walk' up the stem of the helix just
along the imino protons. Short stretches of base connectivities can be checked against
both the primary sequence and the putative secondary structure for a match. In this
way, initial assignments of the base imino protons are made.
The same 2D water NOESY spectrum can be used to walk along the sugar
backbone if the Hi' in the 5-6ppm and base chemical shifts are sufficiently dispersed
(figure 1.3.3-A and B). It is the imino-to-Hi' region of the 2D spectrum that is used for
the sequential walk. The Hi' is typically 3.5 A and from its own base H6/H8 and 4.5 A
from the following H6/H8. In an A-form helical region, along a particular Hi' chemical
shift there should be two peaks corresponding to the two nearby bases, and along a
given base chemical shift there should be two cross peaks corresponding to the two
neighboring Hi' protons. The H8 (purine, PUR) and H6 (pyramidine, PYR) base
protons can be distinguished from one another by the presence of a characteristic
"third" peak along the H6 chemical shift corresponding to the strong H5/H6 cross
peak. Using these simple rules, it is possible to distinguish patterns of PYR and PUR
connectivities. For example, a PUR-PUR-PYR-PUR might match to a unique sequence
in the RNA such as G-G-C-A. The AH2 proton chemical shifts deduced from
examination of the imino region of the spectrum and can be used to link the sugar Hi'
chemical shifts to the base imino resonances. The AH2 proton gives an NOE cross peak
to the 3' Hi' and the cross-strand 3' Hi' (figure 1.3.3, purple balls and arrows). All of
these connectivities in a helical region of the RNA can be further checked by looking for
base-base cross peaks that result from base stacking (yellow balls and arrows) as well as
H2'-base cross peaks (orange balls and arrows). The H2' region of the spectrum is
much more crowded than the Hi' region in homonuclear spectra, and it is only in 3D
experiments that sufficient separation of the H2' signals from the other ribose protons
allows for sequential assignments. The Hi'-to-base and the H2'-to-base sequential
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assignments can be combined with the strong HT'-H2' cross peaks to begin the task of
grouping the ribose protons together.
The assignment procedure described in this section relies on NOE cross peaks for
sugar-to-base and nucleotide-to-nucleotide connectivities. These assignments can be
verified and expanded by the use of heteronuclear through bond NMR experiments.
The previously described HCN experiments allow for correlation of Hi' to base H6/H8.
This is a powerful check on the 'sequential walk' NOE assignments, although it should
be noted that the HCN experiments have low sensitivity. The 3D versions of the COSY,
TOCSY and an HCCH-COSY-TOCSY experiment verify H1'-H2' families and provide
for assignment of the rest of the ribose sugar.
Although the assignments of helical regions of an RNA structure are fairly
straightforward, assignment of non-helical regions of RNA prove more challenging. All
the connectivities in figure 1.3.3 rely on the geometry of stacked bases seen in helical
regions. Nucleotide bulges, internal loops, and hairpin loops do not follow any regular
structure and, therefore, are more difficult to assign. Care must be taken when making
assignments in these regions.
1.3.3 Proteins and peptides
The same general set of NMR observables used for RNA structure determination
apply to proteins; proton and heteronuclear chemical shift, the NOE and J-coupling
constants. The maturity of protein NMR structure determination methods allows for a
greater depth of analysis of these observables. The chemical shift values of a number of
peptide backbone spins, Ha, Ca, Cp and NH, have been correlated with secondary
structure using both surveys of solved structures and theoretical calculations (Wishart
and Sykes, 1994). The chemical shift values for these various spins have a (typical)
given range for random coil and can show significant deviation from these values
depending on whether the peptide backbone adopts an alpha-helical or beta-sheet
conformation. Once these spins have been assigned, programs such as TALOS
(Cornilescu et al., 1999) can be used to quickly and confidently map secondary structure
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onto the peptide primary sequence. The scalar coupling constants can be determined
for both backbone and side chain atoms separated by three bonds and used to calculate
the corresponding torsion angle. Similar to RNA, protein NOE cross peaks can show
characteristic patterns for regular secondary structure. Unlike RNA, however, the
chemical shift deviations and J-coupling constants provide a direct confirmation of
secondary structure conclusions drawn from the NOE data.
Compared to RNA, proteins display a greater degree of chemical shift dispersion
among their various spin systems allowing investigators to solve protein structures
using only homonuclear NMR experiments. But with the ease of isotopic labeling and
the plethora of 3D heteronuclear experiments available, we chose to do 3D NMR and
very little homonuclear NMR on the peptide. 15N-HSQC and 13C-HSQC experiments
were performed to give an idea of the overall 'quality' of a spectra, as well as to
parameterize a number of experiments for assigning the backbone and side chains. A
variety of through-bond experiments, including HCCONH-TOCSY, CCONH-TOCSY,
CBCACONH, HBHACONH, and HNCACB were used to make virtually complete
assignments of the peptide. 15N-NOESY-HSQC experiments using different mixing
times, as well as a CN-NOESY-HSQC, provided NOE data for all the 15N and 13C
attached protons. An HNHA experiment was used to determine 4 torsion angles along
the peptide backbone.
1.3.4 Assignment and structure calculations
Macromolecular structure determination by NMR is an inherently
computationally intensive process. Each stage in the process, from running the
experiments, to processing the data, visualizing the data and generating assignments,
and finally molecular modeling, modern software and fast hardware are required. All
NMR spectra were acquired on Varian and Bruker instruments. The raw data were
processed using NMRPipe (Delaglio et al., 1995), and the spectral data were analyzed
using NMRView (Johnson and Blevins, 1994). The chemical shifts were assigned in the
spectra, and grouped together in particular peptide side chains, riboses or bases. Cross
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peaks in NOESY spectra were assigned to proton-proton pairs. Spectral overlap can
result in ambiguous assignment of some NOESY cross peaks. This collection of NOE
distance assignments constitutes the basis for structure calculations, which proceed in
an iterative fashion of making assignments, revising NOE distances, and performing
structure calculations. Once a critical number of restraints are generated to give an
overall fold for the molecule, these nascent structures can be used as an aid in further
identifying restraints, with the caveat that great care must be taken to avoid model bias
from over interpretation of ambiguous assignments and distance restraints.
The collection of distance and torsion restraints is used in molecular dynamics
(MD) calculations to generate an ensemble of three dimensional structures. These
structure calculations require the minimization of an "energy function", which is
composed of "energy" terms derived from both the input experimental restraints and
terms reflecting the covalent geometry of the system (bond angles, bond distances,
chirality, etc.). The MD algorithms, CNS, and AMBER use energy functions that
operate in real space (dynamic simulated annealing Nilges et al., 1988). Both AMBER
(Kollman et al., 2000) and CNS (Brunger et al., 1998) provide a method of incorporating
NMR-derived restraints into the "energy function". These structure calculations all
require some quasi-realistic starting point, typically peptide and RNA molecules that
have the correct primary sequence but are otherwise random, extended structures. The
quality of the final ensemble of minimized structures is determined by the average root-
mean-square distribution (rmsd) of individual structures in the ensemble about the
average structure and the consistency with which this ensemble satisfies the
experimental restraints.
1.3.5 RNA-peptide complexes
Structure determination of an RNA-peptide complex by NMR is basically a four-
step process; determination of chemical shift assignments for as many RNA and peptide
1H, 15 N, and 13C spins as possible, determination of intramolecular distance restraints,
calculation of the individual RNA and peptide structures, and finally, determination of
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intermolecular restraints, which are combined with the full restraint set to dock and
anneal the RNA and peptide together. Isotopic labeling is essential for collecting
intermolecular distance restraints. In particular, labeling only one component in a
complex with 13C/ 15N results in spectra containing signals derived only from the
labeled molecule. Another source of intermolecular restraints is examination of regions
of 3D NOESY-HSQC spectra that are particular to peptide or RNA. For example, no
RNA chemical shifts extend much below 4 ppm, and the presence of cross peaks below
4 ppm in a 3D NOESY-HSQC on an RNA-only labeled can only arise from RNA-
peptide contacts. As described earlier, the double-half-filtered NOESY and
filtered/edited NOESY experiments take advantage of individual labeling of
components in a complex to give spectra with cross peaks derived from the labeled
component along one axis and the unlabeled component along the other. These
experiments are extremely useful for finding intermolecular restraints that are
otherwise buried in regions of chemical shift overlap between the RNA and peptide.
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Chapter 2. Polyacrylamide Affinity Coelectrophoresis - PACE
2.1 Introduction
The polyacrylamide coelectrophoresis (PACE) assay is a relatively new addition
to the arsenal of techniques used to quantitatively examine the interactions of proteins
and peptides with DNA and RNA (Cilley and Williamson, 1997; Cilley and Williamson,
1999). PACE involves electrophoresis of a radiolabeled nucleic acid through a gel
medium containing the target peptide or protein ligand. The concentration of the
ligand is constant throughout the electrophoresis, and the conditions for binding
equilibrium to the target nucleic acid are maintained throughout the experiment. This
avoids the requirement for formation of complexes that are kinetically stable under the
non-equilibrium conditions typical of a gel mobility shift experiment. A particularly
powerful aspect of the PACE experiment is the ability to probe interactions that are too
weak to be observed in other binding assays such as gel shift or filter binding.
The PACE assay is straightforward. Polyacrylamide plugs containing different
peptide concentrations are sequentially poured into a gel sandwich that is oriented such
that the plates are at a 900 angle relative to their orientation during electrophoresis.
This results in a discrete step gradient of peptide concentration in the gel from left to
right. It is possible to pour plugs that span a wide range of peptide concentrations from
picomolar to micromolar. The PACE gel can be poured such that there are multiple
wells for each gel segment at a given peptide concentration, providing for the
simultaneous measurement of the binding interaction of a wild-type RNA sequence and
several mutant RNAs. Radiolabeled RNA samples are subjected to electrophoresis
through the gel, and then the mobilities of the RNAs are analyzed as a function of
peptide concentration. In general, for complexes that rapidly exchange between free
and bound forms (i.e. weak interactions) the mobility of the RNA is directly
proportional to the fraction of the time spent bound to the peptide during the
electrophoresis. As a result, the mobility of a given RNA will depend on the peptide
concentration.
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In the standard gel mobility shift assay, unstable complexes can dissociate just
prior to or shortly after entering the polyacrylamide gel (Cann, 1989; Carey, 1991). As a
consequence, there may be no clear difference in the mobilities of the bound and
unbound RNA species if the binding is sufficiently weak. In the PACE experiment, the
presence of the peptide ligand in the gel at a uniform concentration ensures that the
complex remains at equilibrium during electrophoresis, and the degree to which
complex formation occurs at any given peptide concentration is reflected in the
decreasing mobility of the nucleic acid. The PACE assay is very robust, and a variety of
factors that affect the binding interaction can be surveyed, including salt, temperature,
pH and detergent.
The PACE assay is related to affinity electrophoresis (Horejsi, 1981), which
involves covalent linkage of one member of a ligand pair to a stationary matrix. The
rate of electrophoresis of the complementary mobile component through the affinity
matrix is retarded by its interaction with the immobilized component. In an extension
of this methodology, affinity coelectrophoresis (Lim et al., 1991), or ACE, labeled nucleic
acid substrates are electrophoresed through an agarose gel containing different
concentrations of protein in each gel slab. In order to increase resolution, we developed
a version of the ACE assay using polyacrylamide in place of agarose. The smaller pore
sizes obtainable with polyacrylamide extend this methodology to include small
peptide-ligand complexes.
During PACE electrophoresis, the RNA is assumed to exist in two distinct states,
an unbound state, which has a mobility equal to that of the RNA in the absence of
peptide, and a bound state which has a mobility that is different from the free state. The
presence of multiple conformations of the RNA-peptide complex (of differing
mobilities), or multiple complexes of different stoichiometry will complicate analysis of
the PACE experiment, as well as other binding experiments. It is also assumed that the
free and bound states are in rapid equilibrium with an exchange rate that is fast relative
to the electrophoresis time. A model exploring the effects of binding kinetics on affinity
electrophoresis suggests that slow kinetics result in a spreading of the bands at peptide
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concentrations close to the apparent dissociation constant, Kd,app (Matousek and Horejsi,
1982). It is important to note that the acrylamide gel matrix and the mechanics of
pouring a PACE gel may have some effect on the binding interaction. The utility of
PACE lies in the ability to test the relative affinities of multiple RNA species under
these same conditions.
(Note - This chapter is largely adapted from Cilley and Williamson, 1999.)
2.2 Materials
2.2.1 Equipment
* Standard equipment for polyacrylamide gel electrophoresis including power
supply, gel box, clamps and heat sink (typically a 1/8" thick aluminum plate).
* Wide, short gels are preferable for the PACE assay because a wider gel allows for
more discreet steps in the concentration gradient, and a shorter gel helps reduce the
amount of peptide needed for each polyacrylamide plug. Our gel plates were 24x36
cm and 26x36 cm (HxW). The actual size of the PACE gel is not critical, and the
procedure can be easily modified for other sized gels, depending upon the particular
application.
* Combs and spacers are custom cut for PACE gels. The PACE assay as described
here utilizes combs and spacers for a 10 step gradient of peptide concentration
across a single gel. The combs and spacers are cut as illustrated and described in
figure 2.2.1.
* 10 ml Luer syringes, 25 gauge needles, gloves and parafilm.
* Light emitting labels (Stratagene, Glogos II, #420201).
* Chromatography paper (3MM Whatman), plastic wrap, and a gel dryer.
* Autoradiography cassettes, X-ray film and developer for the autoradiograph.
* Light box and ruler for quantifying the PACE data.
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Figure 2.2.1: Combs and spacers for the PACE gel. These are cut from 1/32" thick Teflon
sheets. The side spacers (S) are 29.5 x 1 cm. The bottom spacer (B) is 38.5 x 1 cm, with
5 x 5 mm notches spaced 3 cm apart and 5.5 cm of space from the ends. The pouring
comb (P) is 34.5 x 2.5 cm, with 5 x 6 mm deep notches and 3 cm spacing between each
other and the ends. The well comb (W) is cut from a 34.5 x 2.5 cm rectangle of Teflon.
The teeth are 3 mm wide and 5 mm long. They are spaced 3 mm apart with 14 mm
between each grouping of 4 teeth. There is 4.5 mm of space from the first and last teeth
to the ends of the comb. See note 12 for details on obtaining a guide for cutting the
combs and spacers.
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2.2.2 Reagents
e A stock of 5X TBE for use as the gel buffer and the electrophoresis running buffer:
450mM Tris base, 450mM boric acid and 10mM EDTA. To a final volume of 1 L add
54 g Tris base, 27.5 g Boric acid, 20 ml 0.5M EDTA, pH 8.0 and double-distilled
water.
e 40% Acrylamide stock solution (29:1 acrylamide : N',N'-methylene bis-acrylamide,
American Bioanalytical, Acrylease, #AB283).
e 10% ammonium persulfate (APS) (w/v) in water and 99% TEMED (N',N',N',N'-
Tetramethylethylene diamine).
* 32P-radiolabeled substrate RNAs. The PACE binding experiment can be performed
with either 3'-, 5'-, or internally labeled RNA. Standard procedures can be used for
preparation of RNA samples. A high specific activity (>200 dpm/fmol) is desired
since only trace concentrations of RNA are loaded onto the PACE gel (see note H).
0 Peptide and proteins are prepared and purified. Since the PACE assay is very
sensitive, high purity and an accurate measurement of peptide concentration are
essential. Reverse phase HPLC, or a similar high-resolution purification step, is
recommended as part of the purification. Peptide or protein stock solutions should
be prepared by serial dilutions into double-distilled H20 or appropriate storage
buffer. These stocks will be diluted 100-fold into the gel mix to give the final
concentration for each lane in the PACE gel.
e RNA samples are diluted with 6X Type III loading dye.
0 Coomassie protein staining is used for calibrating the run time of the PACE gel.
2.3. Method
2.3.1. Assay
1) Carefully clean each gel plate with non-abrasive soap and water, followed by
ethanol. Ideally, siliconize both plates to insure even spreading of gel mix when
poured. Assemble the gel sandwich with the pouring comb and spacers touching
(figure 2.2.1). Turn the final gel sandwich 90~ and slide the "upper" side spacer
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out to create a pouring gap (figure 2.3.1-A). Draw lines between the "tops" of the
notches as shown to help determine when sufficient gel solution has been added and
label each lane to keep track of the appropriate peptide stock to use.
2) Prepare 200 mL of gel mix: 0.5X TBE, 15% (29:1) acrylamide, and 0.02% ammonium
persulfate (20 ml 5X TBE stock, 75 ml 40% Acrylamide stock, 400 pL 10% APS, 104.6
mL ddH2O). Any additional salts (Na+, K+, Mg++, etc.) or other buffer components
for the particular application should be added to the appropriate final concentration.
To facilitate rapid and complete polymerization, the gel mix is degassed under
aspirator vacuum until vigorous bubbling ceases. If detergent is being used, it
should be added after degassing. The final volume of the gel mix should be 200 ml.
3) Remove the plunger from a 10 ml syringe. Hold a piece of parafilm over the small
hole at the bottom of the syringe barrel while holding it upright. Add 70.7 pL of
10OX peptide stock solution (or buffer for the "0" peptide lane). Add 7 ml of gel mix.
Add 14 ul of TEMED. Tightly cover the end of the syringe with your finger while
gently putting the plunger back into the syringe barrel until it just seats. Invert the
syringe so that the nozzle points up and the trapped air bubble rises to the top.
Remove your finger and the parafilm, pointing the syringe away from you since a
small amount of gel mix will likely squirt out. Push the plunger until it is securely
in the barrel. Again cover the end of the syringe and invert the syringe several times
to mix the solutions. Remove your finger and push the plunger to get the air out of
the syringe until the gel mix is just short of coming out.
4) Carefully attach a 25 gauge needle to the syringe. Insert the needle between the
plates at the top of your gel sandwich (as in figure 2.3.1-A). Slowly squirt the gel
mix in until the level of the gel just reaches the line drawn between the notches.
5) Wait 10 minutes for the gel plug to polymerize. While waiting, remove the needle
and dispose of any remaining gel solution into a proper receptacle. Rinse out the
syringe and needle with distilled water in order to re-use them for the next lane and
be sure to shake them to remove excess water.
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A)
Figure 2.3.1: The PACE Gel.
A- The fully assembled PACE
gel apparatus. The ring stand with a clamp
in the background is used to support the
gel plate sandwich, which is tilted back
slightly to lean against the tube clamp.
There are typically 5 clamps along the long
sides of the gel sandwich (where the
bottom spacer and pouring comb are).
Only 3 clamps are shown here to better
show the sandwich assembly.
B- Forming the wells of the PACE gel.
A pouring and well comb combination is
necessary because such small wells are
difficult to form the way the PACE gel is
poured. After the lanes are poured, the
gel is laid almost flat (an empty tip rack is
used here for propping up the top of the
gel sandwich) before the well comb is used.
B)
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6) After the gel has set, slide a strip of Whatman paper narrow enough to insert in the
pouring gap between the plates to wick out the shallow layer of unpolymerized gel
solution. Tilt the gel sandwich towards the filter paper to soak all of the
unpolymerized gel mix into the filter paper.
7) Repeat from step 4 with each successive peptide concentration until the second to
the last lane is completed.
8) Remove the clips from the "top" of the gel and slide the side spacer until the
pouring gap is very narrow. This will reduce the amount of gel mix exposed to air
for the last plug. Replace the clamps.
9) Pour the last lane. It is helpful to tip the gel sandwich so that the gel solution runs
down toward the pouring comb and the air pocket stays up near the needle as long
as possible. Wait 10 minutes for the gel to polymerize.
10) Lay the gel sandwich flat and then slightly raise (about 2") the end with the pouring
comb. Remove the pouring comb and use Whatman paper to wick out any
unpolymerized gel solution that remains. See figure 2.3.1-B.
11) Make 7 ml of gel solution containing no peptide. Fill the gel sandwich until the gel
mix beads up over the edge of the top plate. Add about 1 ml of TEMED to a
kimwipe tissue and wipe the well comb. Insert the well comb and clamp into place
and allow the gel to polymerize for 15 minutes.
12) Remove the bottom spacer from the gel sandwich. Remove the well comb. Put the
gel sandwich into an electrophoresis box and be certain to attach a metal plate (or
appropriate heat sink) to the outside.
13) Fill the buffer chambers with 0.5X TBE and rinse out the wells and the gap at the
bottom of the gel where the bottom spacer was removed. Do not pre-run the gel.
Load the RNA samples into the appropriate wells. The wells are small so only about
2 pL of sample can be loaded in each well. See note G for comments on how many
dpm of RNA to load for a good signal.
14) The gel should be run at a constant low power to eliminate or reduce heating. Our
experience has been that 3W for an 24x36 cm gel that is 0.8 mm thick is effective,
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regardless of the salt concentration. Run the gel only long enough to keep the RNA
and peptide migration fronts from passing (Note I).
15) Take down the gel sandwich. Remove one of the plates. Cover the gel with plastic
wrap. Be sure to mark on the plastic wrap which lanes correspond to what peptide
concentration. Peel the gel off the other plate and onto the plastic wrap, and lay a
piece of Whatman paper onto the gel.
16) Dry the gel on a gel dryer for about 1 hour. Attach the Glogos in a couple of spots
for reference markers. Expose the gel to film for appropriate amount of time (see
note G).
17) Develop the film and allow the autoradiogram to dry. Align the film to the gel using
the Glogos and mark the interface between the peptide-containing region and the
well-forming region. Measure the distance from that line to the center of each band,
or to the lowest point of a band (sometimes necessary if the lanes are streaked or
cross a boundary between lanes). It is important to use a consistent measuring
scheme.
2.3.2. Analysis
Ideally, the PACE gel autoradiogram will exhibit a single band for each lane, and
the mobility usually decreases with increasing peptide concentration. The total
migration distance (D) for each RNA at each peptide concentration is measured directly
from the autoradiogram (illustrated in figure 2.3.2). The migration distance of the free
RNA (DF) is also measured as a reference, to allow results from different gels to be
compared. In the analysis of a PACE gel, a simple binding equilibrium is assumed:
R+PKd =[R][P]/[RP] (1)
Where [R] and [IP] represent the free, equilibrium RNA and peptide concentrations,
respectively.
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DFD
'DF--
Figure 2.3.2: Idealized PACE autoradiogram. This schematic represents a PACE
experiment run with two test RNAs and eight peptide concentrations (including the
0 nM lane). Migration distances are measured on the autoradiogram from the start of
the peptide.-containing gel to the bottom of the electrophoretic band. DF and D
correspond to themigration distances of the free and fully bound RNAs, respectively.
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The fraction of RNA bound, 0, is given by:
[R]Bound [RP] (2)
[R]Total [RP] + [R]
Under the conditions used in the PACE experiment, [P]Total >> [R]Total, so that [P] =
[P]Total. Combination and rearrangement of equations (1) and (2) yields:
[P]Total
Kd, app + [P]Total
where Kd,app is the apparent dissociation constant for the complex under the particular
PACE gel conditions. When D, the migration distance, equals DF, there is no significant
interaction between the RNA and peptide. At sufficiently high peptide concentrations,
the RNA is completely bound by peptide and is maximally retarded. The migration
distance of the fully formed complex is given by DB. The migration distance DB is a
characteristic of the particular system and may be different for different proteins and
peptides. The fraction of RNA bound at any given peptide concentration can be
determined by:
D-DF
DB- DF
Rearrangement of equation (4) and substitution from equation (3) yields:
0= D-DF (5)
D B -D F
Fitting the PACE derived distance data (D) as a function of [P]Total to equation (5) yields
values for the Kd,app, DB, and DF. After fitting, the data can be normalized using the fit
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parameters DB and DF to allow plotting of 0 versus log [P] for the direct comparison of
different experiments.
Figure 2.3.3 illustrates actual PACE data and analysis. A wild-type and mutant
peptide derived from the X bacteriophage antitermination protein N are compared for
binding to the wild-type RNA hairpin target of N protein and three RNA mutants
(figure 2.3.3-A and -B, respectively). In this experiment, each peptide concentration
spans 6 orders of magnitude (50 pM to 20 pM). The concentration gradient is spread
over two gels, and each gel contains a "0" peptide lane which allows for calibrating the
migration distances between the two gels. The graphs are a plot of the normalized
distances and curve fitting the data to equation (5). The PACE experiment readily
differentiates binding affinities that differ by as little as a factor of 2 and as much as
several orders of magnitude. Table 2.1 summarizes the binding of the different X phage
N peptides to the 3 boxB RNAs. Note that each different N-peptide has higher
specificity for its cognate RNA. This specificity can be rationalized by our subsequent
comparison of the family of RNA-peptide structures.
Table 2.1: The N peptides discriminate between the different boxB RNAs.
All values are Kd,app determined using the PACE assay, 250C, no salt, no detergent.
NX (2-19) N22 (2-30) N+21 (1-41)
X boxBR 5 nM 64 nM 975 nM
P22 boxBL 130 54 216
*21 boxBL 1232 139 173
2.4. Notes
A) All work with acrylamide solutions should be performed wearing latex gloves.
Acrylamide is a potent, cumulative neurotoxin and there is ample opportunity for
inadvertent contact.
46
II. PACE
[NX(2-19)], nM
2 5 10 20 50 100 200 500 1000 2000 5000 10e3 20e3 0
* 4~
4'.
S
I I I 1 111111 1 1 1 111111 1 1 1 111111 1 1 1 111111 1 1 1 111111 1 1 1 111111 1 1 1 111111
106 1 y5 1 C4
B)
0 0.05 0.1 0.2 0.5 1
[NX(2-19:R7A)], nM
2 5 10 20 50 100 200 500 1000 2000 5000 10e32e 0
1.0-
0.8-
0.6-
0.4-
0.2-
0.0-
-0.2-
1011
I I 101I1a I I I I
10(10 i J 10G8 1 G7 1 6 s 54
Figure 2.3.3: A- PACE experiment using a peptide from residues 2 through 19 of the NX
protein. The RNAs loaded onto the gel are the wild-type boxB RNA hairpin in the first
lane of each segment, and three mutant RNAs. The graph corresponds to normalized
data derived by measuring migration distances on the gels. The solid line represents the
curve fit using the derived values of Kd, DF and DB. The error bars are estimates from the
X2 of the least-squares fit to the data. B- The same experiment as in A, but using the R7A
mutant peptide. The actual height of the gel slabs pictured is 10 cm.
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B) The amount of protein or peptide required to run a PACE experiment, as presented
here, is fairly large compared to other methods. For a concentration range of 50 pM
to 20 pM for the experiments in figure 2.3.3, ~275 nmoles of peptide were used. The
oxidizing environment that exists during the polymerization of the PACE gel could
adversely effect any free cysteines in the peptide of interest.
C) Ionic and non-ionic detergents can influence the apparent affinity and specificity of
peptide-RNA complexes. Detergent can be added directly to the gel mix after
degassing. Ionic detergent should be added to both the gel mix and the running
buffer since an ionic detergent will migrate during electrophoresis.
D) Sometimes the addition of detergent can cause the gel to be so slippery that it will
actually slide out from between the glass plates during the run. This problem is
avoided if one or both of the gel plates are not siliconized.
E) The presence of mono- and divalent salts will affect the binding interaction. Salts
will also dramatically alter the current passing through the gel during
electrophoresis. This additional current can cause heating of the gel. In order to
avoid this, use a lower wattage, or a better heat sink that can compensate for
additional heating (i.e. a water bath surrounding the gel).
F) The pH of the 0.5X TBE gel buffer is approximately 8.4. The use of other gel
buffering systems with different pKa's is recommended in order to examine the
effect of pH on the interaction.
G) In order to see a clear band on an autoradiogram exposed overnight, 2000 dpm of
32P-RNA should to be applied for each lane.
H) It is important to keep the total RNA concentration low to ensure that it is always
present in trace quantities with respect to the peptide concentration. There is
typically no difference in the results of the PACE assay using 0.1 to 25 fmoles of
RNA in a given well, corresponding to 50pM to 12.5nM final RNA sample
concentrations. This would seem to violate the analytical assumption that [R] is
much less than [P]. We assume that the mechanics of the PACE gel work to simulate
this condition for low concentrations of RNA in the context of a weak binding
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interaction. A guideline should be to use an RNA sample that is at least 10-fold
lower than the expected Kd. You should determine how many moles of your lowest
activity RNA gives 2000 total dpm and make the appropriate dilutions into water
and Type III loading dye such that 2 pL equals 2000 dpm. If the labeled RNA has a
much lower specific activity, fewer dpm can be used, and the exposure time should
be proportionally increased. It is important to load the same number of dpm for
each lane to ensure that no one lane over-exposes the film and masks the other
bands.
I) Before the first PACE assay is run, it is important to calibrate the migration rates for
both the peptide and the RNA. The RNA will migrate downward through the gel,
while RNA-binding proteins and peptides, which are generally basic, will migrate
upward through the gel. It is important to ensure that the migration fronts do not
pass one another during the PACE experiment, or the shape of the binding curve
may be affected. Pour a PACE gel as described, but add peptide to only one lane at
a final concentration of about luM, which is sufficient to visualize by Coomassie
blue staining. Load a single sample of labeled RNAs in a lane containing no peptide.
Run the PACE gel at 3W for about 3 hours (for a 24x36x0.1 cm gel). Cut the gel in
half vertically. Coomassie stain the half with the peptide lane, and dry down and
expose to x-ray film the half with the labeled RNAs. Basic peptides will migrate
through the gel bottom-to-top and the RNAs will migrate top-to-bottom. The
bottom of the peptide lane will not be stained due to the upward migration of the
peptide. Measure the distance migrated by the peptide and RNAs during the 3
hour run and determine their migration rates in mm/min. The PACE gel should be
run just long enough for the peptide and RNA fronts are about 2 cm apart, given by:
Timemm =Gel length, mm -20 mm
Peptide migration rate, mm / min + RNA migration rate, mm / min
It is important to re-calibrate the gel running time whenever you adjust the assay
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conditions by changing the salt, detergent, pH, or change the peptide or RNA
sequence. This is also the time to check, with either a strip thermometer or by touch,
if the electrophoresis conditions result in any heating. If the gel is warm at the end
of the 3 hours, reduce the wattage and re-calibrate.
J) If you have troubles with the gel sticking to both plates after the run, the gel
sandwich can be placed on a warmed gel dryer for a few minutes to heat up one
plate, which will cause the gel to release more readily.
K) If you have problems with the gel mix not polymerizing near the spacers or comb,
which results in channels, 20uL of TEMED can be pipetted along the outside edge of
the spacer or comb just at the level where the next plug is going to be poured. The
TEMED will wick along the spacer and help to completely polymerize the gel mix.
L) The notches that are cut in the bottom spacer and the pouring comb help to prevent
channeling that results from incomplete polymerization along the edge of the
Teflon.
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3.1 Expression and Purification of Peptide
NMR experiments require samples of sufficiently high concentration, usually >1
mM. For the 2.57 kDa N#21 peptide this translates into 1.6 mg of peptide for a typical
600 tL sample. Peptides for these studies were obtained by using a bacterial expression
system in which the coding sequence for the peptide was fused to the carboxy-terminus
of a poly-His-tagged TrpLE leader polypeptide (figure 3.1.1; Schumacher et al., 1996).
This system allowed for the rapid expression and purification of both unlabeled, and
uniformly isotopically enriched (15N, 13C) peptides. The TrpLE system was chosen
because these fusion peptides had been shown to express to high levels in E. coli, and
the TrpLE leader sequence, which is rich in hydrophobic residues, readily forms
inclusion bodies which are easily purified away from other cellular components. The
$21 peptide was cleaved from the trp leader peptide with cyanogens bromide at a
methionine residue. While the His-tag at the amino-terminal end of the TrpLE leader
sequence is useful for Ni2+ column purification of the fusion peptide under denaturing
conditions, it was not used here.
The coding sequences for the various N*21 peptides studied were synthesized,
both top and bottom strands, with flanking overhangs for HindIII on both ends. These
oligonucleotides were annealed and phosphorylated at their 5' ends, and ligated into a
pKK223 vector containing the His-TrpLE leader sequence from pMMHb (Schumacher
et al., 1996) cut with HindIII and treated with calf intestinal alkaline phosphatase (CIP)
to reduce the incidence of self-ligated vectors and increase the probability that any
transformants were the result of correct inserts. Plasmids from transformants were
sequenced to ensure correct insertion and coding of the N#21 peptide. Plasmids were
then used to transform into the BL2I E. coli strain. The His-TrpLE-N21 fusion is under a
T7 RNA polymerase promoter in the pKK vector, which also carries an ampicillin
resistance gene. The BL21 strain carries the T7 RNA polymerase gene within the
bacterial genome. The T7 RNA polymerase gene is regulated by the lac repressor, and
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A)
. His9 Tagi TrpLE leader sequence Imeti N@21 peptide
pKK pKK
vector vector
B)
Grow E. coli cells to OD600~0.75
Induce with 1 mM IPTG. Grow for 4 hours
Harvest cells
Inclusion body prep
CNBr cleavage and pH neutralization
HPLC purification
Dialysis and lyophilization]
Figure 3.1.1: The expression and purification of N@21 peptides. A- Construct for
expression of N$~21 peptides. The met is the site of CNBr cleavage. Not shown are the
details of the rest of the pKK vector. B- Purification scheme from cell culture to pure
peptide.
52
III. #21 N-Peptide Biochemistry and NMR
inducible with IPTG.
Cells grown in LB media were used for expression of unlabeled peptides. For
expression of isotopically labeled peptides, cells were grown in a modified version of
M9 minimal media, as detailed in table 3.1. Overnight cultures were used to inoculate 1
L cultures of LB media, at 370 C. Ampicillin concentrations of 50 pg/ml were used
throughout. When the culture reached an OD600 of ~0.75, the cells were induced by
addition of 0.5 mM isopropyl-p-D-thiogalactopyranoside (IPTG). The cultures were
grown for an additional 4 hours and the cells harvested by centrifugation at 6000g for 10
minutes. The cell pellets were combined and weighed. The wet weight from a 1 L LB
culture typically ranged from 3-5 grams, while minimal media yielded ~1 g of cells per
liter of culture. These pellets were either frozen and stored at -800C, or the inclusion
body preparation was started immediately.
For the inclusion body preparation, cell pellets were resuspended to a volume in
mL that was equal to 20 times their weight in grams with cold sonication buffer #1: 50
mM Tris-Acetate, pH 8.0, 10 mM MgCl2, 100 mM NaCl and 0.1 mM EDTA. Once the
cells were fully resuspended, 1000 units of DNase I (Sigma D-4263) were added,
followed by 25 mg of lysozyme and the suspension was stirred on wet ice. The addition
of lysozyme aided in breaking down the cell walls, and the DNase I helped to break
down the DNA and reduce viscosity. This suspension was sonicated with a Fisher
Sonic Dismembrator 550, equipped with a large horn at the highest power setting. The
sonicator was cycled for 30 seconds on, 2 minutes off, for a total of 5 minutes of
sonication. Even though it was in an ice bath, the suspension would warm up to about
400C, but this was not a problem because this warming did not solubilize the inclusion
bodies. The suspension was divided among 50 ml polypropylene tubes and centrifuged
at 8000xG for 20 minutes. The supernatant was saved for later analysis. The pellets
were resuspended to 40 mls with cold sonic buffer #2: 20 mM Tris-Acetate, pH 8.0, 0.5
M NaCl, 1 mM EDTA. After the pellets were well suspended, the suspension was
stirred on wet ice and Triton X-100 detergent was added to a final concentration of 1%.
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Table 3.1 Modified M9 minimal media.
A) Basic recipe for media.
Component Concentration Notes
Glucose 1.0 g/L '3C-glucose for labeled peptides
(NH4)2SO4 0.7 g/L '5N-ammonium sulfate for labeled
peptides
KH 2 PO4  1.6 g/L
Na2HPO4 5.3 g/L 10.01 gIL Na2HPO4O7H2O
Na-Citrate 0.5 g/L 0.57 gIL Na-Citrate*2H2O
MgSO4 0.3 g/L
Trace Elements solution 1.5 mL/L See table 3.1.1-B
Vitamin Bi (thiamine) 5 mg/L Recommended for JM109 E. coli growth
Note: All components should be made as filter sterilized concentrated stock solutions.
All components should be added to sterilized water in culture flasks after they have
been autoclaved.
B) Trace Elements solution. This stock solution should be filter sterilized after mixing.
Component Concentration, g/L
Na2-EDTA 20.0
CaCl2*2H2O 0.5
FeC1396H20 16.7
ZnSO4.7H20 0.18
CuSO455H2Oi0.16
MnSO4eH2O30.12
CoCl2e6H2O 0.18
Thiterent usediatine) stag/L ofthi co mndpep sorlJM109zE clilarot
moemba Anmemrnenhol bun proeis, filtesruilizecnrte stockluionois.
B)Te ncatonens solutinfTissoastion weerpaesouderile aboeilize peller wasng
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resuspended with cold (40C) double-distilled water (ddH2O) and sonicated and
centrifuged as described above. The pellet was almost pure white and typically
weighed from 0.6 to 0.8 grams. The fusion peptide was resuspended to a volume of 8
ml with ddH 2O in a polypropylene tube by vortexing and sonication. The fusion
peptide was dissolved by addition of 20 ml of 98% formic acid, yielding a final
concentration of 70% formic acid. Initially suspending the insoluble pellet in water was
important, because otherwise it was very difficult to resuspend the pellet directly with
70% formic acid. The solution became clear with a slight yellow-brown color.
The following steps for cyanogen bromide cleavage were all carried out in a
Laminar flow hood because cyanogen bromide is extremely poisonous. For the
cleavage reaction, 300 mg of CNBr were weighed out and added to the dissolved pellet.
Because CNBr is sensitive to light, the tube was wrapped in foil and kept in the dark for
one hour. The tube was opened and lyophilized for an hour in a speed-vac to remove
residual CNBr. The volume typically decreased by 50%. The solution was neutralized
with 30% (w/v) ammonium hydroxide to pH 6.0 to precipitate the TrpLE leader
sequence and uncleaved fusion peptide and cooled on ice. 1 M Tris-HCl, pH 6.8, was
added to a final concentration of 100 mM and the sample was centrifuged at 8000g for 1
hour. The supernatant was filtered through a 0.2 pm disk filter and stored at 40C. The
N21 peptides were further purified by reverse phase HPLC on a preparative 4.6 x 250
mm C18 column (Vydac) using 0.1% TFA in ddH 20 and 0.1% TFA in acetonitrile (ACN)
as the two mobile phase components, each at 1 ml/min. The supernatant was loaded in
5 ml aliquots in 5% ACN, was washed with 5% ACN for 10 minutes, and then a
gradient from 5-95% ACN over 65 minutes was applied. The N#21 peptide peak came
off at ~35% ACN. The peptide containing fractions were pooled and lyophilized. The
final product was dialyzed extensively against water, and its composition was checked
by amino acid analysis. The concentration was determined by tyrosine absorbance at
276 nm. Yields ranged from 5 to 15 mg per liter of cells.
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3.2 Minimization of the N-nut Complex
Because the NMR experiment places an upper limit on the size of suitable
samples (30 kDa), minimization of a biological macromolecular complex is a necessary
step in structure determination. Reducing the size of the molecules reduces the total
number of signals in a given NMR spectrum, thus reducing spectral crowding and
making chemical shift assignments both easier and less prone to ambiguity.
Additionally, spectral linewidths increase as the overall molecular tumbling rate
decreases, so smaller complexes tend to have better resolved spectra.
Early biochemical work on the NX peptide-boxB RNA system (Cilley and
Williamson, 1997) clearly demonstrated that a small peptide from the amino-terminal
domain of N protein bound the RNA with similar affinity and specificity as the full
length protein, and that both the protein and the peptide bound the full length nut site
and the boxB hairpin with equal affinity. This is an important result, because structure
characterization of a minimized complex assumes that the minimal complex mimics the
structure of the wild-type complex. In this case, the N-nutR complex had binding
affinity and specificity similar to the NX(1-22)-boxBR complex. Prior genetic data had
guided the choice of an NX peptide to test (Franklin, 1993). There was little information,
however, about the amino-terminal domain of N 21. Using the region of homology
between the three phage N proteins (figure 3.2.1), the minimization of the N021 protein
was started with a 41-mer peptide from the amino-terminal domain (figure 3.2.1). This
peptide was used to analyze a series of progressive RNA deletions (figure 3.2.1-A). The
minimized RNA, boxBR021 consists of the boxB hairpin with two additional G-C base
pairs which are required for efficient in vitro transcription by T7 RNA polymerase. The
full length nut021 and the boxBR021 RNAs bind equally well to the N021(1-41) peptide.
Using boxBR$21 as a test RNA, minimization of the N+21(1-41) peptide was carried out by
making a series of deletions from either the carboxy- or amino-terminus of the peptide
(figure 3.2.1-B). The deletion data was combined to make the final N+21(8-29) peptide. It
binds the boxBR@21 RNA with an apparent Kd of 200 nM, under the conditions of the
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Binding toA) RNA deletions peptide
ggUGCUCUUUAACAGUUCUGGCCUUUCACCUCUAACCGGGUGAGCAAGG +
GGCCUUUCACCUCUAACCGGGUGAGCAAGG +
Final boxBR 21 ggUUCACCUCUAACCGGGUGAGcc
Binding to
B) Amino-terminal deletions RNA
aVTIVWKESKGTAKSRYKARRAELIAERRSNEALARKIALK +
IVWKESKGTAKSRYKARRAELIAERRSNEALARKIALK +
ESKGTAKSRYKARRAELIAERRSNEALARKIALK +
TAKSRYKARRAELIAERRSNEALARKIALK -
Carboxy-terminal deletions
aVTIVWKESKGTAKSRYKARRAEL IAERRSNEALARK +
aVTIVWKESKGTAKSRYKARRAEL IAERRSNEA +
aVTIVWKESKGTAKSRYKARRAEL IAERR +
Final N21 peptide (22-mer)
EPKGTAKSRYKARRAELIAER 2 +
Figure 3.2.1: RNA and peptide minimization for NMR structural studies. A- The full
nut site was truncated and tested for binding against the full length 41-mer N$21
peptide. B- Deletions were made from both ends of the peptide and checked for binding
affinity with the boxBR$ 21 RNA.
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PACE assay. This is only slightly higher than the Kd for the 41-mer peptide (135 nM).
This 22 amino acid peptide and 24 nucleotide RNA, N021(8-29)-boxBR$21 peptide-RNA,
was the final minimized complex used for these structural studies.
3.3 Preparation of NMR Samples
Peptide and RNA samples of the highest purity are important for any
biochemical study, but there is an additional need for clean samples for NMR studies.
Many chemical impurities, such as EDTA, Tris, acetate, and other common buffer
components have proton signals that overlap those from amino acids and nucleic acids.
Peptide and RNA samples, after dialysis and lyophilization as described above, were
resuspended with 500 pL of ddH 2O and dialyzed in a microdialysis chamber (BRL) with
a 500 MWCO membrane for 12 to 24 hours each against: 0.5 M NaCl, 10 mM EDTA,
then 0.1 mM EDTA, and finally 2 changes of ddH20. The NaCl in the first step is used
to displace ions Na+ and acetate-. While not used in these studies, the author
recommends use of deuterated Na-acetate for the final ethanol precipitation of RNAs
intended for NMR studies. The acetate is difficult to remove completely from the RNA
samples, particularly with the small (500 or 1000 MWCO) dialysis membranes used in
the microdialysis chamber. Peptide and RNA stocks were stored at -200C in a
lyophilized state until used. Samples were resuspended in N#21 NMR buffer: 25 mM
D6(98%)-succinate (Cambridge Isotopes), pH 6.0, 2 mM NaCl, 0.2 mM EDTA, pH 8.0,
0.05 mM Na-azide, 10% D20. NMR sample volumes were 600 pL. Samples were
exchanged into D20 as needed by lyophilization and resuspension in 99.9% (Cambridge
Isotopes) D20. This was repeated 3 times and after the third lyophilization, the sample
was resuspended in 99.999% D20 to 600ml and transferred to an NMR sample tube.
3.4 Peptide Assignment and Restraints
Protein structural determination by NMR requires a number of different kinds of
experiments, each designed to access a particular set of NMR observables as previously
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Table 3.2: Data acquisition parameters for Nf2' peptide heteronuclear NMR experiments.
Experiment F3 F2 Fl Note Reference
15N-HSQC 1024, 5406, 'H 256, 578, 15 N -- -
13C-HSQC 1024, 6006, 1H 2048, 48052, 13C - --
HNCO 1024, 7000, 'H 128, 1800, 13 C 64, 2000, 15N Muhandiram & Kay, 1994
HNCA 1024, 7000, 'H 128, 7000, 13C 64, 1600, 15 N Ikura & Bax, 1992
HCCH-TOCSY 1024, 5200, 'H 168, 2800, 'H 96, 3800, 13 C Clore et al., 1990
HNHA 2048, 7900, 'H 128, 5800, 'H 48, 1600, 15 N Vuister & Bax, 1993
CBCA(CO)NH 512, 4000, 'H 128, 10000, 1 3 C 60, 1250, 15N Grzesiek & Bax, 1992
HNCACB 512, 4808, 1H 100, 10000, 13C 60, 1250, 15 N Muhandiram & Kay, 1994
HBHA(CO)NH 1024, 4808, 'H 198, 4041, 'H 58, 1250, 15 N Grzesiek & Bax, 1992
H(C)(CO)NH 1024, 4808, 'H 140, 2846, 'H 60, 1250, 1 5N Montelion et al., 1992
(H)C(CO)NH 1024, 4808, 'H 120, 10000, 13C 60, 1250, 15 N Logan et al., 1992
15 N-NOESY-HSQC 1024, 6410, 'H 256, 8333, 1H 78, 1524,' 5 N 50, 145, and Moe.
250 ms
13C,15N-NOESY-HSQC 1024, 6006, 'H 192, 6006, 'H 24,3850, '3C 150 ms Pasca
(CN-NOESY)
2D-Filtered/Edited 1024, 12820, 1H 954, 7142, 'H 200 ms Ikura
NOESY Zwahlen et al., 1998
(J1
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discussed (section 1.3). While not an exhaustive listing, table 3.2 lists information on the
basis set of multi-dimensional experiments that were performed for this thesis project.
Many of the experiments listed in table 3.2 were performed more than once; because of
technical issues, or because the parameters were changed to emphasize quality and
resolution in a particular region of the spectrum, or to insure the integrity of the various
samples over time. Almost all of the experiments listed were done using versions of the
original experiments that were modified to include pulse field gradients (Kay, 1995).
The addition of pulse field gradients to NMR experiments improves spectral quality
without changing the basic nature of the results. The initial 15N-HSQC experiments and
the 15N-NOESY-HSQC were done on a 15N-labeled N021 peptide in complex with
unlabeled boxB RNA. All of the other NMR spectra were collected on a 13C,15N-labeled
N021 peptide in complex with unlabeled boxB RNA. All experiments were done at 25'C
in N021 NMR buffer (section 3.3). Table 3.3 lists chemical shift assignments for the N 21
peptide.
3.4.1 Complex formation
The transition of a peptide from a free to an RNA bound state can be monitored
by changes in chemical shift values. These changes can arise as a result of the peptide
backbone and side chains becoming more ordered or structured, from changes in
chemical environment due to close contact to the RNA, or some combination of these.
Figure 3.4.1 shows the 15N-HSQC spectra of the free peptide and in complex with RNA
at 25'C. Only the peptide is 15N-labeled in this complex, so only signals from the
peptide are detected. There are a number of differences between the spectra of the two
states. There is an increase in the 1H chemical shift dispersion. The backbone amide
proton chemical shifts cluster between 8.0 and 8.6 ppm in the free peptide and
expanded to a range from 7.5 to 9.0 ppm in the complex. All 22 backbone amides are
evident in the complex. Though there was no attempt to make assignments of the free
peptide, the comparison of the free and bound spectra show that almost all of the
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Table 3.3: The 1H, 13C, and 15 N chemical shift assignments for the Nd' peptide in the bound form at 250C. The proton
chemical shifts are referenced to internal TSP. The heteronuclei are referenced to external DSS. The errors in the chemical
shift assignments are 0.02, 0.2 and 0.3 ppm for 'H, 13C, and 15N, respectively.
Residue HN/N C' Ha/Ca Hp/Cp Hy/Cy HS/CS HE/Cc HE/Nc Hr/Nr
Glu8 7.92/125.6 178.0 4.40/59.6 2.57,2.11/27.9 2.45/32.0
Ser9 8.52/116.6 174.3 4.54/58.2 3.86/63.9
Lys1O 8.67/123.9 177.3 4.40/56.4 1.92,1.84/33.3 1.50/24.7 1.73/29.1 3.01/42.1
Glyll 8.53/109.7 174.5 4.01/45.5
Thr12 8.31/113.3 175.7 4.47/61.6 4.50/71.2 1.33/22.2
Alal3 8.83/124.5 180.2 4.04/55.3 1.44/18.6
Lys14 8.37/118.9 178.2 4.29/58.8 1.85/32.1 1.53/24.8 1.76/28.8 3.01/42.0
Ser15 8.04/115.9 177.7 4.16/61.4 4.00,3.92/62.5
Arg16 8.39/123.5 178.5 4.13/59.4 2.03,1.84/30.5 1.80,1.48/28.2 3.34,3.16/43.5 7.31/83.7 6.76/71.3
Tyr17 8.30/122.1 177.4 4.14/61.2 3.31,3.11/38.5 7.03/133.4 6.80/117.8
Lys18 8.35/118.7 179.2 3.70/59.1 1.88/31.9 1.76,1.58/25.3 1.70/28.8 3.00/42.0
Ala19 7.78/122.2 180.0 4.15/54.7 1.51/18.1
Arg20 7.98/120.0 178.8 4.06/58.8 1.91,1.82/30.2 1.76,1.55/27.7 3.23/43.7 7.40/84.4 (6.90/72.0)
Arg2l 8.25/120.4 177.8 3.77/59.0 1.64,1.39/29.8 1.32,1.27/27.9 3.02,2.74/42.7 7.58/86.5 (6.90/72.0)
Ala22 7.78/120.4 180.2 4.04/54.7 1.47/18.0
Glu23 7.57/118.0 177.9 4.08/58.3 2.11/29.5 2.42,2.30/35.6
Leu24 7.82/120.6 179.6 4.09/57.1 1.80,1.57/42.1 1.69/26.8 0.89/25.0
0.87/23.4
Ie25 8.16/119.3 177.8 3.77/63.3 1.89/37.9 1.51,1.21/28.5 0.78/13.0
0.89/17.5
Ala26 7.73/123.6 178.7 4.15/53.9 1.50/18.6
Glu27 7.77/116.7 176.7 4.21/56.68 2.16,2.05/29.9 2.48,2.35/35.6
Arg28 7.79/120.9 175.6 4.28/56.7 1.94,1.85/30.7 1.78,1.67/27.1 3.15/43.9 7.17/84.7
Arg29 7.80/127.2 - 4.17/57.5 1.83/31.6 1.58/27.3 3.13/43.5 7.16/85.3
fr-I
K)
i.
0
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Figure 3.4.1: The $21 N-peptide shows extensive chemical shift dispersion upon binding
to boxB RNA. This is the 1 N HSQC of the free (black) and bound (red) forms of the
peptide. Peaks are labeled with their assignment using the one-letter amino acid code
and sequence number for the protons of the backbone amide (black), arginine epsilon
(blue) and arginine eta (green). The epsilon and eta protons are folded down in the
15N dimension by 32.9 ppm.
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backbone amides undergo changes. Another important difference in the two spectra is
the increased dispersion of the five arginine epsilon protons. In the free peptide, these
He protons have broad peaks at 7.2 ppm in 1H and 85 ppm in 15N. Upon formation of
the complex, these peaks disperse into separate peaks ranging from 7.2 to 7.6 ppm in
the proton dimension and have a 3 ppm spread in the nitrogen dimension. Finally, the
guanidinium groups of 2 of the arginines become observable in the complex. This is
indicative of hydrogen bond formation by these protons.
The 15N-HSQC spectrum of the peptide in the bound state was used to assay a
number of variations in temperature, pH and salt concentration. Visual examination of
the 1H and 15N linewidths and dispersion was used as a metric for determining optimal
NMR conditions. The best quality spectra were obtained in low salt at 25'C. Peaks
became broader or disappeared at 15'C and below, and above 30'C. As a result, all
subsequent NMR experiments were done at 25'C in the buffer N21 NMR buffer (section
3.3).
3.4.2 Through-bond correlation experiments
Assignment of the peptide 1H, 13C, and 15N backbone and side chain chemical
shifts was done using a number of triple resonance through-bond correlation
experiments. These experiments correlate side chains to their backbone HNi and Ni.
This establishes spin systems for each of the amino acids in the peptide. These through-
bond correlation experiments can also be used to interconnect side chains with the
HNi+1 and Ni+1. These HN assignments correspond to the 1H and 15N peaks in the 15N-
HQSC in figure 3.4.1. Analysis of these connectivities helps to unambiguously assign
all of the spin systems in the peptide (figure 3.4.2). The two experiments here are a
CBCA(CO)NH (Grzesiek and Bax, 1992) and an HNCACB (Muhandiram and Kay,
1994). As described in the figure legend, the CBCA(CO)NH spectrum has peaks that
correlate a side chain CBi,CAi.1-HNi. The HNCACB spectrum has that set of peaks as
well as peaks arising from CBi,CAi->HNi. In my peptide sequence there is only a single
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Figure 3.4.2: CBCA walk through the peptide backbone. Shown are pairs of strips from a CBCA(CO)NH spectrum (black
boxes) and an HNCACB spectrum (green boxes) in the slice corresponding to the proton-nitrogen (HN) plane of the residue
listed below each pair. In both of these experiments, beta carbons are negative peaks (red) and alpha carbons are positive
peak (black). The HNCACB experiment gives peaks for the i and i-1 carbons relative to the HNi. The CBCA(CO)NH gives
peaks only for the i-1 carbons relative to the HNi. In this diagram, there should be 3 peaks across for each alpha and beta,
as illustrated with brackets for the alpha (blue) and beta (purple) carbons of residues 11 through 14.
IH. #21 N-Peptide Biochemistry and NMR
glycine. Since glycine has no beta carbon, in the CBCA(CO)NH experiment there
should be an HN that has only a single cross peak. Similarly, in the HNCACB
spectrum, there should be an HN that has only three cross peaks instead of four (note
the second and third strips in figure 3.4.2). This establishes the chemical shift
assignments of the Glyll-Ca and the Thr12-HN and Thr12-N. The beta carbons of
threonine and serine have a unique 13 C chemical shift range, relative to the other amino
acids (Cavanagh et al., 1996), which made identification of Ala13-HN and Ala13-N
straightforward. Continued analysis of this pair of spectra resulted in assignment of all
the backbone amides and the side chain alpha and beta carbons. More generally, in a
larger protein, identification of short stretches of amino acid connectivities define
unique positions in the protein sequence and sequential assignment. Once the
backbone amides have been assigned, other through bond correlation experiments are
used to assign the rest of the side chain carbons, (H)C(CO)NH (Logan et al., 1992), and
protons, H(C)(CO)NH-TOCSY (Montelione et al., 1992). The good dispersion of the
backbone amides in both 1H and 15N resulted in few problems with spectral overlap in
these experiments
3.4.3 Torsions
Peptide backbone 4 torsion restraints were determined from analysis of an
HNHA experiment (Vuister and Bax, 1993). The ratio of the intensities of the cross peak
and diagonal for each HN/Ha pair can be used to determine the coupling constant
(3 JHNHaz).
Icross/ Idiag = -tan 2 ( 21tJHNHa )
where 'cross and Idiag are the intensities of the cross and diagonal peak, C is the delay time
for evolution of 3JHH COuplings (13.O5ms). The angle 4 is calculated using the Karplus
equation:
J = Acos2 (3) + Bcos(O)+C(
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where A = 6.51, B = -1.76, and C = 1.60 and * = |01+600. There can be two or four
values determined for 4 depending on the value of J, and the stereochemically
reasonable value was used. Small HN-Ha coupling constants (<6 Hz) are indicative of
$ values ~-60*, which is typical for an u-helix.
Deviations of the secondary structure of the peptide backbone from random coil
affect the chemical shift values of the backbone atoms. This effect slightly changes the
chemical shift values, and is usually expressed as differences in the chemical shift from
the random coil value (secondary shift). The program TALOS (Cornilescu et al., 1999)
uses a database of chemical shift assignments for the backbone atoms (Ha, Ca, Cp, CO,
N) of a number of proteins of known structure. Given the set of experimentally
determined chemical shift values for these atoms and the primary sequence of the
peptide, TALOS produces quantitative predictions for the protein backbone + and y
angles. TALOS was used as both a check on the HNHA determined * angle restraints
and to generate backbone y torsion restraints. The output from TALOS is a table of
predicted values for + and y and a measure of the uncertainties in these predictions.
Only y torsions that showed the least uncertainty were used as restraints.
3.4.4 NOESY experiments
The NOESY experiment is used to determine distance restraints. Intramolecular
NOEs define the structure of the peptide and intermolecular NOEs define the peptide-
RNA interface. A variety of NOESY experiments were used to generate distance
restraints for molecular modeling. 15N-NOESY-HSQC (Mori et al., 1995) spectra
recorded at 50, 145 and 250ms identify NOEs from the backbone amides as well as the
arginine side chain Hs and Hi. Figure 3.4.3 shows a set of slices from a 15N-NOESY-
HSQC. It highlights the sequential HN-HN connectivities. The patterns of NOE
connectivities can give an indication of secondary structure. For example, cross peaks
corresponding to Hai->HNi+3, and Hcai-Hi+3 are indicative of an a-helical
conformation. An 15N,13C-.NOESY-.HSQC (Pascal et al., 1994) spectrum recorded at
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Figure 3.4.3: 15N NOESY-HSQC strips for the 021 N peptide in complex with boxB RNA. Each strip corresponds to the
proton-nitrogen (HN) plane for the residue labeled above. The HN-HN sequential NOEs are easy to follow (blue line).
Highlighted crosspeaks are Ala13 to Arg16 Hqi* (red), Lys14 to rC8 amino (green) and Arg16 to Tyr17 Hp*(orange). The
mixing time for the NOESY was 145ms.
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150ms was used to identify NOE cross peaks involving protons connected to 13C in the
backbone and side chains.
The identification of intermolecular NOEs is critical for determining the structure
of the peptide-RNA complex. Analysis of the various NOESY spectra identified
potential peptide-RNA NOEs by simple inspection. There are no peptide protons with
chemical shifts in 4.7-6.8 ppm range. Cross peaks that fall in this range are
intermolecular NOEs to the RNA. An example of this is highlighted in figure 3.4.3.
Identification of these NOEs in regions where peptide and RNA chemical shifts overlap
is less straightforward. The addition of a purge sequence (Ikura and Bax, 1992), and use
of adiabatic heteronuclear inversion pulses (Zwahlen et al., 1997; Zwahlen et al., 1998)
to a 2D version of the 15N,13C-NOESY-HSQC can be used to remove signals from 13C-
and 15N-attached protons in one dimension (filtering) and select for these signals in
another dimension (editing). In a filtered-edited NOESY (FE-NOESY) spectrum, the
peptide-peptide and RNA-RNA NOE cross peaks are removed and only peptide-RNA
cross peaks remain. Figure 3.4.4 shows a region of an FE-NOESY and highlights the
NOEs from Ala13 and Ile25 to the RNA.
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Figure 3.4.4: Identification of intermolecular NOEs. An e)1- 13C-Filtered,to2.13C-Edited
NOESY-HSQC spectrum recorded on an unlabeled boxB RNA in complex with a fully
13C,15N-labeled $21 N-peptide. Some crosspeaks are labeled with their RNA and peptide
assignments (red and blue, respectively).
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Chapter 4. #21 boxB RNA Biochemistry and NMR
4.1 Transcription and Purification of RNA
All RNAs were prepared by transcription from synthetic DNA templates using
T7 RNA polymerase (Wyatt et al., 1991), with T7 polymerase overexpressed and
purified from E. coli. These DNA templates consisted of a T7 promoter region followed
by the coding sequence for the RNA of interest. The standard transcription procedure
of (Wyatt et al., 1991) calls for the 18 nucleotide T7 promoter sequence (top strand) of 5'-
TAATACGACTCACTATAGi-3', with the final G corresponding to the first transcribed
nucleotide. The template strand, or bottom strand, of the RNA used for NMR analysis
was:
5'-GGCTCACCCGGTTAGAGGTGAACCTATAGTGAGTCGTATTA-3'
Transcriptions were optimized using an incomplete factorial (or sparse matrix)
approach similar to that used by (Yin and Carter, 1996), rather than simply testing a
single variable [NTPs], [MgCl2], [T7] and [template/top strand] at a time. This proved
to be a faster method to find optimal transcriptions that gave higher yields than the
single variable method (data not shown). Optimizations were carried out in 50 pL
volumes using a-32P-GTP. The products were run on a 29:1 (Acrylamide-Bis) 20% gel
and quantitated by phophorimaging.
A common problem with the T7 RNA polymerase transcription system is large
amounts of N+1 and, to a lesser extent, N+2 products. The T7 RNA polymerase will
readily add nucleotides to the 3' end of the transcript. The presence of a nucleotide
analog that is unable to form hydrogen bonds causes pausing of transcription by T7,
which in turn leads to premature release of the transcript. Use of 4-methyl-indole at the
end of the transcribed sequence causes a dramatic decrease in the amount of N+1 and
higher add-on transcripts (Moran et al., 1996). (Baklanov et al., 1996) found that
addition of a single CC base pair at the 5' end of the promoter region increased
transcription yields by as much as an order of magnitude for the 485bp template they
used. Both of these strategies were employed for production of N@21 RNA for NMR
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samples. Addition of a CG base pair at the beginning of the T7 promoter sequence and
addition of a 4-methyl-indole nucleotide at the 5' end of the template strand increased
the yield of correct length RNA by about 50% (data not shown). This kind of
enhancement is especially important when making isotopically labeled RNAs from
15N/1 3C nucleotides, which are painstaking to produce. Isotopically enriched NTPs
were prepared by the method of Batey et al., 1995.
The optimized transcription conditions used for the N#21 boxB RNA were: 40 mM
Tris-HCl, pH 8.1, 1 mM spermidine, 0.01% Triton X-100, 15 mM DTT, 80 mg/ml PEG-
8000, 300 nM top strand, 300 nM template strand, 10 mM NTPs (total), 7.8 mM MgCl2
and 0.4 pL T7 RNA polymerase per 50 piL of transcription volume (i.e., 32 ptL for a 4 mL
transcription reaction). Transcription reactions were run for 4 hours at 37 0C, and then
extracted with phenol to remove the T7 RNA polymerase protein. The aqueous phase
was extracted with chloroform:isoamyl alcohol (24:1) to remove any remaining phenol.
The aqueous phase was brought to 0.3M sodium acetate, pH 5.2, and then three volume
equivalents of ethanol were added and the RNA was precipitated overnight at -200C.
After centrifugation at 18000g for 30 minutes, the pellets were decanted and allowed to
air dry. The crude RNA was purified using denaturing preparative gel electrophoresis
on 43x35x0.3 cm 20% acrylamide gels (29:1) containing 8M urea. The product band was
visualized by UV shadowing and cut out of the gel. The RNA was electroeluted using
an Elutrap (Schleicher & Schuell). For a single NMR sample, it typically took 3-5 gels
and many days worth of electroeluting. The final pools of electroeluted RNA were
ethanol precipitated. The RNA pellet was resuspended in ddH 2O and extensively
dialyzed against ddH20. For the most accurate determination of the RNA
concentration, a small sample was hydrolyzed in NaOH, pH 12, followed by
measurement of the UV absorbance at 260 nm. Typical yields for this RNA were 0.5 to
1 mg of clean, pure RNA per ml of transcription.
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4.2 RNA Assignment and Restraints
As noted in section 1.3, NMR of RNA has its own unique set of challenges
including line shape and spectral crowding. The use of hetero-nuclear, multi-
dimensional experiments is crucial for structural determination. Table 4.1 lists
information on the various NMR experiments that were used. Except for the NOESY-
watergate, all of the experiments were performed on a 13C,15N-labeled boxB RNA in
complex with unlabeled N+21 peptide. All experiments were done at 25'C in N+21 NMR
buffer (section 3.3). Table 4.2 lists the chemical shift assignments for the N$21 boxB RNA.
4.2.1 Complex formation
Changes in the 13C-HSQC spectrum of the boxB RNA between the free state and
in complex with N@21 peptide are evident in figure 4.2.1. As mentioned before, changes
in this type of spectrum are indicative of complex formation, and possibly structural
changes. In contrast to the increased dispersion seen for the peptide backbone amides,
there is a slight decrease in the dispersion of the RNA chemical shifts in the complex.
The distribution of the ribose C2' and C3' chemical shifts narrows, and the base
resonances, both proton and 13C. condense into a narrower range of ppm. In the H5
region of the spectrum the U-H5 peaks for U9 and U11 become much weaker, and one
isn't even seen at the contour level used (figure 4.2.1). The C-H5 peaks of C10, C14, and
C24 almost merge. These results indicated that the boxB RNA would present a
challenge in determining all of the chemical shift assignments. Some NOESY data
(discussed below) indicated that the RNA maintained a hairpin structure with the A-
form helix intact. As already mentioned, the chemical shift and intensity changes were
likely due to either close contact with the peptide and possibly conformational changes
in the RNA structure. Protons in the helical stem were least likely to undergo structural
changes, meaning it was most likely that the nucleotides which might be involved in
interesting interactions were the ones showing both crowding and diminished intensity.
As the assignments in figure 4.2.1 show, this ultimately turned out to be true. The H5
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Table 4.1: Data acquisition parameters for boxBf 2l RNA heteronuclear NMR experiments.
Exneriment F3 F2 Fl Note
NOESY-watergate
15N-HSQC
13C-HSQC
dqf-COSY
HCCH-COSY
HCCH-TOCSY
HCCH-COSY-TOCSY
15N-NOESY-HSQC
13C-NOESY-HSQC
2D-HCN
2D-Filtered/Edited
NOESY
2048, 12500, 'H
2048, 8802, 1H
1024, 7180, 'H
768, 4805, 1H
512, 3623, 1H
512, 3623, 1H
256, 1800, 'H
1024, 9615, H
1024, 7184, 'H
1024, 640, 'H
1024, 12820, 'H
1024, 12500, 1H
256, 422, 15 N
512, 5405, 13 C
1024, 4805, 'H
200, 2381, 1H
200, 2381, 1H
128, 1800, 'H
256, 6024, 'H
256, 5435, 'H
256, 2800, 15 N
1024, 7142, 'H
50, 145, and 250 ms
48, 6667, 13C
116, 3333, 13 C
60, 5300, 13 C
100, 333, 15 N
128, 5435, 13C
Rance et al., 1983
Clore et al., 1990
Clore et al., 1990
Hu et al., 1998
Mori et al., 1995
Clore et al., 1990
Sklenar et al., 1993
Ikura & Bax, 1992
Zwahlen et al., 1998
200 ms
250 ms
200 ms
Reference
S
NQ
0
N
0
Ct
- - -
Table 4.2: The 1H, 13C, and 15N chemical shift assignments for the N@21 boxB RNA in the bound form at 250 C. The proton
chemical shifts are referenced to internal TSP. The heteronuclei are referenced to external DSS. The errors in the chemical
shift assignments are 0.02, 0.2 and 0.3 ppm for 1H, 13C, and 15N, respectively.
Residue
g1
g2
U3
U4
C5
A6
C7
C8
U9
C1o
Ull
A12
A13
C14
C15
G16
G17
G18
U19
G20
A21
G22
c23
c24
H1'/C1'
5.84/91.5
5.95/92.9
5.56/93.7
5.67/93.2
5.52/93.7
5.93/92.4
5.41/93.2
5.46/93.7
5.63/94.3
5.43/93.9
5.53/94.9
5.76/93.3
5.65/92.1
5.38/93.3
5.55/92.9
5.55/93.7
5.79/92.9
5.82/93.2
5.57/93.3
5.78/92.3
5.95/92.2
5.63/93.1
5.53/93.9
5.78/92.8
H2,5/C2,5 H1,3/N1,3
13.15/115.2
13.52/148.1
5.51/104.0
5.65/103.2
5.73/97.6
7.37/152.5
5.23/96.7
5.16/97.4
5.68/104.7
5.49/97.7
5.23/102.4
7.76/153.0
8.02/153.6
5.42/97.6
5.70/98.1
amino/Nam
12.00/160.8
14.27/161.4
8.43,6.93/96.1
8.30,6.89/96.4
8.31,6.68/96.2
11.83/160.5
H2'/C2'
4.95/74.8
4.75/75.1
4.22/75.6
4.52/75.1
4.42/75.1
4.54/75.2
4.20/75.6
4.52/75.2
4.11/75.8
4.34/75.7
4.75/74.5
4.92/75.2
4.41/75.6
4.42/75.6
4.44/75.9
4.85/74.2
4.70/75.2
4.51/75.0
4.68/75.1
4.58/75.4
4.60/75.8
4.58/74.9
4.20/75.6
4.03/77.3
H3'/C3'
4.71/74.5
4.47/72.6
4.58/72.2
4.57/72.2
4.60/72.5
4.81/72.2
4.34/71.9
4.35/71.8
4.52/72.2
4.34/71.7
4.41/71.9
4.67/71.8
4.77/71.9
4.14/72.1
4.36/72.4
4.25/73.9
4.60/72.0
4.32/72.8
4.58/72.0
4.68/72.9
4.67/72.8
4.22/73.1
4.48/71.6
4.19/69.5
H4'/C4'
4.57/83.2
4.56/82.3
4.47/82.2
4.43/81.8
4.50/81.5
4.52/81.5
4.39/81.5
4.41/81.5
4.42/82.4
4.34/81.8
4.27/81.8
4.34/82.5
4.39/82.1
4.33/81.5
4.32/81.3
4.46/82.9
4.49/81.9
4.49/81.9
4.47/81.8
4.53/81.8
4.51/81.7
4.48/82.0
4.40/81.8
4.18/83.2
H5',5"/C5'
4.46,4.29/66.9
4.53,4.26/65.6
4.57,4.11/64.1
4.60,4.14/64.6
4.56,4.17/65.2
4.67,4.19/64.3
4.57,4.02/64.1
4.47,4.07/64.7
4.50,4.10/64.3
4.61,4.11/64.1
4.41,4.12/64.2
4.35,4.03/63.5
4.36,4.04/63.7
4.50,4.01/64.5
4.38,4.12/64.4
4.24,4.13/67.6
4.46,4.10/64.1
4.48,4.05/65.2
4.58,4.12/64.3
4.53,4.17/65.5
4.60,4.16/64.9
4.37,4.01/66.4
4.50,4.05/63.9
4.47,4.04/64.9
H6,8/C6,8
8.16/138.6
7.56/136.1
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Figure 4.2.1: Monitoring RNA chemical shift changes upon peptide binding. The 13C HSQC spectrum of the boxB RNA
in the free (black) and bound (red) forms. A- The base region of the spectrum. Some of the better resolved assignments
from the bound form are labeled. Brackets indicate typical 1H chemical shift ranges. B- The sugar region of the HSQC.
Typical 13C chemical shifts are denoted by brackets. Note, in A the H6/H8 protons are folded down in the 13C
dimension by 34.86 ppm.
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and H6 resonances of C8, U9, C10, and U11 were difficult to identify and assign.
Strategies for assigning these weak resonances will be discussed shortly.
4.2.2 Through-bond correlation experiments
Ribose spin systems, the protons and carbons in the ribose ring, can be identified
using traditional 3D HCCH-COSY and HCCH-TOCSY experiments (Clore et al., 1990;
Nikonowicz and Pardi, 1993). These experiments take advantage of large one-bond 'JHC
and 1Jcc couplings to transfer magnetization in a 13C-labeled RNA. These 3D
heteronuclear experiments allowed us to identify of a number of ribose spin systems,
but not all because there were still problems with overlap in both the 1H and 13C
chemical shift regions of the spectra. To get past this overlap and obtain complete
assignment of the RNA, a 3D HCCH-COSY-TOCSY experiment (Hu et al., 1998) was
done (figure 4.2.2). It should be noted that HCCH-COSY-TOCSY does not give
assignments for the H5',H5"/C5'. Assignments from each of these three experiments
were checked against each other and used to fill in gaps or areas of overlap. Combined
with sequential assignment data from NOESY experiments (see below), these 3D
experiments allowed us to completely assign the boxB RNA ribose spin systems.
In order to directly establish ribose to base connectivities, a pair of 2D HCN
spectra were collected (Sklenar et al., 1993). The first experiment correlates the ribose
Hi' to the N1/N9 of the base. The second spectrum correlates the base H6/H8 to the
N1/N9. Connectivities from the ribose Hi' to the H6/H8 of the base are established by
identifying peaks in the two spectra associated with the same glycosidic nitrogen
chemical shift. These connectivities served as a check on the sequential assignments
from the NOESY analysis.
4.2.3 Torsions
Sugar pucker conformation can be estimated from the size of the 3JH1n'-H2' coupling
constant. As indicated (figure 1.3.1), a small coupling constant (~2 Hz) is associated
with a C3'-endo sugar pucker, and a much larger coupling constant (~83 Hz) is
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Figure 4.2.2: Identification of the ribose spin systems. This is a slice from a 13C-COSY-
TOCSY spectrum of the boxB RNA at the 3 C chemical shift of C14 C1'. The horizontal
axis is the TOCSY part of the experiment (solid blue lines). Magnetization is transferred
from one proton to the other ribose protons. The vertical axis arises from a COSY
transfer of magnetization (dashed blue line), i.e. the Hi' to the H2', with a subsequent
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associated with a C2'-endo sugar pucker. In a homonuclear COSY spectrum, only
ribose sugars in the C2'-endo conformation will give cross peaks in the H1'/H2' region
of the spectrum because the C3'-endo coupling constant is too small to be observed.
There were no cross peaks observed in this region of the spectrum for the boxB RNA,
indicating that none of ribose sugar puckers were C2'-endo. An empirical check on the
COSY results can be made by examining the carbon chemical shifts for C1', C3' and C4'.
In a C3'-endo conformation, the C1', C3' and C4' resonate at about 93, 73, and 81 ppm,
respectively (Greene et al., 1995; Greenbaum et al., 1995; Jiang et al., 1996). In contrast,
in a C2'-endo conformation, the C1', C3' and C4' resonate at about 86, 78, and 86 ppm,
respectively. All of the boxB ribose Cl', C3', and C4' carbon chemical shifts fall in the
ranges for a C3'-endo conformation.
The glycosidic torsion angle can be inferred from the intensities of the ribose Hi'
to H6/H8 base NOE cross peaks. A strong cross peak is correlated with a short
distance, indicative of a syn conformation. Conversely, the absence of an Hi' to H6/H8
cross peak in a short mixing time (50 ms) NOESY is consistent with an anti
conformation. A strong H3' to base NOE cross peak in C3'-endo nucleotides is also
indicative of an anti conformation (1.8 - 3.5 A vs. 4.3 - 5.2 A). All of the bases in boxB
RNA had cross peak intensities consistent with an anti glycosidic conformation.
4.2.4 NOESY experiments
For RNA, NOESY experiments are important not just for obtaining distance
restraints, but also for connecting base spin systems to ribose spin systems. The
through-bond experiments generate a collection of assigned ribose spin systems, and
by analysis of the NOESY spectra we can connect ribose and base assignments to the
primary sequence. A first step in this process is a 2D homonuclear NOESY experiment.
The imino-imino region of this experiment is shown (figure 4.2.3). As previously
discussed, (figure 1.3.3), the imino protons in an A-form helix are close enough to each
other to give NOB cross peaks. The strong A-H2 to imino cross peak, and the cytosine
amino to imino cross peaks are used to differentiate between U-H3 and G-H1 imino
78
IV. #21 boxB RNA Biochemistry and NMR
10.6
11.1
G22
11.6 G2
U9
U3
12.1
CLa-G1
- 12 .6 18-17 G17
G18
13.1
G2 2-72
13.6- U19
19-18 20-19
14.1
U4
4-20 22-4
14.5 14.0 13.5 13.0 12.5 12.0 11.5 11.0 10.5
1H PPM
Figure 4.2.3: RNA base pair assignment and imino-imino sequential walk. This is the
imino-imino region of a 1H-homonuclear NOESY. The G-H1 and U-H3 assignments
are listed along the diagonal. Crosspeaks are used to identify sequential imino-imino
NOEs observed between stacked base pairs (blue), beginning at G2. The two G-U
base pair crosspeaks are boxed (orange). They are very strong for U3-G22 and weak,
but observable for U9-G16. The mixing time for the NOESY was 150ms.
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protons. Much like the CBCA assignment strategy for peptides, finding a short stretch
of unique sequence, (i.e., GUG), is used to establish the location in the primary
sequence, and subsequent assignment of imino protons proceeds from there. I was
aided in this step by the presence of two G-U base pairs. Both imino protons in a G-U
base pair are typically shifted upfield and show strong cross peaks to one another
(figure 4.2.3). Interestingly, the U9-G16 imino-imino cross peaks are much weaker than
that of U3-G22, indicative of a less stable base pair. In the absence of peptide, the U9-
G16 cross peaks are not detected, further evidence for a structural change in the RNA
upon peptide binding.
It is possible to perform an Hi' to base sequential walk (figure 1.3.3) in a
homonuclear NOESY experiment. There was, however, too much spectral overlap in
both the Hi' to base and H2' to base regions of the spectrum. This spectrum was only
used to assign NOEs for the exchangable imino and amino protons. A 15N-HSQC
experiment was done to determine the nitrogen chemical shifts for the base imino and
amino protons. Proton assignments made in the NOESY experiment were used to
identify their corresponding nitrogen atoms.
A 13C-NOESY-HSQC (in D20, 250 ms mixing time) was collected with a large
number of complex data points in the 13C dimension (64 points). This experiment took
almost 7 days to complete. The hope was that the increased resolution would help
alleviate as much spectral overlap as possible. This strategy paid off, and this spectrum
yielded a large number of NOEs and helped complete the full assignment of the boxB
RNA. Figure 4.2.4 shows a set of sequential walk slices from this spectrum. The full
range of sequential assignment NOEs (figure 1.3.3) were identified in the boxB RNA
stem. The added resolution proved critical for overcoming the crowding and
diminished intensities evident in the 13C-HSQC.
There are no RNA chemical shift resonances below 3.8 ppm, nor between ~6.0
and 7.0 ppm. Simple inspection of the 13C-NOESY spectrum revealed a number of cross
peaks in these ranges, indicative of RNA to peptide NOEs. Figure 4.2.5 shows slices
from the 1 3 C-NOESY highlighting these easily identifiable intermolecular NOEs.
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Figure 4.2.4: Ribose Hi' to base H6/H8 sequential walk. Each strip is a slice in a 13C NOESY-HSQC corresponding to the
Ci' of the Hi' listed at the top. The trace (blue) shows Hi' to basei and Hi' to basej+1 NOEs. Notice that U11 Hi' has four
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Both as a check on NOEs derived from the 13C-NOESY, and to provide additional NOEs
in areas of overlap, an FE-NOESY spectrum, analogous to the one collected for the
labeled peptide, was obtained for the labeled boxB in complex with unlabeled peptide.
Figure 4.2.6 shows a region of this spectrum and highlights RNA to peptide
intermolecular NOEs.
4.2.5 Unusual features
There were two unusual features in the 13C-NOESY spectrum of the labeled boxB
RNA in complex with the unlabeled peptide. First, there was a slice in the Ci' region
that had cross peaks to four base protons from a single Hi'. This was confusing because
in a normal sequential walk, each Hi' should have a cross peak to only two base
protons, i and i-1. The presence of four base cross peaks to an Hi' in a single C1' carbon
plane would imply, naively, that two ribose Hi's had both the same proton and Ci'
carbon chemical shifts. That would not be too unusual, except there was also a C2'
plane that had the same four base cross peaks to a single H2'. Similarly, the H3' also
had the same four cross peaks. It eventually appeared more likely that this was a single
ribose in an unusual conformation. This unusual ribose turned out to be U11 and the
Hi' slice for this proton is in figure 4.2.4. Second, I was able to sequentially walk the
length of the primary sequence of the boxB RNA from 5' to 3'. I incorrectly assumed at
the outset that the canonical set of A-form helical connectivities would be broken
somewhere in the loop. This assumption was not supported by the NOE data. I
convinced myself that many of the sequential assignment connections held up through
the loop region.
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Figure 4.2.6: Identification of RNA to peptide intermolecular NOEs.
An oi-13C-Filtered,o2_13C-Edited NOESY-HSQC spectrum recorded on an unlabeled
peptide in complex with a fulfy 13C,15N-labeled boxB RNA. Some crosspeaks are labeled
with their RNA (red) and peptide assignments (blue).
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Chapter 5. Molecular Modeling
5.1 Summary of Modeling Restraints
Listed in table 5.1 is a summary of the restraint set used for molecular modeling.
These restraints are the result of sequence specific assignment of both the N21 peptide
and boxB RNA, and assignment of NOESY spectra. Generation of this restraint set was
not a sequential process of making peptide assignments, making RNA assignments, and
assigning NOE distance restraints. Instead, initial chemical shift assignments, both
ambiguous and unambiguous, were guided by analysis of 'footprint' regions of NOESY
spectra. This was especially true for the RNA since much of the chemical shift
assignment relies on NOESY. An iterative process of assignment of chemical shifts, and
checking those assignments against reasonable NOE assignments was used.
5.1.1 NOE distances
The upper bounds for the NOE distance restraints in any given experiment were
grouped into three bins: strong (3.0 A), medium (4.5 A), and weak (6.0 A). All NOE
distance restraints had a lower bound of 1.8 A. Setting all the lower bounds to this
short distance is a cautious approach, which does not limit weak peaks to minimum
distances greater than the van der Waals radii. Setting lower bounds greater than 1.8 A
(for example setting weak peaks to a range of 4.5-6.0 A) does not allow for changes in
intensity that are due to relaxation or conformational exchange broadening. NOE
distances for the peptide exchangeable protons were initially estimated by visual
inspection of the peak intensities in each of the 50, 145 and 250 ms mixing time 15N-
NOESY-HSQC experiments. Peaks only in the 50 ms spectrum were assigned as strong,
peaks only in the 250 ms spectra were classified as weak, with the remaining peaks in
the 145 ms spectra set to medium. Non-exchangeable peptide NOF distances in the
15N,13C-NOESY-HSQC were initially assigned by visual inspection of peak intensities
using intraresidue cross peaks as a guide.
RNA distance restraints were initially all set to weak. The majority of these
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Table 5.1: Summary of distance and torsion restraints used for molecular modeling.
# of Restraints Restraints/Residue
Distance
Peptide intraresidue 158 7.2
Peptide interresidue 192 8.7
RNA Hydrogen bonds 48 2.0
RNA intraresidue 286 11.9
RNA interresidue 328 13.7
Peptide-RNA 52 1.1
Total Distance = 1016 22.1
Torsion
Glycosidic bond 18 0.9
Sugar pucker 120 5.0
Peptide4# 15 0.7
Peptide y 14 0.6
Total Torsion = 167 3.6
Total All = 1183 25.7
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distances restraints came from the single, high-resolution 13C-NOESY-HSQC with a 250
ms mixing time. After the initial few rounds of structure calculations, including
hydrogen bond and torsion restraints, visual inspection of the intensities and their
calculated distances were used to set the distance bin cutoffs. Exchangeable proton
RNA NOE distances were set in a manner similar to that of the peptide exchangeable
protons by comparing the peaks and intensities from a 50, 150, and 250ms mixing time
'H-homonuclear NOESY-watergate experiments. Figure 5.1.1 illustrates the RNA-RNA
internucleotide restraints. Figure 5.1.2 shows the peptide to RNA NOE restraints
obtained from the various spectra.
5.1.2 Torsions
Peptide 4 torsions were set using the values calculated from analysis of the
HNHA experiment. These assignments were supplemented with # and y angle
restraints and uncertainties predicted by the TALOS program, but only if those residues
also had patterns of NOE connectivities consistent with an a-helix: ai-+Ni+3 and ai-Pi+3.
In the RNA, all the glycosidic torsions angles in the stem were set to anti and
restrained to 170-235'. Although the data indicated the loop nucleotides were also
likely to be anti, they were left unrestrained to allow the loop greater conformational
freedom during the modeling process. The NMR data indicated that none of the
nucleotides had a C2'-endo sugar pucker. Initially, only the ribose sugar puckers of the
stem nucleotides were restrained to a C3'-endo conformation. The ribose torsions, vO to
v4, were set to values (± 150) that correspond to C3'-endo. The loop nucleotides were
allowed sugar pucker flexibility throughout the structure calculations, but consistently
ended up in C3'-endo sugar puckers. In the final rounds of refinement, the C3'-endo
torsion restraint was added for the loop nucleotides. Figure 5.1.3 summarizes the NOE
and torsion data for the Nd21 peptide.
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Figure 5.1.1: Schematic of NMR derived internucleotide RNA-RNA restraints.
Dashed lines indicate one or more NOEs between the indicated protons.
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Figure 5.1.2: Schematic of NMR derived peptide-RNA restraints. Arrows indicate
one or more NOEs between the peptide sidechain and the RNA ribose (pentagon) or
base (rectangle).
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Figure 5.1.3: Summary of peptide NMR data. A- Primary sequence of the N021 peptide.
B- Chemical Shift Index (CSI) analysis of the backbone chemical shifts (Wishart et al.
1995) Colors indiate likelihood of a-helix (red), s-sheet (blue), and random coil (rey).
C- Coupling constants (Hz) for backbone alpha to amide proton. * indicates the J value
could not be determined. D- NOE connectivities for the indicated proton pairs. Boxes
indicate strong, medium and weak intensities. Open boxes are connectivites that could
not be observed.
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5.1.3 Hydrogen bonds
The imino proton spectra, and the imino-imino sequential walk indicated base
pairing from g2 through U9, to G16 through c23. As a final check, an HCN-COSY
(Wohnert et al., 1999) spectrum was collected to correlate the hydrogen bond donor
N1/N3 to the N3/N1 acceptor. Each hydrogen bond in a given base pair had a proton
to acceptor restraint of 1.70 - 2.20 A, and a heavy atom donor to acceptor restraint of 2.7
- 3.2 A. These distances are in the range observed for nucleotide base pairs (Saenger,
1984).
5.2 Molecular Modeling
5.2.1 Peptide and RNA structures
The molecular modeling of the N21 peptide-boxB RNA complex was done in
three steps. Figure 5.2.1 gives an outline of the structure modeling and refinement
strategy used for this project. Details for the various modeling input files can be found
in appendix A.2. Peptide and RNA structures were generated separately using ab initio
simulated annealing (SA) starting from a random extended structure in CNSsolve
(Brunger et al., 1998). For both the peptide and the RNA, constrained (torsion)
dynamics was used. This approach is more computer intensive than restrained
(Cartesian) dynamics, but the results are better (Rice and Brunger, 1994). A complete
intramolecular restraint set was generated for each molecule. 100 structures each of the
peptide and RNA were generated.
5.2.2 Docking
Each of the 20 lowest energy peptide and 20 lowest energy RNA structures were
combined in single PDB files, in all 400 possible combinations. The RNA was held at
the origin and the peptide was randomly rotated and moved 100 A away from the
origin. These 400 possible "complexes" were docked using CNS. Prior to docking, the
first round of SA had already folded the peptide and RNA. The objective of the
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Figure 5.2.1: Outline of scheme for generating solved structures. Details of annealing
protocols are in appendix A.2.
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docking was to bring the peptide and RNA together without dramatically perturbing
their structures, so the temperatures for the docking were set much lower than in the
initial calculations (1000 vs. 50000 'K).
5.2.3 Refinement
The 100 lowest energy docked structures were minimized using Sander, a
module of AMBER (Pearlman et al., 1995). As with the docking, the temperature was
kept low, and this energy minimization step was repeated a second time. A comparison
of the two rounds of SA is a good indicator of how well the structures are converging.
Our experience has been that structural minimization using AMBER yields better and
more consistent results for nucleic acid, and protein-nucleic acid complexes. We also
wanted to take advantage of the Generalized Born model for solvation that is
incorporated into AMBER. Structure refinement using implicit solvent is
computationally expensive, but results in both faster convergence and higher quality
structures than in vacuo calculations (Bashford and Case, 2000).
5.3 Structure Statistics
The set of 100 lowest energy structures from the final AMBER refinement were
examined. The fourteen lowest structures had low violation energies and no distance
violation >0.5 A. Table 5.2 summarizes the structural statistics for this set of 14
structures. A superposition of these structures is shown (figure 5.3.1). Because there
are no intermolecular NOE restraints below the C7:G18 base pair, the lower stem has
greater conformational flexibility in the structure calculations, relative to the upper stem
and peptide. The lower portion of the stem can still maintain base pairing and torsion
angles while the helix axis shifts around. The first five amino acids of the peptide also
show structural flexibility in the calculations. There are few intraresidue NOEs in this
part of the molecule and no intermolecular NOEs at all. The ordered 'core' part of the
complex extends from Ala13 through I1e25 in the peptide and the portion of the boxB
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Table 5.2: Summary of structural statistics for the N#21 peptide-boxB RNA complex.
{SA}
NOE violations
R.m.s.d. of violations
Number > 0.1 A
Maximum violation
Torsion violations
R.m.s.d of violations
Number > 0.2'
Maximum violation (0)
R.m.s.d. from ideal covalent geometry
Bond length (A)
Bond angle (0)
R.m.s.d (A) of {SAl from <SA>
All heavy
Corea heavy
0.002 ± 0.019
2.60 ± 1.82
0.41 ± 0.25
0.028 ± 0.013
4.86 ± 1.56
1.62 ± 0.68
0.0114 ± 0.0001
2.25 ± 0.04
2.77 ± 0.87
1.16 ± 0.20
{SA} is the ensemble of 14 lowest energy structures.
<SA> is the average structure of obtained by averaging the coordinates of {SA}.
<SA>r is <SA> that has been restrained energy minimized.
a - Core refers to the ordered region of the peptide-RNA complex defined as amino
acids 13-25 and nucleotides 7-18.
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Figure 5.3.1: Superposition of the 14 lowest energy structures of the N 21 peptide-boxB
RNA complex. The alignment was calculated using only the heavy atoms of the
ordered regions of both the RNA (blue) and the peptide (red). Only the backbone
atoms of the peptide are shown. The view on the right is rotated 900 relative to the
image on the left
V. Molecular Modeling
hairpin above the C7:G18 base pair (nucleotides 7-18). The rmsd of all heavy atoms in
each of the 14 structures to the average structure is 1.16 A. In this 'core' region the a-
helical fold of the peptide is clearly evident and the hairpin loop has a well defined
structure, including stacking of the nucleotides A12 to C15. A Ramachandran plot of
the 14 low energy structures (figure 5.3.2) shows that the peptide backbone torsion
angles are predominately confined to favored regions of the Ramachandran plot. The
few outliers are in residues outside the ordered 'core' a-helical region of the peptide.
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5 0
Phi (degrees)
Plot statistics
Residues in most favoured regions [A,B,L]
Residues in additional allowed regions [a,b,l,p]
Residues in generously allowed regions [-a,-b,-l,-p
Residues in disallowed regions
Number of non-glycine and non-proline residues
Number of end-residues (exci. Gly and Pro)
Number of glycine residues (shown as triangles)
Number of proline residues
Total number of residues
239 89.8%
24 9.0%
1 0.4%
2 0.8%
266 100.0%
28
14
0
Based on an analysis of 118 structures of resolution of at least 2.0 Angstroms
and R-factor no greater than 20%, a good quality model would be expected
to have over 90% in the most favoured regions.
Model numbers shown inside each data point.
Figure 5.3.2: Ramachandran plot of the 14 low energy structures. Analysis was done
using PROCHECK-NMR (Laskowski et al., 1996).
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Chapter 6. Structure of the $21 Peptide-RNA Complex
6.1 N Peptide Structure
The N@21 peptide in complex with the boxB RNA forms a core a-helix spanning
residues Ala13 to Ala26, with the first five and last three amino acids in an extended
conformation (figure 6.1.1). The 4 and 'v angles for the amino acids Ala13-Ala26 fall in
the a-helical range of the Ramachandran plot (Morris et al., 1992). The conserved
residues Ala13, Arg16, Arg20, and Arg2l of the N peptide family do not appear to lie on
a particular face of the a-helix (figure 6.1.1). There is a slight curvature of the helical
axis, but no disruption of helical connectivities. There are no apparent hydrogen bonds
between side chains in the structure. In the a-helical portion of the peptide, all side
chains with potential hydrogen bond donor moieties are oriented on one face of the
helix, while the potential hydrogen bond acceptor side chains lie mostly on the opposite
face.
The non-helical regions of the peptide, Glu8-Thr12 and Glu27-Arg29, are
randomly oriented away from boxB RNA in the set of structures, as evident from the
superposition of the 14 low energy structures (figure 5.3.1). These residues had few
inter-residue NOEs and no NOEs to the boxB RNA. Deletion analysis (figure 3.2.1)
showed that a peptide truncated at Thr12, just before the conserved Ala13, was unable
to bind boxB RNA. One reason for the reduced affinity could be a destabilization of the
a-helix at the beginning of the binding region. The first seven amino acids of full-length
N021 contain a number of hydrophobic residues, including two valine, an isoleucine, and
a tryptophan. While not important for RNA binding, these residues could play a role in
subsequent N-protein folding, or contribute to protein-protein interactions in the
complete antitermination complex.
6.2 boxB RNA Structure
The 421 boxB RNA in complex with the N peptide adopts a stem-loop structure,
with the stem mostly Watson-Crick base paired A-form helix, and the hexanucleotide
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Figure 6.1.1: Structure of the average, minimized $21 N-peptide bound to boxB RNA. The backbone ribbon/carbons
(green) and the backbone nitrogens (blue) and oxygens (red) illustrate the predominately a-helical fold of the peptide.
The conserved residues Ala13, Arg16, Arg2O, and Arg2l are highlighted (purple).
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loop showing both extensive base stacking and novel base-base and ribose-base
interactions (figure 6.2.1). The stem of the boxB RNA contains seven Watson-Crick base
pairs and two canonical U:G base pairs, U3:G22 and U9:G16. The stem is essentially A-
form helix, with no significant perturbations of ribose sugar puckers or base glycosidic
angles.
In the hexanucleotide loop of boxB RNA, the four bases on the 3' end stack on the
3' strand of the stem, extending the topology of A-form helix to the tip of the loop
(figure 6.2.1). The nucleotide C15, located at the 3' end of the hexanucleotide loop,
stacks on G16, the 3' base in the U9:G16 loop-closing base pair. This stacking in the
hexanucleotide loop is continued upward with nucleotides C14, A13, and A12. Two
views of the boxB RNA loop are presented in figure 6.2.2, showing the stacking of A12
to C15, and the A-form-like conformation of the RNA backbone.
The ability of these four loop nucleotides to mimic an A-form like stacked
conformation is facilitated by a number of factors. Some backbone torsion angles
deviate from canonical A-form values, predominately the phosphodiester a and ;
angles of nucleotides C10 to A12. This allows a mere two nucleotides to connect the
stacked four nucleotides to the 5' strand of the A-form helical stem. Second, nucleotides
ClO and C15 make base pair-like interactions with each other. In 12 of the 14 low
energy structures, the N4-amino of C15 can hydrogen bond to either the N3 or 02 of
ClO. The C10:C15 pair stacks on the U9:G16 base pair similarly to canonical A-form
helix. This C10:C15 pairing can only be inferred because there is no NMR signal from
either amino proton, which would indicate a stable hydrogen bond. Third, packing of
the U11 ribose against the bases of A12, A13, and C14 makes a tiny hydrophobic core in
the loop, supported by the extensive NOEs observed between the U11 ribose and these
bases. The glycosidic torsion angle of UlI is almost high-anti, ~ 13O0 versus -16Oo. This
twisting of the base relative to the ribose likely results from both interactions with the N
peptide and the unusual orientation of Ull in the boxB loop. Finally, U11 is positioned
to make electrostatic interactions or hydrogen bonds to the phosphate backbone of the
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Figure 6.2.1: Two views of the $21 boxB RNA in the bound form. The peptide is not shown. The heavy atoms and a
ribbon through the phosphate backbone are shown (blue). The hexanucleotide loop residues (cyan) are numbered. The
stem forms a typical A-form helix, closed at the top with the U9-G16 base pair. The four bases at the 3' end of the loop
show extensive stacking. The view on the right is rotated 900 relative to the view on the left.
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A12
A13
U11 C14
C1O C15
Figure 6.2.2: U11 has unusual ribose-to-base interactions in the boxB loop.
Both the Hi' (red) and H2 (green) of Ull (cyan) collectively give NOEs to the base
protons H6/H8 ( ) of A12, A13 and C14 as well as U11. These two views
highlight the postion of the U11 ribose almost in the center of the boxB loop.
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four stacked nucleotides in the loop. The H3-imino of U11 is positioned to interact with
the non-bridging phosphate oxygens of C14, and the U11 ribose 2'-hydroxyl is located
near the phosphate oxygens of A12.
6.3 The #21 Complex
6.3.1 General features
A stereo view of the minimized average structure of the +21 N peptide-boxB
RNA complex is shown (figure 6.3.1). The a-helical N peptide predominately contacts
the 5' strand of the boxB helical stem in the major groove, and contacts the face of the
boxB loop opposite the four stacked nucleotides. The four highly conserved amino acids
(highlighted green in figure 6.3.1) are all oriented toward the RNA, and make extensive
intermolecular contacts, as expected from numerous mutagenesis studies (Lazinski et
al., 1989; Franklin, 1993; Cilley and Williamson, 1997). The ordered a-helical region of
the peptide, residues Ala13 to Ala26, spans the RNA from the C7:G18 base pair in the
stem to nucleotide A12 at the very top of the loop. As expected, there are a variety of
contacts, including hydrogen bonds to bases, ionic interactions with the phosphate
backbone, and numerous van der Waals interactions. The structure of the +21 complex
recapitulates a number of common themes seen in interactions between helical,
arginine-rich peptides and RNA (Weiss and Narayana, 1998; Draper, 1999; Jones et al.,
2001), such as arginines with bidentate hydrogen bonds to the phosphate backbone,
aromatic side chains interacting with non-polar faces of the base and ribose, and an a-
helix structure interacting in the major groove of an RNA stem. There is an extensive
literature of in vitro and in vivo biochemical and mutational studies for the N' protein
(Franklin, 1993; Su et al., 1997) and nut RNA antitermination system in bacteriophage X
(Doelling and Franklin, 1989; Chattopadhyay et al., 1995; Mogridge et al., 1995; Tan and
Frankel, 1995; Cilley and Williamson, 1997). Unfortunately, there is little such data for
the N@21 system. As a result, discussion of the relative importance of specific peptide-
RNA contacts in the N21 complex will be deferred to a later section (6.4) where it can be
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Figure 6.3.1: Stereo view of the minimized average structure of the $21 N peptide-boxB
RNA complex. The heavy atoms and phosphate backbone ribbon of the RNA (blue) is
shown in complex with the peptide (red). The conserved residues, Ala13, Arg16, Arg2O,
and Arg2l, are highlighted (green). The C-terminus, Arg2O, and the 3' and 5' ends of
the RNA, are labeled.
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compared in detail to the solved structures of the homologous N-boxB complexes.
6.3.2 Electrostatic and hydrogen bond interactions
One third of all residues in the N021 peptide are either lysine or arginine. The
N#21 peptide belongs to a loose class of protein sequences called the "arginine-rich
motif"'. Members of this 'class' have ultimately shown little sequence or structure-
specific homology, but all use arginine side chains in binding and recognition of the
RNA major groove. Figure 6.3.2 shows that almost all of the positively charged side
chains of the N021 peptide make extensive contacts with the phosphate backbone. The
guanidino groups of the conserved arginines, Arg16, Arg20, and Arg2l, are within 5 A
of the phosphate backbone on the 5'-ascending stem of the boxB RNA. The guanidino
group of Arg28 is more distant from the phosphate of A12, but could still contribute a
favorable electrostatic interaction in the complex. The amino group of Lys18 is within 5
A of the phosphate group of C14 on the opposite side of the groove. Analysis of the
family of low energy structures indicates that some of these guanidino and amino
groups may be making stronger ionic interactions, or even hydrogen bonds, to the
phosphate backbone. While not as apparent in the average structure (figure 6.3.2), in all
14 structures the guanidino groups of Arg16 are <2.4 A from the non-bridging
phosphate oxygens of C7 and C8, in many cases close to both phosphate groups. The
amino group of Lys18 is equally close to the phosphate of C14 in 13 of the 14 structures.
Arg2l makes an extensive set of interactions, as discussed in the next section. In 12 of
the 14 structures, the Tyr17-Hi is <2.4 A from the C10 phosphate group. While not as
obvious in its ability to provide a positive surface for electrostatic interactions with
RNA backbones, tyrosine has been shown to have a high propensity for forming
hydrogen bonds in protein-RNA complexes (Jones et al., 2001).
There are no clear sequence-specific interactions in the peptide-RNA complex. In
all 14 of the low energy structures, the amino group of Lysl4 penetrates into the major
groove and makes close contacts to one or more of the Hoogsteen faces of G16, G17, and
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Figure 6.3.2: Electrostatic and hydrogen bond interactions with the phosphate backbone.
The boxB RNA is shown (blue transparent surface) with the phosphate (white) and $21
peptide backbone (red). Theside chain heavy atoms of the arginines (purple), one lysine
(orange), and the tyrosine ( ) are shown. The Nil, NC and On of the residues are
shown as spheres. The phosphates are labeled along the phosphate backbone.
Highlighted peptide sidechains are labeled along the peptide backbone using the
single-letter amino acid code.
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G18. The lack of precision in the placement of Lys14 from the NOE data makes it
impossible to definitively assign it a role in sequence-specific recognition of boxB.
Collectively, these arginine and lysine side chains, together with the contribution of
Tyr17, create a unique positive surface on one side of the N@21 peptide ct-helix that
interacts with the negatively charged RNA phosphodiester backbone and contributes to
recognition of boxB RNA.
6.3.3 Role of arginine 21
All of the conserved arginines in the N021 peptide are within electrostatic and
hydrogen bonding distances to the boxB RNA. From examination of the structure of the
complex, we believe the conserved Arg2l plays a role in specific recognition of boxB
RNA. Figure 6.3.3 shows a close-up of Arg2l, with its guanidino and amide hydrogens
highlighted. Arg2l rests in the curve of the phosphate backbone from C10 to A13 at the
top of the boxB loop. The Hc and H1 protons are all close enough to the phosphate
backbone to provide a framework around which the backbone can organize. All of the
other arginines that make contacts to the phosphate backbone do so by simply
extending out towards a particular phosphate or pair of phosphates without any other
contact with the RNA. The 15N-HSQC of the peptide in the complex shows that the
Arg2l-Hc is shifted downfield in both the 1H and '5N dimensions from all of the other
Arg-Hc protons, indicative of being in a structural context different from the other Arg-
Hc protons. In addition to its extensive ionic interactions, the aliphatic part of the Arg2l
side chain makes van der Waals contacts with the base H5 and H6 of U11. The ability of
arginine to make a variety of polar and non-polar interactions in order to accommodate
a particular binding surface on an RNA is a common motif (Weiss and Narayana, 1998;
Legault et al., 1998).
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Arg21
Figure 6.3.3: Close contacts between Arg2l and phosphates in the $21 boxB loop.
This view is perpendicular to the plane of Arg2l (purple). It is evident that the
HE and Hfl protons (green) are in a position to make electrostatic or hydrogen bonds
to the phosphates of C10, U11, A12 and A13 (cyan spheres).
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6.3.4 van der Waals contacts
There are 1100 k2 of buried surface area in the N$21 peptide with its boxB RNA
complex, and non-polar interactions play an important role. Figure 6.3.4 shows that
from Ala3 to Ile25, with each turn of the a-helix, the peptide side chains make van der
Waals contact to the 5' bases and riboses of the boxB RNA. The methyl group of Ala3
lies between C7 and C8, packing against both the ribose and base H5/H6 protons of
these nucleotides. This alanine is conserved among the family of N proteins, and
mutagenesis of this position in the Ni system showed that only alanine and serine
maintained wild-type binding affinity for the boxB RNA (Su et al., 1997). Tyr17 is one
turn up the a-helix and lies between U9 and C10, the next two bases up the stem from
the Ala3 position. In addition to the electrostatic interaction of the Tyr17-Ha, the
phenol ring lies against the edges of H5/H6 protons of U9 and C10, and the ribose of
U9. Further along the a-helix, Arg2l is positioned to make van der Waals contacts with
U11 of the boxB loop, as discussed above. Finally, Ile25 makes extensive van der Waals
contacts with the ribose of A12, at the very top of the boxB hairpin. Although the
interactions of Arg2l with U11 may play a role in supporting the shape of the RNA
backbone in the loop, the close contact of Ile25 may support the backside of the boxB
loop on the 3' side. Lys18 may also play a role in recognition and stabilization of the
boxB loop. The Lys18-Hy and H6 groups make potentially important van der Waals
contacts with the ribose of A13.
6.3.5 Summary of contacts
There is a clear structural divide in the N@21 peptide recognition and binding to the boxB
hairpin; residues in the lower half recognize and interact with the stem part of the boxB
hairpin, and residues in the upper half organize and interact with the boxB loop. A
summary of the various peptide-RNA contacts is graphically shown in figure 6.3.5 and
schematically in figure 6.3.6. The two views in figure 6.3.5 highlight the position of the
peptide along the major groove of the RNA helix. Normally, the major groove of
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Figure 6.3.4: van der Waals contacts in the complex. The boxB RNA shown (transparent blue surface) with the
phosphate backbone (white) and the $21 peptide backbone (red). The side chain heavy atoms of interacting residues( ) are rendered as CPK spheres and labeled along the peptide backbone in the lefthand image. The image on
the right is rotated 1800 relative to the image on the left.
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Figure 6.3.5: N021-peptide contacts the major groove of the boxB RNA stem-loop. Two
stereo views summarize the binding of N021-peptide to boxB RNA, looking down from
the top of the loop (A) and from the major groove side of the hairpin (B). The important
nucleotides (cy an) are all in the 5' half of the RNA (blue). The N021-peptide backbone
and non-interacting sidechains (red) show the a-helix and its solvent-exposed face.
Amino acid sidechains important for electrostatic and hydrogen bonding interactions
include Argl6, Arg2O, Arg2l (purple), Lysl4, and Lys18 (( - ). van der Waals
interactions include Alal3, Tyrl7, and Ile25 ( ). Potential hydrogen bond donors
from peptide sidechains (green) all lie near RNA backbone phosphates (k . n spheres).
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Figure 6.3.6: Schematic of the N 21 peptide-boxB RNA contacts. Only the upper part
of the boxB hairpin that interacts with the peptide is shown. Rectangles, pentagons,
and circles represent the nucleotide base, ribose and phosphate, respectively.
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A-form RNA is too narrow to allow penetration of a peptide a-helix. The ends of RNA
helices, however, are more accessible (Weeks and Crothers, 1993), and that is the case
with this complex. Residues in the lower half of the a-helix, Ala13 through Arg20,
predominately contact the 5'-half of the boxB stem with both van der Waals contacts to
bases and sugars, and electrostatic interactions with the 5'-phosphate backbone. There
is only a single residue, Lys14, that potentially makes sequence-specific interactions.
Only Lys18 contacts the 3'-side of the stem, with the A13-ribose and C14-phosphate.
Residues in the upper half of the peptide helix, Arg21 through Arg28, interact with the
boxB loop. Arg2l has a number of polar and non-polar interactions with multiple
moieties in the loop, while Lys18 and Ile25 contribute to creating the surface of the
peptide presented to the RNA loop above and below Arg2l.
6.4 Comparison to Other N Peptide-boxB Complexes
6.4.1 Overview of X, 421, and P22 N-boxB structures
The NMR solution structures of the N peptide-boxB RNA complexes for
phage X (Legault et al., 1998; Scharpf et al., 2000) and phage P22 (Cai et al., 1998) have
been determined. Figure 6.4.1 shows those structures along with the N021 peptide-boxB
complex. All three peptides bind as a-helices. The NX peptide has a pronounced bend
in the a-helix of ~120' as a result of deviations of the backbone $ and Y angles for
Arg1l. This bend has been shown to be important for NX binding (Tan and Frankel,
1995; Su et al., 1997) and antitermination in vivo (Franklin, 1993; Su et al., 1997). The
NP22 peptide a-helix is also bent, but not as dramatically as that of NX. In contrast, the
N@21 peptide a-helix is almost linear. This result is consistent with the NMR-derived
NOE connectivities and backbone torsion angles. In all three complexes, the conserved
alanine and conserved arginines play important roles in binding their cognate boxB
RNAs, though not always the same in each structure. In addition to the conserved
residues, each peptide has a unique subset of residues that participate in the peptide-
RNA interaction, which will be discussed shortly.
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Figure 6.4.1: The family of lambda phage N peptide-boxB RNA complexes. The three structures show the heavy atoms
and backbone ribbon of the N peptides (red) bound to their cognate boxB RNA (blue). The conserved alanine and three
conserved arginines are highlighted (green). The X complex was solved by Legault et al., 1998. The P22 complex was
solved by Cai et al., 1998.
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All three boxB RNAs form hairpin structures. The stems of each are essentially
A-form helical RNA. The sequences of the pentanucleotide loops of X (GAAGA) and
P22 (GACAA) are similar, and in fact both the X and P22 boxB loops adopt a fold that
almost identical to a GAAA-type GNRA tetraloop (N is any nucleotide and R is any
purine). In each case, one of the five nucleotides in the loop is excluded from the
tetraloop fold. The X boxB loop excludes the fourth nucleotide, G, while in P22 it is the
third nucleotide, C (figure 6.4.1). In a GNRA tetraloop, the first G and last A form a
sheared G-A base pair (type XI; Saenger, 1984). There is a severe change in direction of
the phosphate backbone between the first G and the second nucleotide (N) in the loop.
The last three nucleotides in the GNRA sequence sequentially stack on the 3' stem
below the loop. The GAAA tetraloop structure has been solved by both NMR (Heus
and Pardi, 1991; Jucker et al., 1996), and X-ray crystallography (Scott et al., 1995; Cate et
al., 1996). The rmsd values of superpositions of the X and P22 GAAA tetraloop folds
with GAAA tetraloops from crystal structures were 1.4 and 0.8 A, respectively. The NX
peptide makes no contacts with the bulged G. It was shown that mutation of the fourth
position have no effect on N binding, and mutations that abolish the "GNRA" sequence
diminish NX binding (Doelling and Franklin, 1989; Cilley and Williamson, 1997). By
inspection, the CUAACC sequence of the #21 boxB loop is not a candidate for a GNRA
tetraloop fold. As detailed previously (section 6.2), the $21 hexanucleotide loop folds
with the first 2 nucleotides in unusual conformations that facilitate a sequential stacked
conformation of the last 4 nucleotides.
6.4.2 RNA helical stem binding and recognition
The binding of N021 peptide to its cognate boxB hairpin has a bipartite character;
the residues in the lower half of the a-helix interact with the boxB stem, and the upper
part of the a-helix interacts with the boxB loop. A similar division can be made in the
NX and Nr 22 peptide-boxB complexes. The bend in the NX peptide a-helix occurs at
Argll1 (Legault et al., 1998). The slight bend in the Nr 22 peptide a-helix is centered
between Arg6r 22 and Clu8r22 (Cai et al., 1998). Figure 6.4.1 shows that all three N
115
VI. Structure of the #21 Peptide-RNA Complex
peptides interact with their cognate boxB stems in the lower half of their structures.
Interestingly, the sequence alignment of the three N peptides in figure 1.2.3-B shows
that there exists the greatest degree of homology in the first half of the sequences.
Between the conserved alanine and the last of the three conserved arginines, a total of
nine residues, there is only one position that isn't the same in at least two of the three
sequences. This is graphically illustrated in figure 6.4.2. The high degree of sequence
homology, combined with similar c-helical secondary structure results in the three N
peptides being almost identical in their binding and recognition of the boxB stem.
The conserved alanine, Ala13421, packs against a pair of 5'-nucleotide bases and ribose
sugars that are in the same relative position in the boxB stems (cyan coloring in figure
6.4.2). This is a 5'C-C step in X and 421, and 5'G-C in the P22. Mutation of the X 5'C-C
step to 5'G-G only diminished antitermination activity ~6-fold (Chattopadhyay et al.,
1995). This would imply that while the interaction of this conserved alanine with the
boxB stem at this position contributes to N binding, it is more likely a non-specific than
sequence-specific interaction. The first of the three conserved arginines, corresponding
to Arg1621, make electrostatic interactions with the phosphate backbone (light blue in
figure 6.4.2). Like the conserved alanine, these interactions occur in the same position
along the boxB stem. In both the X and 421 complexes, the guanidino groups of this
arginine make close contact with the phosphate backbone. In the P22 structure, as
reported (Cai et al., 1998), this same arginine is not as strongly oriented towards the
phosphate backbone. An Arg6X->Ala mutation at this position in NX reduces binding
by about >20 fold (Su et al., 1997) and decreases antitermination activity (Franklin,
1993). The next residue up the a-helix is Tyr1721 and arginines in the corresponding
position of X and P22. While not the same residue in all three N peptides, they have
very similar contacts with the pair of 5'-nucleotides next up from the alanine step. The
Tyr7t2, Arg7X, and Arg6r 22 are highlighted in green along with their corresponding
nucleotides in figure 6.4.2. All three make hydrogen bond or electrostatic interactions
with the phosphate backbone, and all three make van der Waals contacts with the bases
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Figure 6.4.2: The N-peptides recognize the boxB stem in a similar fashion. An amino acid sequence alignment of the three
related N-peptides is at the top. In the figures, the three boxB RNA hairpins (blue, phosphates are purple spheres) and the
three peptide backbones have been superimposed using the backbone atoms of cyan and green-colored nucleotides and
the backbone and side chain heavy atoms from the conserved alanine (cyan) to the conserved arginine (It. blue, with
vol et Ni spheres). The pairwise rmsd is 1.41 ± 0.22. The coloring of the sidechains and bases in the figures corresponds
to the coloring in the sequence alignment. The nucleotides on the 3-half of the boxB stem have been removed for clarity.
The view on the right is rotated 900relative to the view on the left.
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and ribose sugars. The arginines in X and P22 at this position also make additional
electrostatic interactions that tyrosine, with its single polar group, would be unable to
duplicate. Finally, the second conserved arginine, Arg20+21, makes electrostatic contacts
with the phosphate backbone in the same region in the three structures. In all three
structures, this arginine appears to have a weaker, more distant interaction than any of
the other arginines. Even so, alanine substitutions at this position in NX had deleterious
effects similar to those described above for Arg6X. It is after this position that the three
N peptides diverge in their recognition of and interactions with their cognate boxB
hairpins. Though previously put forth (Legault et al., 1998; Cai et al., 1998), the
hypothesis that the more conserved part of the three N peptides have similar modes of
binding the boxB RNA stem is only strengthened by addition of the N#21 peptide-boxB
structure. The amino acid sequences of X and P22 in this part of the peptide are almost
exactly the same. N#21 helps to identify the position and types of interactions that are
important for boxB stem binding.
6.4.3 Organization of the boxB loop
Figure 6.4.1 and the right-hand image in figure 6.4.2 show that as the N peptides
traverse up beyond the boxB stem and begin to interact with the boxB loop, they diverge
sharply from the structural homology they shared along the stem. The pronounced
bend in the NX a-helix accommodates the stacking of Trp18 on top of the AAA stack of
the tetraloop. This interaction is a critical determinant in X recognition since neither of
the other N peptides have an aromatic residue near this position in their primary
sequence, and mutation of this position diminishes or abolishes binding (Su et al., 1997).
Most of the residues between Argl1" and Lysl9 X are involved in electrostatic and van
der Waals interactions with the GAAA tetraloop formed by box B . The Nr 22 peptide
interacts with its cognate boxB through extensive van der Waals interactions with C that
is excluded from the tetraloop structure of the rest of the loop. Nr22 has far fewer
interactions with the tetraloop structure of its boxB3 than does 2.
118
VI. Structure of the #21 Peptide-RNA Complex
The boxB hairpin does more than simply anchor N protein to the RNA transcript
and help deliver N to RNA polymerase. A G->C mutation at the fourth position in the
boxBX loop, or substitution of the GAAGA with a GAAA tetraloop sequence have no
effect on NX binding in vitro, but abolish binding of NusA to an N -boxB complex
(Mogridge et al., 1995; Legault et al., 1998). Similar mutations abolish antitermination
activity in vivo and with a minimal N, NusA, RNAP antitermination system, and
indicated that it was the 3'-half of the boxB stem that was being recognized
(Chattopadhyay et al., 1995). This evidence suggests that boxB interacts with other
elements of the transcription antitermination complex. NusA has an S1 homology
region, which are found in proteins that can nonspecifically bind to RNA (Bycroft et al.,
1997). This S1 domain is activated to bind RNA by both N protein and the x subunit of
E. coli RNAP (Mah et al., 2000). Though there has been no direct evidence of a NusA-
boxB interaction in the absence of N protein, NusA is a likely candidate for interaction
with the boxB hairpin.
NP22 and NX peptide-boxB complexes form essentially the same loop structure.
The faces of the stacked adenosines point out and away from the N peptides (figure
6.4.2, right side). What was not clear, prior to this structural determination, was how
the N#21 peptide-boxB complex would structure the boxB421 loop. The loop sequence has
no clear homology to any tetraloop sequences, and is more pyrimidine rich than the X
and P22 loops.
The boxB421 loop has some structural homology with the GNRA-type tetraloops
of boxBk and boxBP22. The last four nucleotides in the loop, AACC, stack on the 3'-stem
analogous to the AAA stacking the tetraloops. Figure 6.4.3 shows a superposition of the
stacked AACC of boxB021 and the stacked Trp20 and AAA of boxBX. This view shows
the face of the loop that would be presented to NusA or other bacterial host factors.
There is a striking similarity in both the geometry and the constellation of hydrogen
bond donors and acceptors between the two loops, and supports the hypothesis that the
N-boxB complex interacts with some other factor in the antitermination complex. This
119
VI. Structure of the #21 Peptide-RNA Complex
021
Trp18
Figure 6.4.3: X and $21 N peptides organize their boxB RNA loops in a similar way.
In this stereo view, the $21 and X peptides are shown as ribbons (red and orange,
respectively), with Trp18 of the X N-peptide the only amino acid displayed (cyan). The
boxB loops of $21 and X (blue and cyan, respectively) are shown as heavy atoms and
ribbons. The X and $21 structures have been superimposed using the heavy atoms of
$21 A12, A13, C14 and C15 with X Trp18, A9, A10 and A12 with a resultant rmsd of
1.9A (106 atoms). The potential hydrogen bond donors and acceptors in both structures
are highlighted as spheres (green and purple, respectively).
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degree of structural similarity would be a surprising coincidence given the disparate
RNA loop sequences and the very different ways in which they bind to their cognate N
proteins. This similarity must be important for function.
6.4.4 Summary of N-boxB structure and recognition
The N proteins show little structure in the absence of RNA, and the RNA loops
are also less structured in the absence of peptide (Legault et al., 1998; Cai et al., 1998).
The N peptides of X, P22 and 421 all interact with the stems of their cognate boxB
hairpins using a very similar set of electrostatic and van der Waals interactions to
present a surface against which a 5'-ascending stem can bind. There is little sequence-
specific recognition along the stem by any of the peptides. The stem binding part of
these a-helices appears to play a role in anchoring the peptide so that the upper part of
the a-helix can bind to the boxB loop. These N peptides bind their boxB loops in very
different ways. The conformational changes that occur down the length of the peptide
and in the boxB loop may play a role in specific recognition. A significant result is that
these three peptides, despite having very different sets of interactions with their boxB
loops, ultimately organize the 3'-half of their boxB hairpins to be structurally and
chemically similar.
6.5 Next Steps
6.5.1 Further explore specificity of the N-boxB complex
The structures of these three related protein-RNA complexes provide a
framework for further biochemical and biophysical investigation of both general and
specific aspects of protein-RNA recognition. As stated earlier, there is little mutagenesis
data on the N+21-boxB complex. This is also true for the Nr2 2 -boxB complex. There is a
wealth of mutational and biochemical data on the N -oxB complex. Generating similar
kinds of data on the effects of base pair changes, amino acid substitutions and chemical
modification of functional groups on the RNA for all three complexes would further
illuminate features of binding affinity and specificity. It would seem that the stem
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binding half of these c-helices is somewhat general and non-specific. All three of the
stems are pyrimidine-rich on their 5'-halves. Are there steric clashes that preclude
purines for high affinity binding?
It is clear that the N peptides are anchored to the boxB stem in a similar fashion.
It is difficult to determine by simple inspection which moieties in the upper part of the
a-helices are involved in binding specificity and in what ways. Thermodynamic studies
would determine what factors contribute to the ability of the different N proteins to
discriminate amongst their cognate boxB RNAs.
6.5.2 N-boxB interaction with NusA
There is evidence that NusA interacts with the 3'-half of the boxB hairpin (Mah et
al., 2000). We have an increased understanding of the binding surface on boxB available
for NusA. Exploration of that binding interaction would further understanding of
protein-RNA recognition.
There remains an important question that is un-answered by any of the three
complexes. NusA cannot bind the X boxB-N peptide complex if the fourth nucleotide (A
or G) is removed or is mutated to a C or U. Supershifts with NusA are sensitive to the
identity at this position. The $21 and P22 structures have no purine base bulged out the
side of the loop, as in the X structure. How is it that NusA can still interact with these
other two boxB RNAs? Or is the X structure somehow changed by mutation or deletion
of that nucleotide?
NusA has some binding affinity for N protein, and the NusA binding and RNA
binding domains of N are distinct (Van Gilst and von Hippel, 1997). How N mediates
RNA binding by NusA is not known. Investigation of this tripartite complex would be
an interesting study of protein-mediated, protein-RNA interactions. NusA plays a role
in pausing of the transcription complex. Interaction of NusA with N and boxB RNA
reverses that role (Mah et al., 2000). There is evidence that NusA binds termination
hairpins on the nascent transcript and through that interaction, has an allosteric effect
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on the RNAP active site (Toulokhonov et al., 2001). What role does N play in
potentially sequestering this function of NusA?
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Appendix A. Modeling Details
A.1 Restraint Details
The restraint lists are done in UPL format, a format used by AMBER. The format of the
UPL distance restraint file is:
From Residue To Residue Optional
# Name Atom # Name Atom [Lower Bound] UpperBound (# PeakNumber:PeakListID#
The format of the torsion angle restraints is:
Residue
# Name AngleName: (#A Res Atom)-(#B Res Atom)-(#C Res Atom)-(#D Res Atom) Lower Upper
A.1.1 Peptide
# Distance restraints
8 GLU Hl
9 SER H
9 SER H
10 LYS H
10 LYS H
10 LYS H
10 LYS H
10 LYS H
10 LYS H
10 LYS H
10 LYS H
10 LYS HA
10 LYS HA
10 LYS QE
10 LYS H
10 LYS H
11 GLY H
11 GLY H
11 GLY H
11 GLY H
11 GLY H
11 GLY QA
11 GLY QA
12 THR H
12 THR MG2
12 THR H
12 THR H
12 THR H
12 THR H
12 THR HA
12 THR H
12 THR HA
12 THR H
12 THR H
13 ALA H
13 ALA H
13 ALA H
13 ALA H
13 ALA H
13 ALA H
13 ALA HA
13 ALA HA
14 LYS H
14 LYS H
14 LYS H
14 LYS H
14 LYS H
14 LYS H
8
8
9
8
9
9
9
10
10
10
10
10
10
10
11
12
10
10
10
10
10
10
12
10
10
11
11
12
12
12
13
13
15
15
12
12
13
15
16
16
16
16
12
12
13
13
13
14
GLU HB2
GLU HA
SER QB
GLU HB3
SER H
SER HA
SER QB
LYS HB2
LYS HB3
LYS QD
LYS QG
LYS QD
LYS QG
LYS QG
GLY QA
THR H
LYS H
LYS HA
LYS HB2
LYS HB3
LYS QG
LYS HB3
THR MG2
LYS HB3
LYS HB3
GLY H
GLY QA
THR HB
THR MG2
THR MG2
ALA H
ALA H
SER H
SER QB
THR HB
THR MG2
ALA MB
SER H
ARG HB3
ARG QH
ARG HB2
ARG HB3
THR HB
THR MG2
ALA H
ALA HA
ALA MB
LYS QB
6.00
4.50
6.00
6.00
4. 50
4.50
4.50
4.50
4.50
6.00
6 00
6.00
4.50
4.50
6.00
6.00
6.00
4.50
4.50
4.50
6.00
6.00
6.00
6.00
6.00
4.50
4.50
6.00
4.50
3.00
6.00
4.50
6.00
4.50
3.00
6.00
3.00
6.00
6.00
6.00
6 .00
6 .00
3.00
6.00
4.50
4.50
4.50
4.50
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(# 240:91
(# 199:91
(# 200:91
(4 153:81
(4 18:71
(4 20:71
(4 22:71
(4 154:71
(4 24:71
(4 454:61
(4 183:71
(# 64:61
(4 70:61
(# 21:61
(4 12:91
(4 225:71
(4 341:61
(4 149:71
(# 270:71
(4 170:71
(4 269:71
(4 297:61
(4 11:61
(# 214:81
(4 496:61
(4 185:71
(4 140:71
(4 487:61
(4 141:71
(4 29:61
(4 142:71
(4 131:61
(4 45:91
(4 308:71
(4 12:71
(4 448:61
(4 13:71
(# 445:61
(# 160:81
(4 159:81
(4 74 0 : 61
(4 1:61
(4 161:91
(# 162:91
(4 112:71
(# 282:71
(4 117:71
(# 115:71
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Appendix A. Modeling Details
29 ARG QD 29 ARG QB 4.50 (# 15:61
29 ARG QG 29 ARG HA 6.00 (# 668:61
# Torsion restraints
13 ALA PHI: (12 THR
14 LYS PHI: (13 ALA
15 SER PHI: (14 LYS
16 ARG PHI: (15 SER
17 TYR PHI: (16 ARG
18 LYS PHI: (17 TYR
19 ALA PHI: (18 LYS
20 ARG PHI: (19 ALA
21 ARG PHI: (20 ARG
22 ALA PHI: (21 ARG
23 GLU PHI: (22 ALA
24 LEU PHI: (23 GLU
25 ILE PHI: (24 LEU
26 ALA PHI: (25 ILE
27 GLU PHI: (26 ALA
13 ALA PSI: (13 ALA
14 LYS PSI: (14 LYS
15 SER PSI: (15 SER
16 ARG PSI: (16 ARG
17 TYR PSI: (17 TYR
18 LYS PSI: (18 LYS
19 ALA PSI: (19 ALA
20 ARG PSI: (20 ARG
21 ARG PSI: (21 ARG
22 ALA PSI: (22 ALA
23 GLU PSI: (23 GLU
24 LEU PSI: (24 LEU
25 ILE PSI: (25 ILE
26 ALA PSI: (26 ALA
A.1.2 RNA
4 Exchangable
1 RG
1 RG
1 RG
2 RG
2 RG
2 RG
2 RG
2 RG
2 RG
2 RG
2 RG
3 RU
3 RU
3 RU
3 RU
3 RU
3 RU
3 RU
3 RU
3 RU
4 RU
4 RU
4 RU
4 RU
4 RU
5 RC
5 RC
6 RA
7 RC
7 RC
7 RC
8 RC
9 RU
9 RU
9 RU
16 RG
17 RG
proton
Hi
Hi
Hi
Hl
Hi
Hi
Hi
Hi
Hi
Hi
HI
Hi'
H3
H3
H3
H3
H3
H3
H3
H3
Hi'
H3
H3
H3
H3
H5
H5
Hi'
H5
H5
H42
H5
H5
H3
H3
Hi
Hi
C)-(13 ALA N)-(13 ALA CA)-(13
C)-(14 LYS N)-(14 LYS CA)-(14
C)-(15 SER N)-(15 SER CA)-(15
C)-(16 ARG N)-(16 ARG CA)-(16
C)-(17 TYR N)-(17 TYR CA)-(17
C)-(18 LYS N)-(18 LYS CA)-(18
C)-(19 ALA N)-(19 ALA CA)-(19
C)-(20 ARG N)-(20 ARG CA)-(20
C)-(21 ARG N)-(21 ARG CA)-(21
C)-(22 ALA N)-(22 ALA CA)-(22
C)-(23 GLU N)-(23 GLU CA)-(23
C)-(24 LEU N)-(24 LEU CA)-(24
C)-(25 ILE N)-(25 ILE CA)-(25
C)-(26 ALA N)-(26 ALA CA)-(26
C)-(27 GLU N)-(27 GLU CA)-(27
N)-(13 ALA CA)-(13 ALA C)-(14
N)-(14 LYS CA)-(14 LYS C)-(15
N)-(15 SER CA)-(15 SER C)-(16
N)-(16 ARG CA)-(16 ARG C)-(17
N)-(17 TYR CA)-(17 TYR C)-(18
N)-(18 LYS CA)-(18 LYS C)-(19
N)-(19 ALA CA)-(19 ALA C)-(20
N)-(20 ARG CA)-(20 ARG C)-(21
N)-(21 ARG CA)-(21 ARG C)-(22
N)-(22 ALA CA)-(22 ALA C)-(23
N)-(23 GLU CA)-(23 GLU C)-(24
N)-(24 LEU CA)-(24 LEU C)-(25
N)-(25 ILE CA)-(25 ILE C)-(26
N)-(26 ALA CA)-(26 ALA C)-(27
distance restraints
24 RC H41
24 RC H42
24 RC HS
3 RU H3
22 RG Hi
22 RG H21
23 RC Hi'
23 RC H41
23 RC H42
23 RC H5
24 RC Hi'
2 RG Hl
3 RU H5
3 RU H6
4 RU H5
4 RU H6
22 RG Hi
22 RG H21
23 RC H41
23 RC H42
3 RU H3
5 RC H41
5 RC H42
21 RA H2
22 RG Hi'
5 RC H41
5 RC H42
20 RG Hi
7 RC H41
7 RC H42
18 RG Hi
8 RC H42
9 RU H3
16 RG Hi
16 RG H22
16 RG QH2
7 RC H42
6.00
6.00
6.00
6.00
6.00
6.00
6.00
4.50
3.00
6.00
6.00
6.00
6.00
6.00
6.00
6.00
3.00
6.00
6.00
6.00
6.00
6.00
6.00
4.50
6.00
4.50
4.50
6.00
6.00
6.00
4.50
6.00
6.00
6.00
6.00
6.00
6.00
129
ALA
LYS
SER
ARG
TYR
LYS
ALA
ARG
ARG
ALA
GLU
LEU
ILE
ALA
GLU
LYS
SER
ARG
TYR
LYS
ALA
ARG
ARG
ALA
GLU
LEU
ILE
ALA
GLU
C)
C)
C)
C)
C)
C)
C)
C)
C)
C)
C)
C)
C)
C)
C)
N)
N)
N)
N)
N)
N)
N)
N)
N)
N)
N)
N)
N)
N)
251.0
286.5
280.5
287.5
256.0
240.0
276.0
280.0
285.0
275.0
247.0
282.5
261.5
271.5
219.5
299.0
299.0
291.0
307.0
300.0
292.0
299.0
301.0
298.0
293.0
296.0
299.0
295.0
296.0
351.0
316.5
316.5
305.5
336.0
360.0
318.0
316.0
321.0
329.0
347.0
312.5
333.5
313.5
333.5
353.0
335.0
345.0
337.0
336.0
346.0
335.0
337.0
340.0
341.0
338.0
335.0
349.0
356.0
(#4
(#4
(#4
(#4
(#4
(#4
(#4
(#4
(#4
(#4
(#4
(#4
(#4
(#4
(#4
(#4
(#4
(#4
(#4
(#4
(#4
(#4
(#4
(#4
(44
(44
(#4
(#4
(#4
(44
(#4
(#4
(#4
(#4
(44
(#4
(#4
145 :41
146 :41
192 :41
60 :41
61 :41
13:41
15:41
10:41
12 :41
16:41
14 :41
158:41
35:41
56:41
34:41
57:41
66:41
33:41
31:41
32:41
160:41
51:41
53 :41
0:41
52:41
102 :41
129:11
148:41
99:41
96:41
128 :31
175:41
149:41
78:41
82:41
79:41
30:41
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17
17
17
17
17
17
17
18
18
18
18
18
18
18
18
19
19
19
19
19
19
19
19
19
19
20
20
20
20
20
20
20
20
21
22
22
22
22
22
22
22
22
23
23
24
24
RG
RG
RG
RG
RG
RG
RG
RG
RG
RG
RG
RG
RG
RG
RG
RU
RU
RU
RU
RU
RU
RU
RU
RU
RU
RG
RG
RG
RG
RG
RG
RG
RG
RA
RG
RG
RG
RG
RG
RG
RG
RG
RC
RC
RC
RC
Hi
Hi
Hi
Hi
Hi
Hi
Hi
Hi
Hi
Hi
Hi
Hi
Hi
Hi
Hi
H3
H3
H3
H3
H3
H3
H3
H3
H3
H3
Hi
Hi
Hi
Hi
Hi
Hi
Hi
Hi
Hi'
QH2
QH2
Hi
Hi
Hi
QH2
Hi
Hi
H5
H5
H5
H5
8
8
8
9
9
18
18
6
7
7
7
8
8
17
19
6
7
7
7
18
19
19
20
20
20
4
5
5
5
6
6
21
21
20
2
3
4
4
22
22
23
23
23
23
23
23
RC
RC
RC
RU
RU
RG
RG
RA
RC
RC
RC
RC
RC
RG
RU
RA
RC
RC
RC
RG
RU
RU
RG
RG
RG
RU
RC
RC
RC
RA
RA
RA
RA
RG
RG
RU
RU
RU
RG
RG
RC
RC
RC
RC
RC
RC
Hi'
H41
H4 2
Hi'
H3
Hi'
H8
H2
H41
H5
H6
Hi'
H42
Hi
Hi'
H2
Hi
H41
H42
Hi
Hi'
H5
Hi
Hi'
H8
H3
Hi'
H41
H42
H2
H8
H2
H8
Hi
Hl
H3
Hi'
H3
H21
Hi
Hi'
H41
H41
H42
H41
H42
# Non-exchangable proton distance restraints:
1 RG Hi' 1 RG H3'
1 RG Hi' 1 RG H4'
1 RG Hi' 1 RG H8
1 RG H2'1 1 RG H4'
1 RG H2'l 1 RG H8
1 RG H3' 1 RG H5'2
1 RG H3' 1 RG H8
1 RG H5'1 1 RG Hi'
1 RG H5'1 1 RG H2'l
1 RG H5'1 1 RG H3'
1 RG H5'1 1 RG H8
1 RG H5'2 1 RG Hi'
1 RG H5'2 1 RG H2'1
1 RG H8 1 RG H4'
1 RG H8 1 RG H5'2
1 RG Hi' 2 RG H8
1 RG H2'l 2 RG H5'2
1 RG H2'l 2 RG H8
1 RG H3' 2 RG H8
1 RG H4' 2 RG H8
2 RG Hi' 1 RG H2'l
2 RG H5'1 1 RG H2'l
2 RG H5'2 1 RG H3'
2 RG H8 1 RG H8
2 RG Hi' 2 RG H3'
2 RG Hi' 2 RG H8
2 RG H2'l 2 RG H8
6.00
4.50
4.50
4.50
6.00
4.50
6.00
6.00
4.50
6.00
6.00
6.00
6.00
6.00
6.00
3.00
6.00
6.00
6.00
4.50
6.00
6.00
6.00
6.00
6.00
6.00
6.00
4.50
3.00
6.00
6.00
4.50
6.00
6.00
6.00
6.00
6.00
6.00
4.50
3.00
6.00
6.00
6.00
6.00
6.00
6.00
4.50
4.50
6.00
4.50
6.00
6.00
6.00
6.00
6.00
6.00
6.00
6.00
6.00
6.00
6. 00
6 .00
6. 00
4 .50
6 .00
6 .00
6.00
6.00
6. 00
6. 00
6.00
6 .00
6 .00
(f 28:41
(# 137:41
Ut 26:41
(# 139:41
(# 83:41
(f 27:41
(# 140:41
(# 20:41
(f 18:41
U# 25:41)
(# 19:41
(ft 24:41(f 22:41(ft 63:41 )
(ft 23:41)
(ft 4:41
(ft 8:41 )
(ft 2:41 )
(ft 5:41 )
(f 58:41
(t 7:41
(#t 9:41(#t 59:41)(# 6:41
(ft 3:41 )
(f 68:41
(f 44:41
(ft 36:41 )
(ft 41:41)
(ft 39:41
(ft 37:41)
(ft 40:41 )(t 38:41
(# 147:41
(# 180:41
(# 182:41
(f 49:41
(ft 69:41 )
(f 48:41
(# 181:41
(ft 50:41 )
(f 46:41
(ft 98:41 )
(ft 97:41
(# 101:41
(# 94:41
(# 242:21
(# 243:21
(ft 47:21)
(# 588:21
(# 159:21
(# 593:21
(# 163:21
(# 697:21
(# 819:21
(# 632:21
(# 698:21
(# 700:21 )
(# 820:21
(# 351:21
(f 352:21
(ft 48:21)
(ft 589:21)
(ft 160:21)
(ft 164:21)
(ft 406:21)
(ft 522:21)
(ft 835:21)
(ft 839:21)
(ft 442:21)
(#t 231:21)
(ft 32:21)
(ft 148:21)
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Appendix A. Modeling Details
6 RA H4' 6 RA H8 6.00 (# 432:21
6 RA H5'1 6 RA Hi' 6.00 (# 828:21
6 RA H5'1 6 RA H3' 6.00 (# 666:21
6 RA HS'l 6 RA H4' 4.50 (# 667:21
6 RA H5'1 6 RA H8 6.00 (# 738:21
6 RA H5'2 6 RA Hi' 6.00 (# 829:21
6 RA H8 6 RA H5'2 6.00 (# 345:21
6 RA Hi' 7 RC H6 6.00 (# 37:21
6 RA H2 7 RC H2'1 6.00 (# 773:21
6 RA H2'i 7 RC H5 6.00 (# 261:21
6 RA H2'1 7 RC H6 3.00 (# 143:21
6 RA H3' 7 RC H5 6.00 (# 283:21
6 RA H3' 7 RC H6 6.00 (# 180:21
6 RA H4 7 RC H6 6.00 (# 433:21
6 RA H8 7 RC H6 6.00 (# 446:21
7 RC Hi' 6 RA H2 4.50 (# 30:21
7 RC Hi' 6 RA H2'i 6.00 (# 228:21
7 RC H5 6 RA Hi' 6.00 (# 771:21
7 RC H5 6 RA H8 6.00 (# 68:21
7 RC Hi' 7 RC H5'2 6.00 (# 520:21
7 RC Hi' 7 RC H6 6.00 (# 29:21
7 RC H3' 7 RC H5 6.00 (# 290:21
7 RC H3' 7 RC H5'2 4.50 (# 622:21
7 RC H3' 7 RC H6 4.50 (# 193:21
7 RC H4' 7 RC H6 6.00 (# 435:21
7 RC H5'1 7 RC Hi' 6.00 (# 1129:21
7 RC H5'1 7 RC H4' 4.50 (# 677:21
7 RC H5'1 7 RC H6 6.00 (# 753:21
7 RC H6 7 RC H2'1 6.00 (# 334:21
7 RC H6 7 RC H5'2 6.00 (# 335:21
7 RC H2'1 8 RC H5 6.00 (# 257:21
7 RC H2'1 8 RC H5'2 4.50 (# 1028:21
7 RC H2'1 8 RC H6 6.00 (# 137:21
8 RC H1' 8 RC H3' 4.50 (# 1033:21
8 RC Hi' 8 RC H6 6.00 (# 15:21
8 RC H2'1 8 RC H6 6.00 (# 145:21
8 RC H3' 8 RC H6 6.00 (# 194:21
8 RC H4' 8 RC Hi' 6.00 (# 395:21
8 RC H4' 8 RC H6 6.00 (# 434:21
8 RC H5 8 RC Hi' 6.00 (# 1285:21
8 RC HS'l 8 RC H6 6.00 (# 732:21
8 RC HS'2 8 RC Hi' 6.00 (# 736:21
8 RC H5'2 8 RC H6 6.00 (# 735:21
8 RC Hi' 9 RU H6 6.00 (# 14:21
8 RC H2'1 9 RU H5'2 6.00 (# 585:21
8 RC H2'1 9 RU H6 4.50 (# 144:21
8 RC H3' 9 RU H6 6.00 (# 199:21
9 RU H6 8 RC H5 6.00 (# 93:21
9 RU Hi' 9 RU H6 6.00 (# 5:21
9 RU H2'1 9 RU H6 4.50 (# 1248:21
9 RU H3' 9 RU H6 6.00 (# 182:21
9 RU H4' 9 RU Hi' 6.00 (# 383:21
9 RU H4' 9 RU H6 6.00 (# 414:21
9 RU H5 9 RU H3' 6.00 (# 1281:21
9 RU H5 9 RU H5'2 6.00 (# 1282:21
9 RU H5'1 9 RU Hi' 6.00 (# 741:21
9 RU H5'l 9 RU H4' 3.00 (# 680:21
9 RU H5'l 9 RU H6 6.00 (# 754:21
9 PU H5'2 9 PU HG 6.00 (#i 747:21
9 PU H2'1 10 PC H4' 6.00 (if 863:21)
9 PU H2'1 10 PC H5 6.00 (if 250:21)
9 PU H2'1 10 PC HG 6.00 (if 138:21)
9 PU H3' 10 PC H5 6.00 (if 861:21)
9 PU H3' 10 PC H46 6.00 (if 1249:21)
9 PU Hi' 16 PG QH2 6.00 (if 162:41)
10 PC Hi' 9 PU H2'1 6.00 (if 213:21)
10 PC PG 9 PU Hi' 6.00 (if 958:21)
10 PC Hi' 10 PC H5'1 6.00 (if 510:21)
10 PC Hi' 10 PC HG 6.00 (if 8:21)
10 PC H2'1 10 PC H5'1 6.00 (if 901:21)
10 PC H2'l 10 PC H6 6.00 (if 900:21)
10 PC H3' 10 PC H5'1 6.00 (if 1268:21)
10 PC H3' 10 PC HG 6.00 (if 1266:21)
10 PC H4' 10 PC Hi' 4.50 (if 392:21)
10 RC H4' 10 RC H6 6.00 (# 427:21 )
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Appendix A. Modeling Details
13 RA H3' 13 RA H8 6.00 (# 186:21
13 RA H4' 13 RA Hi' 6.00 (# 387:21
13 RA H5'1 13 RA Hi' 6.00 (# 991:21
13 RA H5'1 13 RA H3' 6.00 (# 685:21
13 RA HS'l 13 RA H 6.00 (# 765:21
13 RA H8 13 RA Hi' 6.00 (# 106:21
13 RA H8 13 RA H5'2 6.00 (# 341:21
13 RA Hi' 14 RC H5 6.00 (# 1064:21
13 RA Hi' 14 RC H6 6.00 (# 46:21
13 RA H2 14 RC H2'1 6.00 (# 470:21
13 RA H2 14 RC H3' 6.00 (# 471:21
13 RA H2 14 RC H6 6.00 (# 1270:21
13 RA H2'1 14 RC H5'2 6.00 (# 571:21
13 RA H2'1 14 RC H6 3.00 (# 133:21
13 RA H3' 14 RC H5 6.00 (# 285:21
13 RA H3' 14 RC H6 6.00 (# 187:21
13 RA H4' 14 RC H6 6.00 (# 420:21
13 RA H8 14 RC H5 6.00 (# 108:21
13 RA H8 14 RC H6 6.00 (# 448:21
14 RC Hi' 13 RA H2 4.50 (4 21:21
14 RC H5 13 RA H2'1 4.50 (# 492:21
14 RC Hi' 14 RC H3' 4.50 (# 865:21
14 RC Hi' 14 RC H6 6.00 (# 23:21
14 RC H2'1 14 RC H5'2 6.00 (# 1087:21
14 RC H3' 14 RC H5'2 6.00 (# 624:21
14 RC H3' 14 RC H6 6.00 (# 196:21
14 RC H4' 14 RC H6 6.00 (# 437:21
14 RC H5 14 RC H3' 6.00 (# 493:21
14 RC H5 14 RC H5'2 6.00 (# 494:21
14 RC H5'1 14 RC Hi' 6.00 (# 731:21
14 RC H5'1 14 RC H6 6.00 (# 730:21
14 RC H6 14 RC H5'2 6.00 (# 325:21
14 RC Hi' 15 RC H6 6.00 (# 22:21
14 RC H2'1 15 RC H6 4.50 (# 132:21
14 RC H3' 15 RC H5 6.00 (# 291:21
14 RC H3' 15 RC H6 4.50 (# 195:21
14 RC H4' 15 RC H5 6.00 (# 397:21
14 RC H4' 15 RC H6 6.00 (# 1261:21
14 RC H5 15 RC H6 6.00 (# 62:21
14 RC H5'1 15 RC H6 6.00 (# 988:21
14 RC H5'2 15 RC H5 6.00 (# 1180:21
14 RC H5'2 15 RC H6 6.00 (# 986:21
14 RC H6 15 RC H6 6.00 (# 452:21
15 RC H5 14 RC H2'1 6.00 (# 485:21
15 RC H5 14 RC H5 6.00 (# 844:21
15 RC H5 14 RC H6 6.00 (4 57:21
15 RC H5'1 14 RC 1' 6.00 (# 745:21
15 RC 1' 15 RC H5'2 6.00 (# 524:21
15 RC H2'1 15 RC H6 4.50 (# 1025:21
15 RC H3' 15 RC H5 6.00 (# 1000:21
15 RC H3' 15 RC H6 4.50 (# 185:21
15 RC H4' 15 RC Hi' 6.00 (# 398:21
15 RC H4' 15 RC H6 6.00 (# 436:21
15 RC H5'1 15 RC Hi' 6.00 (# 743:21
15 RC H5'1 15 RC H5 6.00 (# 989:21
15 RC H5'1 15 RC H6 6.00 (# 744:21
15 RC H5'2 15 RC H6 6.00 (# 1149:21
15 RC H6 15 RC H11' 6.00 (# 128:21
15 PC H2'1 16 PG H8 4.50 (#4 1253:21)
16 PG H8 15 PC 113' 6.00 (#* 353:21)
16 PG H18 15 PC 115 6.00 (#* 114:21)
16 PG 12'1 16 PG H18 6.00 (#* 165:21)
16 PG 113' 16 PG H11' 6.00 (#* 400:21)
16 RG H13' 16 PG HS'2 6.00 (#* 600:21)
16 PG 113' 16 PG H18 6.00 (#* 167:21)
16 PG 114' 16 PG H11' 6.00 (#* 381:21)
16 RG 114' 16 PG H2'1 6.00 (#* 841:21)
16 PG 114' 16 PG H18 6.00 (#* 408:21)
16 PG H5'1 16 PG Hi' 6.00 (#* 694:21)
16 PG H15'1 16 PG H2'1 6.00 (#* 826:21)
16 PG H5'l 16 PG H18 6.00 (#* 693:21)
16 PG H5'2 16 PG Hi' 6.00 (#* 696:21)
16 PG HS'2 16 PG H12'1 6.00 (#* 827:21)
16 PG H18 16 PG H11' 6.00 (#* 115:21)
16 RG H8 16 RG H5'2 4.50 (# 355:21 )
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16 RG H2'i 17 RG Hi' 6.00 (# 808:21
16 RG H2'1 17 RG H3' 6.00 (# 1118:21
16 RG H2'1 17 RG H5'1 6.00 (# 595:21
16 RG H2'1 17 RG H5'2 6.00 (4 597:21
16 RG H2'1 17 RG H8 3.00 (# 166:21
16 RG H3' 17 RG H8 4.50 (# 168:21
16 RG H4' 17 RG H8 6.00 (# 409:21
16 RG H5'i 17 RG H8 6.00 (# 824:21
16 RG H5'2 17 RG H8 6.00 (# 825:21
16 RG QH2 17 RG H8 6.00 (# 172:41
17 RG Hi' 16 RG QH2 4.50 (# 86:41
17 RG H8 16 RG Hi' 6.00 (# 120:21
17 RG H8 16 RG H8 6.00 (# 441:21
17 RG Hi' 17 RG H8 6.00 (# 34:21
17 RG H2'1 17 RG H8 6.00 (# 401:21
17 RG H3' 17 RG Hi' 4.50 (# 287:21
17 RG H3' 17 RG H8 6.00 (# 189:21
17 RG H4' 17 RG H8 6.00 (# 423:21
17 RG H5'1 17 RG Hi' 6.00 (# 843:21
17 RG H5'2 17 RG Hi' 6.00 (# 759:21
17 RG H8 17 RG H5'1 6.00 (# 363:21
17 RG H8 17 RG H5'2 6.00 (# 365:21
17 RG Hi' 18 RG H8 6.00 (4 35:21
17 RG H2'1 18 RG H5'2 6.00 (# 579:21
17 RG H2'1 18 RG H8 4.50 (# 149:21
17 RG H3' 18 RG H8 6.00 (# 190:21
18 RG Hi' 17 RG H2'1 6.00 (# 995:21
18 RG H5'1 17 RG H2'1 6.00 (# 831:21
18 RG Hi' 18 RG H8 6.00 (# 17:21
18 RG H2'1 18 RG H8 6.00 (# 156:21
18 RG H3' 18 RG Hi' 6.00 (# 278:21
18 RG H3' 18 RG H8 4.50 (# 174:21
18 RG H4' 18 RG Hi' 6.00 (# 389:21
18 RG H4' 18 RG H8 6.00 (# 417:21
18 RG H5'1 18 RG Hi' 6.00 (# 717:21
18 RG H5'1 18 RG H8 6.00 (# 716:21
18 RG HS'2 18 RG Hi' 6.00 (# 720:21
18 RG H8 18 RG H5'2 6.00 (# 372:21
18 RG Hi' 19 RU H6 6.00 (# 16:21
18 RG H2'1 19 RU H5 4.50 (# 399:21
18 RG H2'1 19 RU H6 3.00 (# 155:21
18 RG H3' 19 RU H5 6.00 (# 404:21
18 RG H3' 19 RU H6 6.00 (4 403:21
18 RG H8 19 RU H6 6.00 (# 440:21
19 RU Hi' 6 RA H2 6.00 (# 812:21
19 RU H5 18 RG Hi' 6.00 (# 505:21
19 RU H5 18 RG H8 6.00 (# 55:21
19 RU Hi' 19 RU H5 6.00 (# 813:21
19 RU Hi' 19 RU H6 4.50 (# 20:21
19 RU H3' 19 RU H5 6.00 (# 1017:21
19 RU H3' 19 RU H6 4.50 (# 1021:21
19 RU H4' 19 RU Hi' 6.00 (# 1242:21
19 RU H4' 19 RU H6 6.00 (# 965:21
19 RU HS'l 19 RU Hi' 6.00 (4 1141:21
19 RU H5'1 19 RU H6 6.00 (# 739:21
19 RU HS'2 19 RU Hi' 6.00 (# 1192:21
19 RU H5'2 19 RU H6 6.00 (# 1195:21
19 RU H6 19 RU H2'1 6.00 (# 1309:21
19 RU H2'1 20 RG H5'2 6.00 (44 583:21)
19 RU H2'1 20 RG H8 3.00 (44 150:21)
19 RU H4' 20 RU HR 6.00 (#4 1255:21)
20 RU Hi' 6 RA H2 4.50 (44 43:21)
20 RG HR 6 RA H2 6.00 (#4 790:21)
20 RG H5'l 19 RU Hi' 6.00 (44 833:21)
20 RU H5'1 19 RU H2'1 6.00 (44 656:21)
20 RG RB 19 RU Hi' 6.00 (44 122:21)
20 RU HR 19 RU H3' 4.50 (44 367:21)
20 RG H2'l 20 RU H8 6.00 (44 903:21)
20 RU H3' 20 RU Hi' 6.00 (#4 276:21)
20 RU H3' 20 RU HB 6.00 (44 171:21)
20 RU H4' 20 RU Hi' 6.00 (44 388:21)
20 RU H4' 20 RU RB 6.00 (#4 421:21)
20 RU H5'1 20 RU RB 6.00 (44 712:21)
20 RU HS'2 20 RU Hi' 6.00 (#4 714:21)
20 RG HS'2 20 RG H3' 4.50 (# 658:21 )
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20 RG H8 20 RG Hi' 6.00 (# 121:21
20 RG H8 20 RG H5'2 6.00 (# 368:21
20 RG Hi' 21 RA H8 6.00 (# 42:21
20 RG H2'1 21 RA H8 4.50 (# 141:21
20 RG H8 21 RA H8 6.00 (# 791:21
21 RA Hi' 21 RA H2 6.00 (# 40:21
21 RA Hi' 21 RA H8 6.00 (# 38:21
21 RA H2 21 RA H2'l 6.00 (# 464:21
21 RA H2'1 21 RA H8 6.00 (# 402:21
21 RA H3' 21 RA Hi' 6.00 (# 277:21
21 RA H3' 21 RA H8 4.50 (# 172:21
21 RA H4' 21 RA Hi' 6.00 (# 1022:21
21 RA H4' 21 RA H8 6.00 (# 422:21
21 RA HS'l 21 RA H' 6.00 (# 722:21
21 RA H5'1 21 RA H8 6.00 (# 721:21
21 RA R5'2 21 RA Hi' 6.00 (# 726:21
21 RA H8 21 RA H5'2 6.00 (# 348:21
21 RA Hi' 22 RG H8 6.00 (# 39:21
21 RA H2 22 RG H8 6.00 (# 1288:21
21 RA H2'1 22 RG H1' 6.00 (# 247:21
21 RA H2'1 22 RG H4' 6.00 (# 565:21
21 RA H2'1 22 RG H8 3.00 (# 130:21
21 RA H3' 22 RG H8 6.00 (# 173:21
22 RG QH2 4 RU H6 6.00 (# 168:41
22 RG Hi' 21 RA H2 4.50 (# 27:21
22 RG H8 21 RA H8 6.00 (# 439:21
22 RG Hi' 22 RG H3' 6.00 (# 227:21
22 RG Hi' 22 RG H4' 4.50 (# 226:21
22 RG Hi' 22 RG H8 6.00 (# 28:21
22 RG H2'1 22 RG H8 6.00 (# 152:21
22 RG H3' 22 RG H8 6.00 (# 170:21
22 RG H5'l 22 RG Hi' 6.00 (# 703:21
22 RG H5'2 22 RG Hi' 6.00 (# 702:21
22 RG H8 22 RG H4' 6.00 (# 374:21
22 RG H8 22 RG H5'1 6.00 (# 375:21
22 RG H8 22 RG H5'2 6.00 (# 377:21
22 RG Hi' 23 RC H6 6.00 (# 26:21
22 RG H2'1 23 RC H5 6.00 (# 266:21
22 RG H2'1 23 RC H6 3.00 (# 151:21
22 RG H3' 23 RC H5 6.00 (# 275:21
22 RG H3' 23 RC H6 6.00 (# 169:21
22 RG H4' 23 RC H5 6.00 (# 385:21
22 RG H5'1 23 RC H5 6.00 (# 704:21
22 RG H5'1 23 RC H6 6.00 (# 821:21
22 RG H5'2 23 RC HS 6.00 (# 707:21
22 RG HS'2 23 RC H6 6.00 (# 705:21
22 RG H8 23 RC H6 6.00 (# 438:21
22 RG QH2 23 RC H6 6.00 (# 169:41
23 RC H1' 22 RG H2'1 4.50 (# 209:21
23 RC Hi' 22 RG QH2 4.50 (# 88:41
23 RC H5 22 RG H8 6.00 (# 66:21
23 RC Hi' 23 RC H5'2 6.00 (# 509:21
23 RC H1' 23 RC H6 4.50 (# 7:21
23 RC H3' 23 RC Hi' 6.00 (# 293:21
23 RC H3' 23 RC H5 6.00 (# 294:21
23 RC H3' 23 RC H5'2 4.50 (# 626:21
23 RC H3' 23 RC H6 3.00 (# 198:21
23 RC H4' 23 RC Hi' 6.00 (# 391:21
23 RC H4' 23 C HG 4.50 (#t 426:21 )
23 RC KS 23 RC Hi' 6.00 (ft 1284:21)
23 RC H5'1 23 RC Ri' 6.00 (ft 1221:21)
23 PC HG 23 RC K2'1 4.50 (ft 314:21)
23 RC Hi' 24 PC HG 6.00 (ft 1257:21)
23 PC H2'l 24 PC KG 3.00 (ft 136:21)
23 RC KS 24 RC KS 6.00 (ft 797:21)
23 RC KG 24 RC KS 6.00 (ft 91:21)
24 PC H5 23 RC H2'1 4.50 (ft 488:21)
24 RC H5 23 RC H3' 6.00 (#t 487:21)
24 RC KG 23 RC H3' 4.50 (# 306:21)
24 RC KG 23 RC KS 6.00 (ft 1286:21)
24 RC Ri' 24 RC KG 4.50 (ft 33:21)
24 RC H2'1 24 RC KS 6.00 (ft 245:21)
24 RC H2'1 24 RC KG 4.50 (ft 129:21)
24 PC K3' 24 RC KS 6.00 (ft 297:21)
24 RC H3' 24 RC H6 3.00 (# 201:21
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Appendix A. Modeling Details
19
19
19
20
20
20
20
20
21
21
21
21
21
22
22
22
22
22
23
23
23
23
23
24
24
24
24
24
# Glycosidic
1 GUA CHI:
2 GUA CHI:
3 URA CHI:
4 URA CHI:
5 CYT CHI:
6 ADE CHI:
7 CYT CHI:
8 CYT CHI:
9 URA CHI:
16
17
18
19
20
21
22
23
24
GUA
GUA
GUA
URA
GUA
ADE
GUA
CYT
CYT
CHI:
CHI:
CHI:
CHI:
CHI:
CHI:
CHI:
CHII:
CHI:
bond torsion restraints:
(2
(3
(4
(6
(7
(8
(9
(1
(1
(J1
(1
(2
(2
(2
(2
RG 04')-(1 RG
RG 04')-(2 RG
RU 04')-(3 RU
RU 04')-(4 RU
RC 04')-(5 RC
RA 04')-(6 RA
RC 04')-(7 RC
RC 04')-(8 RC
RU 04')-(9 RU
L6 RG 04')-(16
L7 RG 04')-(17
.8 RG 04')-(18
L9 RU 04')-(19
20 RG 04')-(20
21 RA 04')-(21
22 RG 04')-(22
23 RC 04')-(23
24 RC 04')-(24
C1')-(1 RG t
Cl')-(2 RG t
C1')-(3 RU b
C1')-(4 RU I
C1')-(5 RC I
C1')-(6 RA I
C1')-(7 RC I
C1')-(8 RC I
C1')-(9 RU I
RG Cl')-(16
RG C1')-(17
RG C1')- (18
RU Cl')-(19
RG C1')-(20
RA C1')-(21
RG Cl')-(22
RC C1')-(23
RC C1')-(24
N9) -(1
19) - (2
N1) - (3
N1) -(4
N1) -(5
N9) - (6
N1) -(7
N1) -(8
N1) -(9
A.1.3 Complex
# Intermolecular NOEs
7
7
7
7
7
7
8
8
8
8
8
9
9
9
9
9
9
9
9
9
10
10
RC
RC
RC
RC
RC
RC
RC
RC
RC
RC
RC
RU
RU
RU
RU
RU
RU
RU
RU
RU
RC
RC
H3'
H3'
H5
H5
H6
H6
H5
H5
H6
H5
H3'
H5
H3'
H5' 1
H5'2
H6
H6
H6
H2 '1
H3'
H5
H5
originating from
13 ALA
13 ALA
13 ALA
13 ALA
13 ALA
13 ALA
13 ALA
13 ALA
13 ALA
14 LYS
17 TYR
14 LYS
17 TYR
17 TYR
17 TYR
17 TYR
17 TYR
17 TYR
21 ARG
21 ARG
17 TYR
17 TYR
either
HA
MB
HA
MB
HA
MB
HA
MB
MB
HA
QE
HA
QE
QE
QE
HB2
QD
QE
HD2
HD2
QD
QE
the peptide or the RNA:
6.00 (# 25:51
6.00 (# 543:21
6.00 (# 503:21
4.50 (# 473:21
6.00 (# 28:51
6.00 (# 460:21
6.00 (# 1279:21
6.00 (# 472:21
6.00 (# 937:21
6.00 (# 495:21
6.00 (# 5:51
6.00 (# 1277:21
4.50 (# 184:21
6.00 (# 740:21
6.00 (4 748:21
6.00 (# 1278:21
6.00 (# 881:21
6.00 (4 454:21
6.00 (# 39:51
6.00 (# 1298:21
6.00 (4 875:21
6.00 (4 58:21
139
URA NU2:
URA NU3:
URA NU4:
GUA NUO:
GUA NUl:
GUA NU2:
GUA NU3:
GUA NU4:
ADE NUO:
ADE NUl:
ADE NU2:
ADE NU3:
ADE NU4:
GUA NUO:
GUA NUl:
GUA NU2:
GUA NU3:
GUA NU4:
CYT NUO:
CYT NUl:
CYT NU2:
CYT NU3:
CYT NU4:
CYT NUO:
CYT NUl:
CYT NU2:
CYT NU3:
CYT NU4:
(19
(19
(19
(20
(20
(20
(20
(20
(21
(21
(21
(21
(21
(22
(22
(22
(22
(22
(23
(23
(23
(23
(23
(24
(24
(24
(24
(24
RU
RU
RU
RG
RG
RG
RG
RG
RA
RA
RA
RA
RA
RG
RG
RG
RG
RG
RC
RC
RC
RC
RC
RC
RC
RC
RC
RC
Cl')-(19 RU
C2)-(19 RU
C3')-(19 RU
C4')-(20 RG
04')-(20 RG
C1')-(20 RG
C2')-(20 RG
C3')-(20 RG
C4')-(21 RA
04')-(21 RA
C1')-(21 RA
C2')-(21 RA
C3')-(21 RA
C4')-(22 RG
04')-(22 RG
Cl')-(22 RG
C2')-(22 RG
C3')-(22 RG
C4')-(23 RC
04')-(23 RC
C1')-(23 RC
C2')-(23 RC
C3')-(23 RC
C4')-(24 RC
04')-(24 RC
Cl')-(24 RC
C2')-(24 RC
C3')-(24 RC
C2')-(19 RU
C3')-(19 RU
C4')-(19 RU
04')-(20 RG
Cl')-(20 RG
C2')-(20 RG
C3')-(20 RG
C4')-(20 RG
04')-(21 RA
C1')-(21 RA
C2')-(21 RA
C3')-(21 RA
C4')-(21 RA
04')-(22 RG
C1')-(22 RG
C2')-(22 RG
C3')-(22 RG
C4')-(22 RG
04')-(23 RC
C1')-(23 RC
C2')-(23 RC
C3')-(23 RC
C4')-(23 RC
04')-(24 RC
C1')-(24 RC
C2')-(24 RC
C3')-(24 RC
C4')-(24 RC
C3')-(19 RU
C4')-(19 RU
04')-(19 RU
C1')-(20 RG
C2')-(20 RG
C3')-(20 RG
C4')-(20 RG
04')-(20 RG
C1')-(21 RA
C2')-(21 RA
C3')-(21 RA
C4')-(21 RA
04')- (21 RA
Cl')-(22 RG
C2')-(22 RG
C3')-(22 RG
C4')-(22 RG
04')-(22 RG
C1')-(23 RC
C2')-(23 RC
C3')- (23 RC
C4')-(23 RC
04')-(23 RC
C1')-(24 RC
C2')- (24 RC
C3')-(24 RC
C4')-(24 RC
04')-(24 RC
C4')
04')
Cl')
C2')
C3')
C4')
04')
Cl')
C2')
C3
C4')
04')
Cl')
C2')
C3')
C4')
04')
Cl')
C2')
C3')
C4')
04')
Cl')
C2')
C3'
C4')
04')
Cl')
19.8
-49.8
6.5
-15.0
-36.5
19.8
-49.8
6.5
-15.0
-36.5
19.8
-49.8
6.5
-15.0
-36.5
19.8
-49.8
6.5
-15.0
-36.5
19.8
-49.8
6.5
-15.0
-36.5
19.8
-49.8
6.5
49.8
-19.8
36.5
15.0
-6.5
49.8
-19.8
36.5
15.0
-6.5
49.8
-19.8
36.5
15.0
-6.5
49.8
-19.8
36.5
15.0
-6.5
49.8
-19.8
36.5
15.0
-6.5
49.8
-19.8
36.5
RG C4)
RG C4)
RU C2)
RU C2)
RC C2)
RA C4)
RC C2)
RC C2)
RU C2)
170 C
170. C
170. C
170.0C
170. C
170.C
170.C
170. C
170 .C
C4)
C4)
C4)
C2)
C4)
C4)
C4)
C2)
C2)
235.0
235.0
235.0
235.0
235.0
235.0
235.0
235.0
0 235.0
170.0
170.0
170.0
170.0
170.0
170.0
170.0
170.0
170.0
RG N9)-(16
RG N9)-(17
RG N9)-(18
RU N1)- (19
RG N9) - (20
RA N9)-(21
RG N9)-(22
RC N1)-(23
RC N1)-(24
RG
RG
RG
RU
RG
RA
RG
RC
RC
235.0
235.0
235.0
235.0
235.0
235.0
235.0
235.0
235.0
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10
10
11
11
11
11
11
12
12
12
12
12
12
12
12
12
12
12
12
12
12
13
13
13
13
13
14
14
14
16
RC
RC
RU
RU
RU
RU
RU
RA
RA
RA
RA
RA
RA
RA
RA
RA
RA
RA
RA
RA
RA
ALA
RA
RA
RA
RA
LYS
LYS
LYS
ARG
H6
H5
H5
H5
H5
HS
H5
H3'
H4'
H4'
H4'
H4'
H41'
H5'l1
H5'l1
H5'l
H5'l1
H5'2
H5'2
H5'2
H5'2
MB
H4'
H4'
H5'l1
H5'l1
H
H
QE
QH
17
21
17
21
21
21
21
25
25
25
25
25
25
25
25
25
25
25
25
25
25
7
18
18
18
18
8
8
8
7
A.2 Modeling Scripts
Table A.2 lists the details of the CNSsolve energy minimization runs.
The energy minimization protocol used in AMBER was:
simulated annealing protocol
&cntrl
imin=0,
nstlim=12000, pencut=0.001, nmropt=1,
tempO=0.5, tautp=0.1, ntpr=100, ntt=l,
ipnlty=l, ig=2000301, TEMPI=200.0, cut=12.0,
igb=1, ntb=O, ntc=l, vlimit=10.0, scee=1.2,
&end
type='TEMPO',
type='TEMPO',
type='TEMPO',
type='TEMPO',
type='TAUTP',
type= 'TAUTP',
type='TAUTP',
type='TAUTP',
type= 'TAUTP',
type= 'TAUTP',
istepl=0,
istep1=3001,
istepl=9001,
istep1=10001,
istepl=0,
istepl=1001,
istepl=3001,
istepl=7001,
istepl=9001,
istepl=11001,
istep2=3000,
istep2=9000,
istep2=10000,
istep2=12000,
istep2=1000,
istep2=3000,
istep2=7000,
istep2=9000,
istep2=11000,
istep2=12000,
valuel=1000.0,
valuel=1000.0,
valuel=200.0,
valuel=0.0,
valuel=0.4, v
valuel=0.2, v
valuel=2.0, v
valuel=1.O, v
valuel=0.5, v
valuel=0.05, v
value2=1000.0,
value2=200.0,
value2=0.0,
value2=0.0,
alue2=0.4,
alue2=0.2,
alue2=2 . 0,
alue2=1.0,
alue2=0.5,
alue2=0.05,
&end
&end
&end
&end
&end
&end
&wt type='REST', istepl=O,
&wt type='END'
LISTOUT=POUT
DISANG=phiC. rst
istep2=12000, valuel=1.0, value2=1.0, &end
&end
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TYR
ARG
TYR
ARG
ARG
ARG
ARG
ILE
ILE
ILE
ILE
ILE
ILE
ILE
ILE
ILE
ILE
ILE
ILE
ILE
ILE
RC
LYS
LYS
LYS
LYS
RC
RC
RC
RC
QE
HD2
QE
HD2
HD3
HG2
QH
MD
HB
HG12
HG1 3
MD
MG2
HG12
HG13
MD
MG2
HG12
HG13
MD
MG2
H2 '1
HG2
QE
HG2
QE
H42
HS
H41
H5'l
6.00
6.00
6.00
6.00
6.00
6.00
6.00
6.00
6.00
6.00
6.00
4.50
6.00
6.00
6.00
6.00
6.00
6.00
6.00
6.00
6.00
6.00
6.00
6.00
6.00
6.00
6.00
6.00
6.00
6.00
(#
(#*
(#*
(#*
(#*
(#
(#*
(#
(#*
(#*
(#
(#*
(#*
(#*
(#*
(#*
(#*
(#*
(#*
(#*
(#*
(#*
(#*
(#*
(#*
(#*
(#*
(#*
(#*
(#*
880 :21
1264 :21
8 :51
504 :21
1274 :21
1275:21
149:11
542 :21
845:21
535:21
536:21
538:21
537 :21
1293 :21
1294:21
547:21
546:21
1296:21
1295:21
548:21
849:21
7 : 101
847 :21
846 :21
1292:21
1289:21
162 : 81
165 : 81
701:61
694:61
&wt
&wt
&wt
&wt
&wt
&wt
&wt
&wt
&wt
&wt
&end
&end
&end
&end
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Table A.2 CNS dynamic annealing protocol parameters.
These are the input values for the anneal.inp module file.
Type of MD
Hot Phase
Start (*K)
# of Steps
Scale vdW (repel)
Scale NOE energy
Scale dihedral energy
Timestep (ps)
Cool Phase
Start (*K)
# of steps
Scale vdW (repel)
Scale NOE
Scale dihedral
Timestep
Anneal temp. step
Final Minimization
Scale NOE
Scale dihedral
Number of steps
Number of cycles
Number of Structures
N peptide boxB RNA Docking
& __ ____
Torsion
50000
1000
0.1
150
100
0.015
50000
1000
1.0
150
200
0.015
250
75
400
200
10
100
Torsion
20000
4000
0.1
150
5
0.015
20000
1000
1.0
150
200
0.015
250
75
400
200
10
100
Cartesian
1000
4000
0.1-
150
100
0.015
600
2000
4.0
150
150
0.015
25
2nd Coolinga
200
3000
1.0-+4.0
150
200
0.005
25
75
400
200
10
400
a - There was a second cooling phase for the docking protocol, only.
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Appendix B. Productivity Tools
B.1 Introduction
There are a number of steps involved in a structure determination by NMR. An
outline of this process was diagrammed in figure 5.2.1. Different computer programs
are used throughout this process. Some of the software tools that were developed for
this project are presented here. These tools addressed a wide range of needs, from a
desire to have a simpler interface to some other program, to the need for a new tool
within NMRView to make spectral analysis faster or easier, or to meet specific
requirements for data formats, both input and output. The "manual" page section for a
number of these programs are listed here, with intervening code replaced with "#.#. .".
A full set of these tools, and their code listings are available at:
http://williamson.scripps.edu/Tools .
B.2 Data Acquisition
procBruker
#! /usr/local/bin/perl
# procBruker
# . . .
# Parse command line options
if ($opt-h == 1 || $opthelp == 1 | $needHelp == 1)
print "\nUsage: procBruker [-h] [-d 213] [-nord h~c~n] [-o outfidname] [-sr #] [-
f outfiddir] [-x1 start number] [-xn end-number] [-im \"macro\"] [-type amxldmx] [-
noswap] [-xmode xMODE] [-zmode zMODE] [-aq2D aq2D] [-1[11213] label]\n";
print<< 'END';
Options: (Default in parenthesis.)
-h I -help This message.
-d 2|3 2- or 3-dimensional data. (3)
-nord hicin The dimensional order. hhc, hcn, hh, etc. (hcn)
-o outfidname Easenaie of output fid files. (data)
-sf # Value of SF, CAR = [(SF04-SF4)/SF4] *0A6
Without an SF value, CAR =04 / SF04
-jl # Carrier jumped jl Hz for the X (acquisition or t3) dimension.
--j2 4#are updj zfo h t)dmnin
--j3 4#are updj zfrteZdmnin
-f outfiddir Lcto fotu fi ietr o iexz .
-in "macro" Tefl aht h ar n n pin. (oe
-type [amnxldmx]Whttpofmcieteeprmnrao. (dx
-noswap Trsofsapn. (rxnsane oseiyfrax
-xmnode xMODE Tyial "DDor"ope. (Q)
-yinde yODE Typ iallysiomlorer "ch-ntihoet. (Cmle)
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-zmode zMODE
-aq2D value
-11
-12
-13
Typically "Complex" or "Real". (Complex)
Typically "States" or "States-TPPI". (States-TPPI)
Label for first (X) dimension. (tn value)
Label for second (Y) dimension. (dn value)
Label for third (Z) dimension. (dn2 value)
Description: The procBruker script will look for the Bruker parameter files
and extract out useful parameters, creating a file called "params.txt".
It will also generate an "fid.com" file for doing the first bruk2pipe
conversion. It assumes your current working directory is where the data
(numbered) directories are. To save space, it will automatically compress
all the "ser" files. With correct values for SF and J[1-3] it will
correctly reference the data.
Note: You may put multiple "-m" macros on one command line. They will
be processed in the order you supplied them.
Example:
procBruker -d 3 -nord hhc -o cnoesy -f /work2/cdcilley/cnoesy_990102 
-type amx -sf
600.3699564 -jl 2822 -j2 2000 -xmode DQD -zmode Complex -aq2D States-TPPI -m
"/usr/local/nmrpipe/Macros/bruk ranceZPS.M -noRd -noWr -var PO 0.0 P1 0.0"
v2.7 3/13/99
END
}
Christopher Cilley (cdcilley@scripps.edu)
exit (0)
B.3 Data Manipulation
crosswin
# CROSSWIN.TCL
#
# Format: crosswin [simil]
4 Desc: Creates a window that dynamically lists the x, y and z values
# for the 2 crosshairs. It also calculates the differences
4 between them, highlighting in red when the labels don't match
# It tries to line up 2D vs. 3D intelligently to match labels.
4 There are three font size choices, s)mall, m)edium and 1)arge.
# Medium is the default.
pdbXlate
4! /usr/local/bin/perl
4 pdbXlate
4
4 Read in a pdb, output in indicated format.
use Getopt::Long;
$version = "pdbXlate vO.2 3/10/2001 Christopher Cilley (cdcilley\@scripps.edu)";
if (scalar(@ARGV) == 0) {
print "\nUsage: pdbXlate [-amb -cns -ins -leap] [-rnaswap] <pdbFile>\n";
print<<'END';
Options:
-amb
-cns
-ins
-leap
-rnaswap
Amber
CNS
Insight
Leap
Swap names of nucleic acids as RNA.
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RA <-> ADE
Description:
Leaves all non-"ATOM" lines alone (REMARK, TER, END, CONNECT, etc.)
Notes:
CNS has OT1 which is converted to 0.
CNS has HST which is converted to P.
Example:
pdbXlate -ins this.pdb >! new.pdb
END
printf "%s\n\n", $version;
exit(0);
B.4 Structure Calculation
starTOupi
#! /usr/local/bin/perl
# starTOupl
# ...
$version = "starTOupl v1.9 2/9/01 Christopher Cilley (cdcilley\@scripps.edu)";
use Getopt::Long;
# Parse command line options
if (scalar(@ARGV) == 0) {
print "\nUsage: starTOupl [-s
[-i] [-a] [-ul [-mal-mg|-ml] [-nx
<peaklist>\n";
print<<'END';
Options:
-s #
-m f#
-w #
-us f#
-um 4
-uw f#
-ls #
-lm ft
-lw #
# -m # -w #] [-us # -um # -uw #] [-s f# -lm # -lw #]
#] [-limit #-#] [-inter #] -r <STAR filename>
Minimum value for Strong volumes.
Minimum values
Minimum values
Upper distance
Upper distance
Upper distance
Lower distance
Lower distance
Lower distance
for Medium volumes.
for Weak volumes.
boundaries for Strong volumes.
boundaries for Medium volumes.
boundaries for Weak volumes.
boundaries for Strong volumes.
boundaries for Medium volumes.
boundaries for Weak volumes.
-i Use the Intensity to determine distance.
-a Report only ambiguous restraints.
-u Report only unambiguous restraints.
-malmglml For mirror'ed peaks, take the Average,
Greater or Lesser value for the intensity/
volume of the two peaks.
-nx # The peaklist ID#, or nxpk value in RST file.
-limit #-# Limit the restraints to fall withing the
specified range of residue numbers. Useful
for extracting intra-molecular restraints
from a multi-molecular STAR file.
-inter # Only generates restraints where FROM is <=#
and TO is > # (or vice versa).
-r <filename> The input STAR file.
(0)
(0)
(0)
(4.0)
(5.0)
(6.0)
(1.8)
(1.8)
(1.8)
volume)
(both)
(both)
(-ma)
(0)
(all)
Description:
Generates an UPL restraint file using the STAR file from nmrView (v4.1) by
extracting the <peaklist>'s information. Two files are generated,
<peaklist>.upl, with the restraints, and <peaklist>.map with the
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ambiguous mappings. The <peaklist>.upl files contains information
about command line flags, peaks used to determined bins, etc.
starTOupl is able to read and execute commands containted in the
"Comments" section of each peak. These commands need to be enclosed
in parenthesis (). Valid command formats are:
(div #) : Divides the volume/intensity by #.
(mul #) : Multiplies the volume/intensity by #.
(add #) : Adds # to the volume/intensity.
(sub #) : Subtracts # from the volume/intensity.
(strong #) : Use this peaks volume/intensity multiplied
by # to determine the Strong cutoff value.
(medium #) : Use this peaks volume/intensity multiplied
by # to determine the Medium cutoff value.
(weak #) : Use this peaks volume/intensity multiplied
by # to determine the Weak cutoff value.
(mirror #) : Set the volume/intesity of this peak to the
average of this peak and peak #.
(set strong)
(set medium)
(set weak) : Force this peak into a particular cutoff bin.
(dist #) : Explicitly set the upper bound of the distance restraint.
(skip) : Do not use this peak for either calculating
bin cutoffs, or report it in the restraint list.
Commands are executed on all peaks in the following order:
div - mul - add - sub - mirror - strong - medium - weak - set - dist
You may have multiple commands for a given peak.
Multiple peaks marked with cutoff commands will have their volumes
averaged and that average will be used as the cutoff bin value.
Command line values have precedence over "comment" calculated values.
Peaks with a "?" in the assignments in any of the dimensions will be
ignored for the purposes of calculating cutoffs and reporting the
restraint. This is the same as putting "(skip)" in the comment
section.
Example: starTOupl nnoesy_981221 -i -us 2.8 -um 4.8 -r ../Data/peptide.str
END
printf "%s\n\n", $version;
exit(0);}
checkUPL
#! /usr/local/bin/perl
# checkUPL
# ...
$version = "checkUPL vl.2 10/19/99 Christopher Cilley (cdcilley\@scripps.edu)";
# Parse command line options
if (scalar(@ARGV) ==0){
print<<'END';
Usage: checkUPL -p cpcdb_file> <upl files>
Options:
-p Input pdib file.
Description:
Check UPL files for duplicate and reciprocal restraints.
The input pdib file should have atom naming that matches
the UPL files, with pseudo-atom names being extracted
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from the UPL file on the fly.
Example:
checkUPL -p peptide.xyz nnoesy.upl Cnoesy.upl wtgnoe.upl
or
checkUPL -p phiN.pdb *.upl
END
printf "%s\n\n", $version;
exit(0);}
B.5 Analysis of Calculated Structures
procNOEcns
#! /usr/local/bin/perl
# procNOEcns
# .
$version = "procNOEcns vl.9 2/24/01 Christopher Cilley (cdcilley\@scripps.edu)";
# Parse command line options
if (scalar(@ARGV) == 0) {
print "\nUsage: procNOEcns -pdb <pdb_basename> [-thresh #] [-pseudo] [-insight #]
[-anyonel-r6sum] [-all | -allnoviol] [-nograph] [-report #] [-only <PDB file>] <.tbl
files>\n";
print<<'END';
Options:
-pdb <basename>
-pseudo
-insight #
-anyone
-r6sum
-all
-allnoviol
-nograph
-report #
-thresh #
-only <PDBfile>
The basename of the numbered pdb files.
"phiN_001.pdb" would be "phiN_".
Report non-stereo-specifically assigned atoms
indivudually. HB* would be reported as HB2 and HB3.
Otherwise, the HB* distance is calculated using R-6.
Create an insight source file for the # best
structures, by overall energy. The default is 20.
Use the shortest distance from a set of pseudo atoms or
ambiguous restraints.
Use the sum or RA-6 distances.
Default is R^-6 averaging.
Examine all of the NOE data. List average/stdev
for distances within the NOE distance as well as
violation information.
Just show the distance information for all structures
for all NOE data.
Normally the violations for all PDB files are graphically
diagrammed in the output. This turns that off.
Generate report file. i is the cut-off # of intermolecular
residue numbers.
The threshold value for the -report of restraint
violations. The default is 0.1.
Examine the NOE data for a single PDB file.
Description:
procNOEcns reads in all the restraint files (.tbl) used by cns. It
then goes through each of the pdb files and determines the NOE distance
violations. For ambiguous restraints, it reports the violations for all the
members, including those that do not show any violations.
The -anyone and -pseudo flags are sort of orthogonal. The -all and -allnoviol
flags are mutually exclusive.
Output:
<pdb-basename>senergy
<pdb-basename>noeviol
The summary of the energy information, sorted by noe.
All of the noeviolation information.
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<pdbbasename>insight.log An InsightII format source file.
Example:
procNOEcns -pdb anneal-phiN_ -thresh 0.2 -nxpk "ll:nnoesy 981221" *.tbl >
phiN.noeviol
END
printf "%s\n\n", $version;
exit (0);
reporttorsions
#! /usr/local/bin/perl
# reporttorsions
# . . .
$version = "report-torsions v1.0 1/15/01 Christopher Cilley (cdcilley\@scripps.edu)";
use Getopt::Long;
# Parse command line options
if (scalar(@ARGV) == 0)
print<<'END';
Usage: report_torsions [-1] [-n] [-s] <pdbfile(s)>
Options:
-l Only list out the atoms used for the calculations.
-n Also list the values for nuO, nul, nu2, nu3 and nu4
in nucleic acids.
-s Statistics output. Generate actual values for phi/psi.
Description:
The program calculates these torsions
Protein segments - phi, psi, chil, chi2, chi3 and chi4
Nucleic acid segments - PPA, chi, alpha, beta, gamma,
delta, epsilon, and zeta
If there is more than one input pdb (i.e. a family of structures),
then reporttorsions generates the averages and stdev for these
angles. There can be multiple MODELs in the single pdb as well.
Example:
report-torsions phiR.pdb
or
report-torsions complex.???.pdb
Note:
The statistical output for nucleic acid residues that results from
reading in multiple PDB files is too wide for standard text printing.
Use the enscript command to either print in landscape mode (-r) or
use a smaller font (-fCourier7) . For example:
report-torsions complex.???.pdb I enscript -r -o complex tors.ps
or
report_ torsions complex.???.pdb | enscript -fCourier7 -o complex tors.ps
END
printf "%s\n\n", $version;
exit (0);}
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